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ABSTRACT: 
The uranyl ion, [UVIO2]
2+, possesses rigorously trans, strongly covalent, and chemically robust U-
oxo groups. However, through the use of anaerobic reaction techniques, both one and two-electron 
reductive functionalization of the uranyl oxo groups have been discovered and developed. Prior to 
2010, this unusual reactivity centered around the reductive silylation of the uranyl ion which entailed 
conversion of the oxo ligands into siloxy ligands, and reductive metalation of the uranyl oxo with 
Group 1 and f-block metals. This review surveys the large number of new examples of reductive 
functionalization of the uranyl ion that have been reported since 2010, including reductive borylation 
and alumination, metalation with d- or f-block metals, and new examples of reductive silylation. Other 
examples of oxo-group functionalization of [UVIO2]
2+ that do not involve reduction, mainly with 
Group 1 cations, are also covered, along with new advances in the photochemistry of the uranyl(VI) 
ion that involve the transient formation of formally uranyl(V) [UVO2]
+ ion. 
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1. INTRODUCTION 
The uranyl(VI) ion, [UVIO2]
2+, is the dominant form of uranium in the environment. It is a 
linear cation which exhibits mutually trans and strongly covalent oxo groups, denoted here as U–Oyl. 
These U–Oyl bonds are formally triple bonds, arising from one σ- and two π-bonds between 2p orbitals 
on the oxo-groups and hybrid orbitals (5f and 6d) on uranium.1 The result is a gas-phase bond energy 
of 604 kJ mol-1 for the UVIO2
2+ ion, making it thermodynamically stable and generally inert to 
chemical functionalization in the laboratory. However, the one-electron reduction of [UVIO2]
2+ to 
[UVO2]
+ is readily achieved by minerals and microbes in the environment under anaerobic 
conditions;2,3 under these conditions [UVO2]
+ disproportionates into [UVIO2]
2+ and [UIVO2], of which 
the latter is insoluble in water.4 In recent years, anaerobic reaction conditions have been deployed and 
proven effective for the isolation of both [UVO2]
+ (uranyl(V)) and [UIVO2] (U(IV) dioxo) compounds 
through reductive functionalization processes (Scheme I). There is significant interest in studying 
uranyl(V) complexes due to the more Lewis-basic oxo groups showing an increased propensity to 
bridge to other metals. These interactions are often referred to as cation-cation interactions, CCIs, but 
the use of this specific term is not warrented as metal oxo-group basicity is common in d-block 
chemistry. This phenomenon is very rare in uranyl(VI) chemistry, but relatively common in heavier 
actinyl (i.e. neptunium and plutonium) chemistry. Through the formation of oxo-bridged complexes, 
3 
 
UV has the potential to disrupt nuclear waste separations such as in the PUREX process;5 
consequently, the study of oxo-functionalised UV complexes is spurred by understanding these 
interactions. With an estimated two million tonnes of depleted uranium waste globally,6 maximizing 
the efficiency of waste remediation processes is of paramount importance to the nuclear industry. 
While actinyl compounds require specialized containment procedures to handle, their chemistry can 
be modelled through the study of uranyl(V) compounds in a standard laboratory (and therefore more 
convenient and less costly) environment. Additionally, understanding the processes by which various 
elements reductively functionalize water-soluble uranyl ions to insoluble uranium(IV) oxides is also 
relevant to the mineral and microbial-initiated reductions that occur in the environment , for example 
in iron-containing strata such as goethite7 or with geobacter microbes.8 The chemistry of such a 
traditionally inert oxo group is also of great academic interest, since its lack of reactivity contrasts so 
strongly with the lighter Group 6 congeners such as the chromyl ion. 
The uranyl(V) ion is also a key intermediate in photochemical processes involving the 
uranyl(VI) ion. Solutions containing [UVIO2]
2+ are photochemically active when exposed to 
ultraviolet (UV) and near-UV light sources (ca. 420 nm), generating [*UO2]
2+, a long-lived (≤ µs) 
and highly oxidising (ca. +2.6 V, comparable to F2) excited state of uranyl.
9,10 Subsequent ligand-to-
metal charge transfer (LMCT) that arises from U(5f)O(2p) transitions generates the [UVO2]+ 5f1 
intermediate which contains an extremely reactive oxyl radical, O• (Scheme 1b). This intermediate 
may generally be quenched by H-atom abstraction (HAA) if the quencher is aliphatic (to give a 
functionalized [O=UV-OH]2+ motif),11-13 or by electron transfer if the quencher is unsaturated.14-19 
The highly oxidizing nature of photoactivated UVIO2
2+ has previously been exploited in the 
degradation of volatile organic compounds, VOCs, such as methanol,20 and many other applications, 
including in metal ion sensing and biochemistry, have been developed since the last reviews appeared 
in 2010 and 2013.9,10,21,22 
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Scheme 1. (a) Thermal and (b) photochemical reduction and functionalization of the uranyl ion, 
[UVIO2]
2+. 
 
While several generalized reviews of the chemistry of the uranyl ion have been published in 
recent years, the last review dedicated to oxo-group reactivity of the uranyl cation was published in 
2010.10,22-24 This current review therefore focuses on the significant advances that have occurred in 
reductive functionalization of the uranyl ion since 2010, including reductive borylation and 
alumination, metalation with d-block and f-block metals, and substitution of the oxo-functionalized 
groups coordinated to uranyl(V) complexes by Group 1 and d-block metals, stannyl, silyl and alkyl 
groups. Emphasis is placed on the synthesis and reactivity of these compounds. Discussions of the 
more complex physical properties of these compounds such as magnetism and gas-phase uranyl-oxo 
reactivity25,26 are beyond the scope of this review. There have also been numerous reports of the 
coordination chemistry of newly designed ligands with the uranyl ion, and unless those complexes 
possess activated/functionalized U–Oyl groups, they are beyond the scope of this review. We also 
note recent developments in the computational chemistry of the actinides, which possess complex 
electronic structures and are difficult to model effectively; interested readers are referred to recent 
contributions from Dolg27 and Kaltsoyannis,28 and we will not cover these issues further in this 
review. For completeness we include a section on functionalized uranyl(VI) complexes for 
comparison, excluding hydrogen-bonded and halogen-bonded uranyl complexes. We use the term 
“thermal” to represent any non-photochemical means of generating a uranyl(V) or U(IV) dioxo 
species. This review is therefore divided into sections that cover: oxo-functionalization reactions of 
uranyl(VI) complexes that occur without reduction; one-electron uranyl(VI)uranyl(V) reduction 
reactions and further reactions of these that do not involve uranium redox; two-electron reduction and 
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sequential uranyl(VI)U(IV) dioxo processes; a survey of the solid-state structures and OUO 
vibrational stretching frequencies of [UVIO2]
2+, [UVO2]
+ and [UIVO2] complexes reported since 2010; 
and photochemical reactions of uranyl(VI) complexes that involve uranyl(V) intermediates. 
 
2. [UVIO2]2+ OXO FUNCTIONALIZATION WITHOUT REDUCTION 
The poor Lewis basicity of the uranyl(VI) oxo groups means that their functionalization is 
considerably rarer than that of the UV or UIV analogues. Current examples are limited to examples of 
Lewis adduct formation with the highly electropositive cations Li+ or K+ such as UVI–Oyl–Li+ adduct 
formation in [Li(py)2][U
VIO2{N(SiMe3)2}3] (1) from 1 equiv. of [U
VIO2{N(SiMe3)2}2(py)2] (2-py) 
and LiN(SiMe3)2;
29 [Li(dme)1.5]2[U
VIO2(CH2SiMe3)4] (3) from [U
VIO2Cl2(THF)2] (4-THF) and 4 
equiv. of Li(CH2SiMe3) in the synthesis of a rare U
VIO2
2+-alkyl “-ate” complex;30 
[Li(THF)]2[U
VIO2{N(SiMe3)2}2(tmtaa)] (5; tmtaa = dibenzotetramethyl-tetraaz[14]annulene) and 
[Li(THF)3][Li(THF)2][(U
VIO2Cl2)2(tmtaa)] (6) from Li2(tmtaa) and [U
VIO2{N(SiMe3)2}2(THF)2] (2-
THF),31 and Li2(tmtaa) and 2 equiv. of 4-THF,
32 respectively, to target the isolation of the as-yet 
unseen “cis-uranyl”; [Li(THF)(TMEDA)][UVIO2(NCtBu2)3] (7) and 
[Li(THF)(OEt2)]2[U
VIO2(NC
tBuPh)4] (8) from 4-THF and 6 equiv. of LiNC
tBu2 or 8 equiv. of 
LiNCtBuPh in THF, respectively, as the first examples of uranyl ketimide complexes (Figure 1).33 
Further, Li+-functionalization has also been seen in [Li(THF)3][U
VIO2{N(HSiMe3)(
tBu)}3] (9);
34 in 
the uranyl(VI) Pacman complex, [UVIO2(S)(HLiL
Me)] (S = THF (10-THF), py (10-py)), formed by 
treating [UVIO2(S)(H2L
Me)] (S = THF (11-THF), py (11-py)) with 1 equiv. of LiR (R = H, NH2, N
iPr2, 
N(SiMe3)2, CPh3, C5H5; H4L
Me = a Pacman-shaped macrocyclic Schiff-base ligand with methyl 
substituents on the meso-carbon atoms and a dimethylphenylene hinge);35  and in 
[Li(MeIm)][UVIO2(Ar2nacnac)(κ1-C-C4H5N2)2] (12; MeIm = 1-methylimidazole, Ar2nacnac = 
ArNC(Me)CHC(Me)NAr, Ar = 2,6-iPr2C6H3), which was synthesized by treating 0.5 equiv. of 
[UVIO2Cl(Ar2nacnac)]2 (13) with 2 equiv. of 2-lithio-1-methylimidazole in toluene/THF. Compound 
12 features imidazole coordination to the UVI center through the central carbon atoms rather than the 
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flanking nitrogen atoms (Figure 1); the donor atom can be switched from the imidazole carbon to the 
nitrogen atoms by treatment of 12 with MCl2 (M = Fe, Co), affording 
[MCl(MeIm)][UVIO2(Ar2nacnac)(κ1-N-C4H5N2)2] (M = Fe (14), Co (15)).36  
 
Figure 1. Examples of Li-functionalized [UVIO2]
2+ complexes.29-36  
Adducts between K+ and uranyl(VI), i.e. UVI-Oyl--K
+ have also been reported in an effort to 
further manipulate the bonding and reactivity of the uranyl dication. Starting from 4-THF, 6 equiv. 
of the fluorinated diarylamide KNPhFpy (PhF = C6F5) or 8 equiv. of [KNAr
FPh(THF)0.5] (Ar
F = C6H3-
3,5-(CF3)2) reacts with 4 in THF to produce [{K(THF)3}{U
VIO2(NPh
Fpy)3}]n (16) and [K(η6-
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C6H5CH3)2][U
VIO2(NAr
FPh)4] (17), respectively (Figure 2). These complexes possess non-covalent 
π-K+ and F-K+ interactions in their solid-state structures, in addition to UVI-Oyl--K+ interactions.37 
 
Figure 2. Examples of K+-functionalized [UVIO2]
2+ complexes; ArF = C6H3-3,5-(CF3)2.
37
 
Adduct formation between K+ and uranyl(VI) has also been observed in a bis(uranyl(VI)) 
Pacman complex, [K(py)3]2[K(py)]2[(U
VIO2)2(µ-O2)(L
Me)]2 (18), which is synthesized via oxidation 
of the bis(uranyl(V)) Pacman complex, {[K(py)3][K(py)][(U
VO2)2(L
Me)]}2 (19-py; see Scheme 48 in 
Section 6 for the synthesis of 19-py), using dry O2 in pyridine; both uranyl(V) ions have been oxidized 
to uranyl(VI) and a peroxide ligand bridges the two UVI centers (Scheme 2). Alternatively, 19-py 
reacts with pyridine-N-oxide to form [K(py)3]2[K(py)]2[(U
VIO2)2(µ-O)(L
Me)]2 (20), in which an oxo 
ligand bridges the two UVI centers (Scheme 2).38 
Scheme 2. Oxidation of [K(py)3]2[K(py)]2[(UVO2)2(LMe)]2 (19-py) to [K(py)3]2[K(py)]2[(UVIO2)2(µ-
O2)(L
Me)]2 (18) and [K(py)3]2[K(py)]2[(U
VIO2)2(µ-O)(L
Me)]2 (20) using dry O2 and C5H5NO, 
respectively. The Pacman macrocycle, H4L
Me, and an abbreviated depiction of the bis(uranyl(V)) 
Pacman complex are provided at the top of the Scheme.38  
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Adduct formation between K+ and uranyl(VI) has also been observed in 
[{UVIO2(OH)K(C6H6)(H2L
Me)}2] (21), which is formed by treating [U
VIO2(THF)(H2L
Me)] (11-THF) 
with KH in THF (Scheme 3). Complex 21 likely forms as a result of KOH impurities in the KH, or 
decomposition of [UVIO2(THF)(K2L
Me)] (22) by reaction with adventitious H2O. Compound 21 may 
also be formed directly by treating 11-THF with dry KOH in THF (Scheme 3). Complex 21 is a 
uranyl(VI)/uranyl(VI) dimer formed via bridging K+···[UVIO2]
2+ interactions involving the 
exogeneous oxo ligand, referred to as Oexo. Dissolving 21 into a mixture of THF and benzene followed 
by crystallization results in the formation of [UVO2(OH)K(THF)2(H2L
Me)] (23; Scheme 3). In this 
case, the K+ cation is coordinated to the endogenous oxo ligand of the uranyl(VI) ion, referred to as 
Oendo. Furthermore, coordination of K
+ to THF in 23 results in cleavage of the uranyl(VI)/uranyl(VI) 
dimer, yielding a monomeric uranyl(VI) complex. The U–O bond lengths in 21 are nearly equal 
within s.u.s (1.796(2), 1.803(2) Å), whereas one of the U–O bond lengths in 23 is elongated relative 
to the other (1.788(6), 1.821(6) Å). In both cases, the elongated U–oxo bond corresponds to the oxo 
ligand coordinated to the K+ cation. Furthermore, complexes 21 and 23 give rise to asymmetric OUO 
stretching frequencies of 894 and 895 cm–1,39 respectively, which are at lower frequency relative to 
the unactivated uranyl(VI) analogue, 11-THF (908 cm–1),40 indicating a decrease of electron density 
at the uranyl ion in these complexes. 
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Scheme 3. Synthesis of [{UVIO2(OH)K(C6H6)(H2L
Me)}2] (21) either by treating 
[UVIO2(THF)(H2L
Me)] (11-THF) with KH in THF, or with dry KOH in THF. 
[UVO2(OH)K(THF)2(H2L
Me)] (23) is formed by dissolving 21 in THF/benzene. A depiction of the 
uranyl(VI) Pacman complex 11 is given on the left of the Scheme, in which Oexo and Oendo have been 
labelled (S = coordinating solvent).39  
 
 Similarly to the tris- and tetrakis-ketimide complexes [Li(THF)(TMEDA)][UVIO2(NC
tBu2)3] 
(7) and [Li(THF)(OEt2)]2[U
VIO2(NC
tBuPh)4] (8; see Figure 1),
33 significant elongation of the U–O 
bond lengths is often observed on moving from neutral to ‘ate’ UVI complexes. For example, the UVI 
K+···[OUVIO]2+ - containing ‘ate’ complex K2[K(OEt2)2]2[UVIO2(dippAP)2]2 (24; dippAP = 4,6-di-tert-
butyl-2-{(2,6-diisopropylphenyl)amido}phenolate) (prepared from [UVIO2(
dippISQ)2(THF)] (25; 
dippISQ = 4,6-di-tert-butyl-2-{(2,6-diisopropylphenyl)imino}semiquinone) by reduction with 2 equiv. 
of KC8 (Scheme 4)) has U–O bond lengths of 1.824(3) and 1.834(3) Å. These are significantly longer 
than in the neutral UVI precursor 25 (1.762(4) and 1.786(3) Å), and likely arises from increased π-
donation to the uranium center, as well as the electrostatic K+···[OUVIO]2+ adduct formation.33,41 The 
role of increased ligand donor ability in U–O bond length elongation was highlighted by removal of 
the oxo-coordinated K+ cations from 24 using 2 equiv. of 18-crown-6 to make [K(THF)2(18-c-
6)]2[U
VIO2(
dippAP)2(THF)] (26). The U–O bond lengths (1.812(2) and 1.814(2) Å) of the 
unfunctionalized uranyl(VI) unit in 26 are shorter than in the K-coordinated 24 but still longer than 
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in the neutral 25,41 comparing well with those in the tris- and tetrakis-ketimide complexes 7 and 8, 
respectively.33 
Compound 25 also reacts with either 4 equiv. of B-chlorocatecholborane (Cl-Bcat) in THF to 
afford [UIVCl4(
dippIQ)(THF)2] (27; 
dippIQ = 4,6-di-tert-butyl-2-{(2,6-
diisopropylphenyl)imino}quinone) and 2 equiv. of O(Bcat)2, or with 4 equiv. of pivaloyl chloride 
(ClCO(tBu)) in benzene to yield [UIVCl4(
dippIQ)2] (28) and 2 equiv. of O(CO(
tBu))2.
41  
Scheme 4. Synthesis of K2[K(OEt2)2]2[U
VIO2(
dippAP)2]2 (24; 
dippAP = 4,6-di-tert-butyl-2-{(2,6-
diisopropylphenyl)amido}phenolate) from [UVIO2(
dippISQ)2(THF)] (25; 
dippISQ = 4,6-di-tert-butyl-2-
{(2,6-diisopropylphenyl)imino}semiquinone) and 2 equiv. of KC8 (dipp = 2,6-di-iso-
propylphenyl).41 
   
The contact- or separated-ion pairs, [M][UVIO2{N(SiMe3)2}3] (M = K (29), Rb (30), Cs (31)), 
[M(THF)x][U
VIO2{N(SiMe3)2}3] (M = Li, x = 2 (32) or 4 (33); M = Na, x = 2 (34) or 6 (35); M = K, 
x = 6 (36)), [M(2,2,2-crypt)][UVIO2{N(SiMe3)2}3] (M = Li (37), Na (38), K (39), Rb (40), Cs (41)) 
and [M(L)2][U
VIO2{N(SiMe3)2}3] (M = Li, L = 12-c-4 (42); M = Na, L = 15-c-5 (43); M = K, L = 
15-c-5 (44); M = Rb, L = 15-c-5 (45); M = Cs, L = 15-c-5 (46), -c- = -crown-), have also recently 
been reported, formed by the interaction of Group 1 cations with the uranyl bis(silyl)amide anion, 
[UVIO2{N(SiMe3)2}3]
–.34,42,43 It was stated that the oxophilicity of Li+ versus the heavier Group 1 
congeners is the key driver in decreasing UVI–Oyl bond lengths descending the series. However, it 
should be noted that while the UVI–Oyl bond length for the Li+ functionalized compound is 
significantly longer than the remainder in the series (1.88(1) Å), these differences are statistically 
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insignificant for the remainder of the Group 1 cations as they range from 1.810(5) Å for Na+ to 
1.804(3) Å and 1.80(3) Å for K+ and Rb+, respectively.34,42,43 
The only examples of non-group 1 functionalized [UVIO2]
2+ derive from coordination of PbII 
in the bottom N4-donor compartment of the mono(uranyl) “Pacman” complex, 11-THF or 11-py. 
This produces [UVIO(OPb)(THF)(LMe)] (47-THF), [UVIO{OPb(py)}(py)(LMe)] (47-py) or 
[UVIO{OPb(py)}(Opy)(LMe)] (48; Scheme 5) in which the UVI–O bond lengths range from 1.759(7)-
1.853(8) Å. These bond distances are similar to other UVI–Oyl functionalized complexes, with the 
exception being the longer, 1.853(8) Å bond for 48, which is consistent with its IR spectrum (ν[OUO 
asym.] = 893 cm–1). No oxo-coordination to Pb2+ was reported for the larger anthracenyl-hinged 
macrocycle, H4L
A (see Scheme 45 in Section 5 for a depiction of the H4L
A ligand).44 
Scheme 5. Synthesis of complexes 47 and 48.44  
 
Table 1. Structural and spectroscopic data for unfunctionalized uranyl(VI) complexes reported since 
2010. With respect to the tabulated IR data, sym. refers to the symmetric OUO stretching frequency 
determined by Raman spectroscopy and asym. refers to the asymmetric OUO stretching frequency 
determined by IR spectroscopy.  soln. = solution-state. The compounds are numbered within the table 
according to how they appear in the text, and any lattice solvent molecules are not included in the 
chemical formulae. 
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Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X [°] ν(OUO) 
[cm–1] 
Reference 
[UO2{N(SiMe3)2}2(py)2] (2-py) 1.779(3) – 170.5(2) – 935 (asym.) 29,45 
[UO2(THF)(H2LMe)] (11-THF) 1.787(3), 
1.770(3) 
– 177.0(2) – 908 (asym.) 39 
[FeCl(MeIm)][UO2(Ar2nacnac)(κ1-N-
C4H5N2)2] (14) 
1.777(4), 
1.780(4) 
– 177.2(2) – 911 (asym.) 36 
[CoCl(MeIm)][UO2(Ar2nacnac)(κ1-N-
C4H5N2)2] (15) 
1.767(5), 
1.771(4) 
– 178.0(2) – 911 (asym.) 36 
[UO2(dippISQ)2(THF)] (25) 1.762(4), 
1.786(3) 
– 175.4(2) – Unassigned 41 
[K(THF)2(18-c-6)]2[UO2(dippAP)2(THF)] 
(26) 
1.812(2), 
1.814(2) 
– 174.5(1) – Unassigned 41 
[Li(THF)4][UO2{N(SiMe3)2}3] (33) 1.784(4) – 179.8(2) – 969 (asym., 
soln.) 
42 
[Na(THF)6][UO2{N(SiMe3)2}3] (35) 1.791(3) – 179.8(1) – 973 (asym., 
soln.) 
42 
[K(THF)6][UO2{N(SiMe3)2}3] (36) 1.786(3) – 179.6(1) – 973 (asym., 
soln.) 
42 
[Li(2,2,2-crypt)][UO2{N(SiMe3)2}3] (37) 1.797(3) – 179.0(2) – 964 (asym.), 
809 (sym.) 
42 
[Na(2,2,2-crypt)][UO2{N(SiMe3)2}3] 
(38) 
1.772(8) – 179.8(4) – 963 (asym.), 
811 (sym.) 
42 
[K(2,2,2-crypt)][UO2{N(SiMe3)2}3] (39) 1.801(2) – 178.58(9) – 963 (asym.), 
809 (sym.) 
42 
[Rb(2,2,2-crypt)][UO2{N(SiMe3)2}3] 
(40) 
1.80(1) – 180 – 964 (asym.), 
810 (sym.) 
42 
[Cs(2,2,2-crypt)][UO2{N(SiMe3)2}3] (41) 1.80(2) – 180 – 961 (asym.), 
809 (sym.) 
42 
[Li(12-c-4)2][UO2{N(SiMe3)2}3] (42) 1.787(4) – 178.8(2) – 962 (asym.), 
808 (sym.) 
42 
[Na(15-c-5)2][UO2{N(SiMe3)2}3] (43) 1.79(2) – 178.0(8) – 960 (asym.), 
810 (sym.) 
42 
[K(15-c-5)2][UO2{N(SiMe3)2}3] (44) 1.79(1) – 180 – 964 (asym.), 
811 (sym.) 
42 
[Rb(15-c-5)2][UO2{N(SiMe3)2}3] (45) 1.788(2) – 178.7(2) – 964 (asym.), 
805 (sym.) 
42 
[Cs(15-c-5)2][UO2{N(SiMe3)2}3] (46) 1.789(3) – 178.0(2) – 964 (asym.), 
804 (sym.) 
42 
[UO2(OTf)2(AracnacH)2(OEt2)] (57) 1.750(6), 
1.746(6) 
– 176.5(3) – 940 (asym.) 46 
[UO2{N(SiMe2Ph)2}2(py)2] (69) 1.782(3) – 180.0 – Unassigned 45 
[UO2(THF)(H2LEt)] (89-THF) 1.768(3), 
1.790(3) 
– 175.1(2) – 907 (asym.) 47 
[UO2(dpaea)] (120) 1.75(3) – 176.9(7) – 913 (asym.) 48 
[UO2(SCS)(py)2] (126) 1.776(5), 
1.787(5) 
– 171.8(2) – 920 (asym.)  49 
[UO2(Mesaldien)] (150) 1.779(3), 
1.784(3), 
1.770(3), 
1.786(3) 
– 173.3(2), 
174.1(1) 
– Unassigned 50 
[UO2Cl(Lnacnac)] (152) 1.757(9), 
1.785(8) 
– 178.4(4) – Unassigned 51 
[{UO2(Lnacnac)}2(µ-O)] (153) 1.79(1), 
1.80(1), 
1.80(1), 
1.82(1), 
1.81(1), 
1.82(1), 
1.79(1), 
1.79(1) 
– 176.2(5), 
172.8(5), 
175.2(5), 
173.0(6) 
– Unassigned  51 
[UO2(salfen-tBu2)] (167) 1.778(3) – 177.1(2) – Unassigned 52  
[UO2(PhCOO)2(py)2] (176) 1.769(5) – 180.0 – Unassigned 53 
[Cp*UO2(MesPDIMe)] (181) 
 
1.799(5), 
1.790(5) 
– 168.3(2) – 876 (asym.), 
788 (sym.) 
54 
[Cp*UO2(tBu-MesPDIMe)] (182) 
 
1.77(1) – 167.4(4) – 878 (asym.), 
787 (sym.) 
54 
13 
 
[UO2Cl(L')] (205) 
 
1.766(4), 
1.763(4) 
– 175.5(2) – 920 
(asym.)a 
55 
[CoCp2][UO2Cl(L'')] (208) 
 
1.772(3), 
1.779(3) 
– 176.5(1) – Unassigned 55 
[{UO2(py)}2(LA)] (209) 1.747(4), 
1.779(4) 
–  174.0(2) – 912 (asym.) 56 
[UO2(tBuacnac)2] (220) 1.770(3) – 180.0 – 907 (asym.), 
823 (sym.) 
57 
[UO2(L')][B{3,5-(CF3)2-C6H3}4] (229) 1.753(2), 
1.762(2) 
– 173.6(1) – 952 (asym.) 58 
[UO2(OTf)(L')] (230) 1.763(3), 
1.759(3) 
 
– 176.5(1) – Unassigned 58 
[UVIO2(HOEt)(Lsalen)] (240) 1.773(8), 
1.816(9) 
– 177.6(4) – 908 (asym.), 
850 (sym.) 
59 
{[K(py)2)][UVIO2(C6H5COO)3] }n (244) 1.773(7)  179(1)  Unassigned 60 
[K(THF)5][UO2(NPhF2)3(THF)] 
 
1.770(6), 
1.772(5) 
– 177.0(2) – Unassigned 37 
[K(THF)5]2[UO2(NPhFPh)4] 
 
1.765(3) – 180.0(2) – Unassigned 37 
[K(18-c-6)(dme)]2[UO2(NArFPh)4] 1.789(4), 
1.792(4) 
– 178.9(2) – Unassigned 37 
[UO2(DOPOq)2] 
 
1.765(4), 
1.768(5) 
– 179.9(2) – 937 (asym.), 
843 (sym.) 
61 
[UO2Cl2(HN4)] 
 
1.776(5), 
1.785(5) 
– 164.1(3) – 813 (sym.) 62 
[UO2Cl2(MeN4)] 
 
1.779(6) – 168.2(3) – 815 (sym.) 62 
[UO2(OTf)2(HN4)] 1.759(6), 
1.781(6) 
– 162.8(3) – 833 (sym.) 62 
[UO2(OTf)(THF)(MeN4)][OTf] 1.76(1), 
1.77(1) 
– 161.7(5) – 831 (sym.) 62 
 [{UO{OGe(THF)}(THF)}(LA)] 1.757(2), 
1.762(2) 
– 175.2(1) – 925 (asym.), 
928/910 
(soln.) 
44 
 [{UO{OSn(THF)}(THF)}(LA)] 1.781(3), 
1.782(3) 
– 175.6(2) – 921 (asym.), 
927/911 
(soln.) 
44 
[{UO{OPb(THF)}(THF)}(LA)] 1.761(4), 
1.764(4), 
1.767(4), 
1.780(4) 
– 174.6(2), 
175.1(2) 
– 916 (asym.), 
905 (soln.) 
44 
 [{UO{OPb(THF)}(Opy)}(LA)] 1.779(7), 
1.787(7) 
– 178.5(2) – Unassigned 44 
 [{UO{OPb(py)}(Opy)}(LA)] 1.776(4), 
1.779(4) 
– 178.8(1) – 902 (asym.) 44 
[UO2(tmtaaH){N(SiMe3)2}(THF)] 
 
1.787(5), 
1.789(4) 
– 174.0(2) – 805 (sym.) 31 
[UO2(tmtaaH)2] 1.752(7) – 180 – 805 (sym.) 31 
[UO2(LtBu)] 
 
1.778(2), 
1.790(2) 
– 175.83(9) – Unassigned 63 
[UO2(Lnap)] 
 
1.789(3), 
1.780(3) 
– 175.9(1) – Unassigned 63 
[UO2(Lm)] 
 
1.786(5), 
1.774(6) 
– 180 – Unassigned 64 
[Li(12-c-4)2][UO2{N(HSiMe2)(tBu)}3] 1.787(6) – 179.2(5) – Unassigned 34 
[UO2(tBu-bipy){N(HSiMe2)(tBu)}2] 1.748(5), 
1.803(5) 
– 175.8(2) – Unassigned 34 
[UO2(BIPMTMS)(DMAP)2] 1.794(2), 
1.785(2) 
– 167.2(1) – 860 (asym.) 65 
[UO2(Htrensal)] 1.783(3), 
1.787(3) 
– 173.5(1) –  Unassigned 66 
[{UO2(trensal)}2Fe(py)2] 1.789(2), 
1.785(2) 
– 175.52(8) – Unassigned 66 
[UO2(dpaea)(OH2)]  1.777(4), 
1.780(4) 
– 170.7(2) – Unassigned 48 
[UO2(SCHS)(OTf)(OEt2)] 1.759(8), 
1.764(8) 
– 177.8(4) – 929 (asym.) 49 
[UO2(SCHS)2] 1.767(2), 
1.769(2) 
– 178.8(1) – 916 (asym.) 49 
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Table Footnotes: a reassigned or reclassified as unassigned in the light of more recent information on this and related complexes since the original 
publication appeared. The compounds are numbered within Table 1 according to how they appear in the text, and any lattice solvent molecules are not 
included in the chemical formulae. 
 
Table 2. Structural and spectroscopic data for functionalized uranyl(VI) complexes reported since 
2010. With respect to the tabulated IR data, sym. refers to the symmetric OUO stretching frequency 
determined by Raman spectroscopy and asym. refers to the asymmetric OUO stretching frequency 
determined by IR spectroscopy. soln. = solution-state; the compounds are numbered within the Table 
according to how they appear in the text, and any lattice solvent molecules are not included in the 
chemical formulae. 
 
[UO2Cl2(DPPFO2)] 1.764(4), 
1.760(4) 
– 176.9(2) – 916 (asym.) 67 
[UO2(dipytolyl)2(THF)] 1.765(5), 
1.768(5), 
1.758(5), 
1.755(4) 
– 170.9(2), 
177.4(2) 
–  963 (asym., 
DMAP 
adduct) 
68 
[UO2(dipyanis)2(THF)] 1.759(4), 
1.764(4), 
1.762(4), 
1.762(4) 
– 176.8(2), 
170.5(2) 
– 963 (asym., 
DMAP 
adduct) 
68 
[UO2(dipyFc)2(THF)] 1.773(3) – 177.0(2) – 963 (asym., 
DMAP 
adduct) 
68 
[UO2(dipyMes)2(DMAP)] 1.776(4), 
1.764(4) 
– 176.9(2) – 963 (asym.) 68 
[UO2(OTf)2(dippIQ)(THF)] 1.745(5) – 179.1(2) – Unassigned 41 
[UO2Cl(dippISQ)(dippIQ)] 1.757(3), 
1.758(3) 
– 175.1(1) –  Unassigned 41 
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Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X [°] ν(OUO) 
[cm–1] 
Reference 
[Li(py)2][UO2{N(SiMe3)2}3] (1) 
 
1.81(1), 
1.88(1) 
1.83(3)  178.2(5) 169(2) 935 (asym.), 
969 (asym., 
soln.) 799 
(sym.) 
29,42  
[Li(dme)1.5)]2[UO2(CH2SiMe3)4] (3) 1.885(4) 1.87(1)  180 141.3(4) Unassigned 30 
[Li(THF)]2[UO2{N(SiMe3)2}(tmtaa)] (5) 1.80(2), 
1.77(2) 
1.95(5)  175.9(9) 132(2)  Unassigned 31 
[Li(THF)3][Li(THF)2][(UO2Cl2)2(tmtaa)] 
(6) 
1.764(6), 
1.792(6), 
1.776(5), 
1.786(6) 
1.88(2), 
1.93(2) 
176.8(3), 
178.0(3),  
168.9(6), 
171.8(6) 
Unassigned 32 
[Li(THF)](TMEDA)][UO2(N=CtBu2)3] 
(7)  
1.804(5), 
1.830(5) 
1.85(1) 
 
179.4(2) 172.2(5) Unassigned 33 
[Li(THF)(OEt2)]2[UO2(N=CtBuPh)4] (8) 1.838(4), 
1.822(4) 
1.97(1), 
1.94(1) 
180.0 106.2(4), 
107.7(4) 
Unassigned 33 
[Li(THF)3][UO2{N(HSiMe3)(tBu)}3] (9) 1.785(4), 
1.853(5) 
1.88(1) 179.7(2) 174.21(6) Unassigned 34 
[UO2(THF){(THF)LiHLMe}] (10-THF) 1.794(3), 
1.767(3) 
2.06(1)  176.1(2) 120.7(3) 899 (asym.) 35 
[Li(MeIm)][UO2(Ar2nacnac)(κ1-C-
C4H5N2)2] (12) 
1.778(4), 
1.788(4) 
2.19(1)  176.1(2) 108.2(4) 886 (asym.), 
806 (sym.) 
36 
{[K(THF)3][UO2(NPhFpy)3]}n (16) 
 
1.769(7), 
1.775(7), 
1.779(7), 
1.783(7) 
2.707(7), 
2.716(7), 
2.738(7), 
2.693(8) 
178.0(4), 
178.4(4) 
157.1(4), 
176.1(4) 
Unassigned 37 
[K(η6-C6H5CH3)2]2[UO2(NArFPh)4] (17) 
 
1.802(2), 
1.806(2) 
2.589(2), 
2.615(3) 
177.8(1) 139.3(1), 
149.5(1) 
Unassigned 37 
[K(py)3]2[K(py)]2[(UO2)2(µ-O2)(LMe)] 
(18) 
1.788(6), 
1.781(6), 
1.787(6), 
1.784(5) 
2.884(7), 
2.642(6), 
2.722(6), 
3.325(6)  
176.0(3), 
176.1(3) 
107.8(3), 
174.0(3), 
122.7(3), 
165.3(3) 
924 (asym.) 38 
[K(py)3]2[K(py)]2[(UO2)2(µ-O)(LMe)] (20) 1.817(7), 
1.803(6), 
1.786(6), 
1.798(7) 
3.079(8), 
3.283(8), 
2.951(7), 
2.699(6), 
2.583(6) 
177.5(3), 
176.5(3) 
101.5(3), 
99.1(3), 
176.1(3), 
124.3(3), 
162.7(3) 
Unassigned 38 
[{UO2(OH)K(C6H6)(H2LMe)}2] (21) 1.796(2), 
1.803(2) 
2.813(2), 
2.838(2)  
179.16(7) 108.19(7), 
123.01(8) 
894 (asym.) 39 
[UO2(OH)K(THF)2(H2LMe)] (23) 1.788(6), 
1.821(6) 
3.194(7) 178.5(3) 100.9(2) 895 (asym.) 39 
K2[K(OEt2)2]2[UO2(dippAP)2]2 (24) 1.824(3), 
1.834(3) 
2.701(3), 
2.741(3), 
2.688(3) 
172.2(1) 139.3(1), 
111.4(1), 
129.1(1) 
Unassigned 41 
[K(THF)3][UO2{N(SiMe3)2}3] (29) 1.776(3), 
1.804(3) 
2.669(3) 179.4(2) 174.0(2) 940 (asym.), 
799 (sym.), 
973 (soln.) 
42 
[Rb][(UO2{N(SiMe3)2}3] (30) 1.80(3) 2.74(3) 180.0 159.6(3) 940 (asym.), 
804 (sym.), 
973 (soln.) 
42 
[Cs][UO2{N(SiMe3)2}3] (31) 1.79(1) 2.93(1) 180.0 155.0(2) 941 (asym.), 
804 (sym.), 
971 (soln.) 
42 
[Li(THF)2][UO2{N(SiMe3)2}3] (32) 1.786(4), 
1.841(4)34 
1.89(1)34 179.2(1)34 166.5(4)34 943 (asym.), 
798 (sym.), 
969 (soln.)42 
34,42 
[Na(THF)2][UO2{N(SiMe3)2}3] (34) 
 
1.781(5), 
1.810(5)42 
 
2.201(6)42 179.3(2)42 161.7(2)42 938 
(asym.),42 
928 
(asym.),43 
973 ( 
soln.),42 795 
(sym.),42 
805 (sym.)43  
42,43  
[{UO(OPb)(THF)}(LMe)] (47-THF) 1.78(1), 
1.817(9) 
2.5 176.5(4) 137.8(4) 896 (asym.), 
898 (soln.) 
44 
[{UO{OPb(py)}(py)}(LMe)] (47-py) 1.77(1) 2.91(1) 175.3(6) 149.5(6) 908 (asym.), 
895 (soln) 
44 
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The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X = oxo-
functionalizing unit) determined by single crystal X-ray diffraction, and characteristic spectroscopic 
data (OUO vibrational stretching frequency) determined by FTIR or Raman spectroscopies for 
unfunctionalized and functionalized uranyl(VI) complexes reported since 2010 are provided in Tables 
1 and 2, respectively, and their trends are discussed in more detail in Section 7 (vide infra). Elongated 
U–O bond lengths in uranyl(VI) complexes (i.e. greater than 1.83 Å) may be accessible when 
employing strong equatorial σ-donors (i.e. silylamides, alkyl, ketimides, amides and other O-donor 
ligands), providing a “push” by way of the equatorial ligands, and a “pull” of UVI–Oyl through Lewis 
adduct formation, and appears primarily to be an electronic effect.63,64 While deviations from linearity 
of the OUO unit are scarce across many of these compounds, bond lengths vary considerably and are 
dependent on equatorial ligand coordination, with steric forces and crystal packing effects appearing 
to have little structural influence. 
 
3. UVIUV REDUCTIVE FUNCTIONALIZATION 
The combination of the strongly electron donating β-ketoiminate ligand, Aracnac 
(Aracnac = ArNC(Ph)CHC(Ph)O; Ar = 3,5-tBu2C6H3), and single oxo-group coordination by 
the Lewis acidic borane B(C6F5)3 resulted in the activation of the uranyl(VI) ion towards 
reductive silylation, providing both uranyl(V) and uranium(IV) dioxo products (see Section 
6, vide infra). To expand the scope of this borane-mediated silylation, dibenzoylmethanate 
(dbm; OC(Ph)CHC(Ph)O) was used as an equatorially coordinating ligand; 
[UVIO2(dbm)2(THF)] (49) was prepared by treating [U
VIO2Cl2(THF)2] (4-THF) with 2 equiv. 
of Na[dbm]. When 49 was treated with 1 equiv. of R3SiH (R = Et, Ph) and 1 equiv. of B(C6F5)3, 
the complexes [UV{OB(C6F5)3}(OSiR3)(dbm)2(THF)] were obtained (R = Et (50), Ph (51); 
Scheme 6). Complexes 50 and 51 are products of UVIUV reductive silylation, in which one 
[{UO{OPb(py)}(Opy)}(LMe)] (48) 1.759(7), 
1.853(8) 
2.612(8) 177.5(3) 121.3(3) 893 (asym.) 44 
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oxo ligand has been converted into a siloxy ligand and the other is coordinated to the borane. 
The U–O bond lengths are significantly elongated compared to those of uranyl(VI) complexes, 
with U–OB bond lengths of 1.960(2) and 1.952(2) Å and U–OSi bond lengths of 2.011(2) and 
2.024(2) Å for 50 and 51, respectively;the uranyl(V) units also remain linear with OB–U–OSi 
bond angles of 178.43(8) and 175.06(8)° for 50 and 51, respectively. The yields of 50 and 51 
are higher when 0.25 equiv. of THF are added to the crystallization solutions, and THF-free 
50 may be isolated in the absence of excess THF, affording [UV{κ2-O,F-
OB(C6F5)3}(OSiEt3)(dbm)2] (52). Complex 52 possesses a short U···Fortho intramolecular 
contact with one C6F5 ring, with considerably elongated U–OB and U–OSi bond lengths of 
1.915(2) and 1.981(3) Å, respectively, and retains a linear OB–U–OSi angle of 169.3(1)°.69 
Scheme 6. Borane-assisted UVIUV reductive silylation of a dibenzoylmethanate-coordinated 
uranyl(VI) complex, [UVIO2(dbm)2(THF)] (49).
69  
 
Alternatively, 49 reacts with 2 equiv. of Ph3SiOTf in the absence of a borane activator, 
forming [UV(OSiPh3)2(dbm)2(OTf)] (53; Scheme 7), which possesses two siloxy ligands trans-
coordinated to the UV center, with an O–U–O bond angle of 178.81(8)° and U–O bond lengths of 
2.005(2) and 2.018(2) Å.70  
Scheme 7. UVIUV reductive silylation of [UVIO2(dbm)2(THF)] (49) via double silylation of the 
uranyl oxo ligands, forming [UV(OSiPh3)2(dbm)2(OTf)] (53).
70  
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A similar result is achieved if the uranyl(VI) bis(β-ketoiminate) complex, [UVIO2(Aracnac)2] 
(54), is treated with two equiv. of Ph3SiOTf in CH2Cl2, in which U
VIUV reductive silylation is 
achieved, yielding [UV(OSiPh3)2(
Aracnac)2][OTf] (55; Scheme 8).
70 Compound 54 also reacts with 
excess Me3SiI to afford [U
V(OSiMe3)2I2(
Aracnac)] (56) and ArNC(Ph)CHC(Ph)OSiMe3 
(AracnacSiMe3) and 0.5 equiv. of I2 as reaction by-products, or with excess Me3SiX to yield 
[UVIO2X2(OEt2)n(
AracnacH)2] (X = OTf, n = 1 (57); X = Cl, n = 0 (58); Scheme 8).
46 Both oxo ligands 
in 55 and 56 have been converted into siloxy ligands, and the U–O bond lengths range from 1.986(5)-
2.044(2) Å46,70 and are indicative of UVIUV reduction, whereas the equivalent metrics of 1.750(6) 
and 1.746(6) Å in 57 indicated that no reduction of the UVI center had occurred.46 The identity of the 
reducing agent in the formation of 53 and 55 is not immediately obvious, since 2 equiv. of Ph3SiOTf 
are required but only 1 equiv. of [OTf]– is incorporated into the final product, but is thought that 1 
equiv. of either the dbm or Aracnac ligand undergoes a one-electron oxidation, yielding a ligand-based 
radical which then reacts to abstract an H-atom from solvent.70 This hypothesis is based on the 
observation of unreacted Ph3SiOTf and Hdbm in the 
1H NMR spectrum recorded during the formation 
of 53. On the other hand, the reducing agent in the formation of 56 is hypothesized to be I− which 
forms I2 as a reaction by-product. The formation of I2 in this reaction has been experimentally verified 
by adding PPh3 into the reaction mixture, forming Ph3PI2. The U
VIUV reduction is facilitated by a 
decrease in the uranyl reduction potential upon Me3Si
+ coordination to the uranyl oxo groups (in a 
similar fashion to the effects of coordinating the Lewis acid B(C6F5)3 to uranyl), as well as the 
difference in Si–I and Si–O bond dissociation energies.46  
Scheme 8. UVIUV reductive silylation of both uranyl oxo ligands in [UVIO2(Aracnac)2] (54) using 
either 2 equiv. of Ph3SiOTf or excess Me3SiI, providing [U
V(OSiPh3)2(
Aracnac)2][OTf] (55) and 
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[UV(OSiMe3)2I2(
Aracnac)] (56). Alternatively, 54 reacts with excess Me3SiX (X = OTf, Cl) to yield 
[UVIO2X2(OEt2)n(
AracnacH)2] (X = OTf, n = 1 (57); X = Cl, n = 0 (58)).
46,70 
 
The exploitation of the Pacman ligand framework in uranyl chemistry has led to a wide variety 
of new reactions that enable the controlled reductive functionalization of the uranyl dication. While 
treating the uranyl(VI) Pacman complex, [UVIO2(S)(H2L
Me)] (S = THF (11-THF), py (11-py)), with 
1 equiv. of LiN(SiMe3)2 results in the formation of [U
VIO2(S)(LiHL
Me)] (S = THF (10-THF), py (10-
py); see Figure 1 in Section 2), the reaction of 11-THF or 11-py with 2 equiv. of a LiR base (R = 
NiPr2, C5H5, CPh3, NH2, H) results in U
VIUV reduction and formation of [UVO(OLi)(S)(LiHLMe)] 
(S = THF (59-THF), py (59-py); Scheme 9), in which one of the pyrrole groups in the bottom N4-
donor pocket and the exo-oxo ligand have been metallated. Furthermore, treating 11-THF or 11-py 
with 3 equiv. of LiN(SiMe3)2 in pyridine yields [U
VO(OLi)(py)(Li2L
Me)] (60), which is the product 
of UVIUV reduction and metallation of both pyrrole groups and the exo-oxo ligand; further treating 
11-THF or 11-py with 4 equiv. of LiN(SiMe3)2 in THF provides 
Li[UVO{OLiN(SiMe3)2}(THF)(Li2L
Me)] (61; Scheme 9), in which UVIUV reduction has been 
achieved, both pyrrole groups in the bottom N4-donor pocket have been metallated and the exo-oxo 
ligand has been functionalized with LiN(SiMe3)2. In this structure a Li
+ cation is present to balance 
the charge (Scheme 9). Performing the 3 equiv. reaction in THF results in the formation of a mixture 
of paramagnetic species. Complexes 59-py, 60 and 61 crystallize as 
20 
 
[{UVO{OLi(py)3}(py)}{(py)LiHL
Me}] (62-py), [{UVO[OLi(py)3](py)}({(py)Li}2L
Me)] (63-py) and 
[(UVO{OLiN(SiMe3)2(THF)})({(THF)Li}3L
Me)] (64-THF), respectively, which possess U–O bond 
lengths of 1.834(4) and 1.879(5) Å, 1.894(2) and 1.859(2) Å, and 1.850(2) and 1.921(2) Å, 
respectively. These values are in the range expected for uranyl(V) (see Tables 3, 4 and 6 and Section 
7).35  
Scheme 9. The uranyl(VI) pacman complex, [UVIO2(S)(H2L
Me)] (S = THF (11-THF), py (11-py)), 
reacts with 1 equiv. of LiN(SiMe3)2 or 2 equiv. of LiR (R = N
iPr2, C5H5, CPh3, NH2, H) to provide 
[UVIO2(S)(LiHL
Me)] (S = THF (10-THF), py (10-py)) and [UVO(OLi)(S)(LiHLMe)] (S = THF (59-
THF), py (59-py)), respectively. Alternatively, 11-THF or 11-py react with 3 equiv. of LiN(SiMe3)2 
in pyridine to provide [UVO(OLi)(py)(Li2L
Me)] (60), or 4 equiv. of LiN(SiMe3)2 in THF to afford 
Li[UVO{OLiN(SiMe3)2}(THF)(Li2L
Me)] (61).35   
    
 When 11-THF or 11-py are reacted with 2 equiv. of the weakly reducing silylamide 
LiN(SiMe3)2, both diamagnetic and paramagnetic products are observed by 
1H NMR spectroscopy, 
with complex 60 as the paramagnetic component. However, the addition of dihydroanthracene (DHA) 
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to the reaction mixture results in the sole formation of 59. This divergent reactivity relative to the 
other LiR bases stems from the presence of two different operative mechanisms during UVIUV 
reduction and metallation. The LiR bases (R = NiPr2, CPh3, C5H5, NH2, H) act as simple reductants 
with release of a radical (R•), which is quenched by the Pacman ligand through H-atom abstraction 
(as determined by 2H NMR spectroscopy and incorporation of deuterium into the Pacman ligand). 
Alternatively, in the case of LiN(SiMe3)2, an H-atom abstraction mechanism by the uranyl complex 
is invoked, requiring the presence of the H-atom donor DHA for clean reactivity. However, it is 
unknown whether a U=O group or a pyrrolyl radical is responsible for C–H bond cleavage (Scheme 
10); DFT calculations were unable to distinguish between the two mechanisms. Treatment of 11-
THF or 11-py with 2 equiv. of either LiNH2 or LiH also forms a mixture of 60, 10 and unreacted 11; 
heating this mixture drives the reaction towards 59. Overall, this reactivity suggests that endogenous 
bonding of a lithium cation to the uranyl oxo group facilitates reduction chemistry.35  
Scheme 10. Two different mechanisms are operative for the synthesis of 60. The LiR reactant in Path 
A acts as a reductant, whereas the LiR reactant in Path B initially acts as a base, deprotonating the 
second pyrrole group in the bottom N4-donor pocket. At that point, C–H bond cleavage in weak C–H 
bond substrates occurs either by the U=O group or a pyrrolyl radical, generating 60.35  
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Treating 59-py with 2 equiv. of HCl provides the uranyl(V) hydroxide 
[UVO(OH)(py)(H2L
Me)] (65); 59-py can be regenerated by treating 65 with 2 equiv. of LiN(SiMe3)2 
(Scheme 11). While 65 was not crystallographically characterized, its identity was verified by NMR 
and IR spectroscopy; an asymmetric OUO stretch located at 765 cm–1 in the corresponding IR 
spectrum confirms the presence of a UV center. Complex 11-py may be regenerated from 65 by 
treatment with either Ph3CCl, forming 0.5 equiv. of Gomberg’s dimer, 11-py and HCl, or by treatment 
with TEMPO, forming 11-py by H-atom abstraction (Scheme 11).71 
Scheme 11. [UVIO2(py)(H2L
Me)] (11-py) reacts with 2 equiv. of LiNiPr2 to provide 
[UVO{OLi(py)2}(py)(HLiL
Me)] (59-py). 59-py reacts with 2 equiv. of HCl to yield 
[UVO(OH)(py)(H2L
Me)] (65), which reacts with 2 equiv. of LiN(SiMe3)2, 1 equiv. of Ph3CCl/TEMPO 
or 1 equiv. of Cl-SiR3 to regenerate 59-py, regenerate 11-py or form [U
VO(OSiR3)(py)(H2L
Me)] (SiR3 
= SiMe3 (66), SiMe2
tBu (67), SiPh2H (68)), respectively.
71  
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 Complex 65 also reacts with chorosilanes, ClSiR3 (SiR3 = SiMe3, SiMe2
tBu, SiPh2H), to 
provide the uranyl(V) mono oxo-silylated products, [UVO(OSiR3)(py)(H2L
Me)] (SiR3 = SiMe3 (66), 
SiMe2
tBu (67), SiPh2H (68); Scheme 11). While NMR and IR spectra were sufficient to determine 
the identity of complexes 66-68, the solid-state structures of 66 and 67 were also obtained to verify 
their assignments, although due to issues with multiple twinning the structure of 67 only supports 
connectivity. The U–Oexo and U–Oendo bond lengths in 66 are 2.034(4) and 1.854(4) Å, respectively, 
and lie in the expected range for uranyl(V) complexes (see Tables 3, 4 and 6 and Section 7).71  
[UVIO2(py)(H2L
Me)] (11-py) also reacts with an additional 1.5 equiv. of 
[UVIO2{N(SiR3)2}2(py)2] (SiR3 = SiMe3 (2-py), SiMe2Ph (69)) to provide the butterfly-shaped 
complexes [{UVO(OSiR3)}2(L
Me)] (SiR3 = SiMe3 (70), SiMe2Ph (71); Scheme 12a). Alternatively, 
H4L
Me reacts with 2.5 equiv. of 2-py to generate 70, although in only 37 % yield. Complexes 70 and 
71 are the products of UVIUV reduction of both U centers that have been installed into the [LMe]4– 
Pacman ligand and silylation of both exo-oxo ligands. Compounds 70 and 71 are butterfly-shaped 
bis(uranyl(V)) dimers and display an unusual structural motif for high-valent uranium in which one 
of the four uranyl(V) oxo ligands has migrated from a trans-coordination position to a cis-
coordination position, giving rise to a UV2O2 core. The U–O bond lengths range from 2.034(4)-
2.099(4) Å and 2.030(5)-2.087(5) Å in 70 and 71, respectively, and the asymmetric OUO stretching 
frequency is found at 862 and 802 cm–1 for 70 and between 890-850 cm–1 for 71, which are indicative 
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of uranyl(V). Furthermore, the U···U distance is very short in complexes 70 and 71, which is 
3.3557(5) and 3.3562(4) Å, respectively.45 
Scheme 12. (a) Synthesis of [{UVO(OSiR3)}2(L
Me)] (SiR3 = SiMe3 (70), SiMe2Ph (71)) by heating 
[UVIO2(py)(H2L
Me)] (11-py) with 1.5 equiv. of [UVIO2{N(SiR3)2}2(py)2] in pyridine, alongside 30% 
of an aggregate mixture with empirical formula [(UO2)2.5(L
Me){HN(SiR3)}]. (b) When heated 
between 20 and 70 °C, H4L
Me reacts with 2.5 equiv. of [UVIO2{N(SiR3)2}2(py)2] to afford only the 
aggregate mixture, with further heating to 120 °C providing trace amounts of 70 and 71. Alternatively, 
adding Cl-SiR3 to the aggregate mixture provides 70 and 71 in high yields. (c) Treating the aggregate 
mixture with empirical formula [(UO2)2.5(L
Me){NH(SiMe2Ph)}(py)] with Cl-SiMe3 results in the 
formation of 70 (75%) and [{UVO(OSiMe3)}{U
VO(OSiMe2Ph)}(L
Me)] (75; 25%), and (d) exposure 
of the aggregate mixture with empirical formula [(UO2)2.5(L
Me){NH(SiMe3)}(py)] to air results in the 
formation of [{{UVO(OSiMe3)}(U
VO2)(L
Me)}UVIO2(µ-OH)2(THF)2]2 (76).
45  
 
25 
 
 
 During the formation of 70 and 71, an insoluble aggregate mixture of uranyl-LMe species was 
obtained in an approximate 30% yield, and was identified as 
[UVIO2(py)2{(U
VO2){U
VO(OH)}(LMe)}2] (72), [{U
VO(OSiR3)}{U
VO(OH)}(LMe)] (73-Me/73-Ph) 
and [{UVO{OUVIO2(NHSiR3)(py)}}{U
VO(OH)}(LMe)] (74-Me/74-Ph; Scheme 12a; 73-Me and 74-
Me are derived from [UVIO2{N(SiMe3)2}2(py)2] and 73-Ph and 74-Ph are derived from 
[UVIO2{N(SiMe2Ph)2}2(py)2]). If H4L
Me reacts with 2.5 equiv. of [UVIO2{N(SiR3)2}2(py)2] below 70 
°C, only the paramagnetic aggregate mixture and 4 equiv. of HN(SiR3)2 are observed by NMR 
spectroscopy. If this mixture is then heated to 120 °C, only trace amounts of 70 and 71 are produced. 
However, if the aggregate mixture is treated with Cl-SiR3, complexes 70 and 71 are obtained in good 
yields (Scheme 12b). The aggregate mixture was identified as 72, 73-Me/73-Ph, and 74-Me/74-Ph 
based on the following observations: (i) 4 equiv. of HN(SiR3)2 are produced as a by-product when 
treating H4L
Me with 2.5 equiv. of [UVIO2{N(SiR3)2}2(py)2], 2.5 equiv. of [U
VIO2]
2+ are consumed per 
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equivalent of [LMe]4– and an additional equivalent of HN(SiR3)2 is produced upon treating the mixture 
of species 72, 73-Me/73-Ph, and 74-Me/74-Ph with Cl-SiR3, giving rise to an empirical formula of 
[(UO2)2.5(L
Me){NH(SiR3)}(py)] (which is supported by elemental analysis; Scheme 12b), (ii) treating 
the mixture of species 72, 73-Ph and 74-Ph with Cl-SiMe3 produced 70 (75%) and the mixed silylated 
[{UVO(OSiMe3)}{U
VO(OSiMe2Ph)}(L
Me)] (75; 25%), indicating that not all of the oxo groups in the 
mixture are silylated given that the silyl groups in complexes 70 and 71 are known to not rearrange 
(Scheme 12c), (iii) laser desorption ionization (LDI) mass spectrometry supported this assignment, 
and (iv) an X-ray crystal structure of the mixed-valence complex, 
[{{UVO(OSiMe3)}(U
VO2)(L
Me)}UVIO2(µ-OH)2(THF)2]2 (76) was obtained following adventitious 
oxidation of the mixture of 72, 73-Me and 74-Me (Scheme 12d); mixed-valence 76 contains the 
UV2O2 butterfly core with one exo-oxo ligand silylated and the other dimerized through the oxo 
groups as a uranyl(VI) hydroxide. The source of the silyl group in 70 and 71 can be traced back to 
the uranyl(VI) silylamide starting material and not the HN(SiMe3)2 by-product, as there is no evidence 
for the formation of 70 or the mixed-silyl complex 75 upon treating 11-py with 1.5 equiv. of 
[UVIO2{N(SiMe2Ph)2}2(py)2] in the presence of N(SiMe3)3. It is envisioned that initial one-electron 
UVIUV reduction in 11-py occurs via U–N bond homolysis upon the addition of 1.5 equiv. of the 
uranyl silylamide starting material to 11-py, and that additional uranyl silylamide is required for 
reduction of the second U center and silylation by N–Si bond homolysis. Remarkably, complexes 70 
and 71 neither decompose upon exposure as solids to air for 48 hours nor in wet benzene solutions, 
which contrasts greatly to the known instability of uranyl(V) species towards disproportionation to 
uranyl(VI) and uranium(IV) dioxo species. Furthermore, the solution cyclic voltammagram (CV) of 
70 and 71 did not show any electrochemical oxidation processes, which was further supported by a 
lack of reactivity between 70 and 71 with I2 or [Ce(OTf)4]. The electronic structure and magnetic 
behavior of 70 and 71 have also been investigated but these results are beyond the scope of this 
review.45  
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The first example of covalent bond formation to a uranyl oxo group in the form of reductive 
silylation was reported in 2008 with the synthesis of [UVO(OSiMe2R)(THF)(M2X2L
Me)] (M = Fe, X 
= I, R = Me (77); M = Fe, X = I, R = Ph (78); M = Zn, X = I, R = Me (79); M = Zn, X = Cl, R = Me 
(80)) formed by reacting 11-THF with the silylamido base, KN(SiMe3)2, in the presence of a 
transition metal dihalide.40 Since the synthesis of complexes 77-80, the mechanism of this reaction 
has been probed and compared to alternative reactions that lead to oxo-group metalation.72 It was 
originally postulated that the Group 1 base was essential to this reaction, and that the oxo-group 
reactivity was enhanced by coordination to a Lewis acidic metal in the bottom N4-pocket of the 
Pacman ligand. When 11-THF is treated with 2 equiv. of KN(SiMe3)2 followed by 2 equiv. of ZnCl2, 
reductive silylation of the uranyl ion is observed, forming [(Me3SiOU
VO)(py)(ZnCl)2(L
Me)] (81; 
Scheme 13a). In contrast, treating 11-THF with 2 equiv. of the Group 1 metal bases LiNiPr2 or KH 
followed by the addition of 2 equiv. of ZnX2 (X = Cl, I) results in reductive zincation of the uranyl 
ion, forming [{(py)X2ZnOU
VO}(py){Zn(py)}(HLMe)] (X = Cl (82), I (83); Scheme 13b).40 These 
different reaction pathways were explored by deploying various zinc(II) and magnesium(II) reagents. 
Complex 11-py reacts with 2 equiv. of Mg(N'')2 (N'' = N(SiMe3)2) to afford 
[{(py)2(N'')MgOU
VO}(py){Mg(py)}(HLMe)] (84), the product of UVIUV reductive oxo-metalation 
of the uranyl and metalation of one of the two pyrroles in the bottom donor pocket of the ligand 
(Scheme 14a). One-electron reduction of the uranyl ion occurs through Mg–N bond homolysis.72  
Scheme 13. Treatment of [UVIO2(py)(H2L
Me)] (11-py) first with a Group 1 metal base 
followed by a zinc dihalide leads to: (a) UVIUV reductive silylation, yielding 
[(Me3SiOU
VO)(py)(ZnCl)2(L
Me)] (81), or (b) UVIUV reductive metalation, providing 
[{X2(py)ZnOU
VO}(py){Zn(py)}(HLMe)] (X = Cl (82), I (83)).72 
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In contrast, 11-py reacts with only one of 2 equivs. of Zn(N'')2 to afford [U
VIO2(py){Zn(py)}(HL
Me)] 
(85), in which reduction of the uranyl ion is not observed, and both pyrrole NH groups have been 
metallated (Scheme 14b). Furthermore, 85 does not react with MgN''2. These results indicate that 
coordination of the zinc cation to the endo-oxo group of uranyl is insufficiently activating to enable 
uranyl(VI) reduction by M–N bond homolysis, and it is likely that coordination of a more Lewis 
acidic metal dication (i.e. Mg2+) to the endo-oxo group results in enhanced activation of the uranyl 
ion, thus enabling UVIUV reduction by M–N bond homolysis. Importantly, it was found that the 
reaction between the mixed-ligand reagent ZnCl(N'') and 11-py formed 81 in 62% yield; the 
remaining 38% was composed of 11-py, 82, and [UVIO2(py)(ZnCl)(HL
Me)] (86; Scheme 15a). 
Complex 86 was also prepared from 11-py and 1 equiv. of ZnCl(N'') and was characterized by NMR 
spectroscopy (Scheme 15b).72  
Scheme 14. Treatment of [UVIO2(py)(H2L
Me)] (11-py) with: (a) 2 equiv. of MgN''2 or (b) ZnN''2 to 
provide [{(py)2N''MgOU
VO}(py){Mg(py)}(HLMe)] (84) and [UVIO2(py){Zn(py)}(HL
Me)] (85), 
respectively.72  
 
Scheme 15. Treatment of [UVIO2(py)(H2L)] (11-py) with: (a) 2 equiv. of ZnCl(N'') provides a mixture 
of 11-py, [UVIO2(py)(ZnCl)(HL
Me)] (86), [(Me3SiOU
VO)(py)(ZnCl)2(L
Me)] (81) and 
[{Cl2(py)ZnOU
VO}(py){Zn(py)}(HLMe)] (82), and with (b) 1 equiv. of ZnCl(N'') provides only 86.72  
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In order for oxo-silylation to be favored over oxo-metalation, N–Si bond homolysis 
must be preferred over M–N bond homolysis (M = Zn, Mg) within an oxo-coordinated M–N–
SiR3 group. Furthermore, the silylation pathway is driven by the formation of a strong Si–O 
bond and is enhanced when the alternative O–M bond is weaker. The zinc compound 
ZnCl(N'') is well suited to both oxo group activation and silyl group delivery, as is highlighted 
by the formation of both 81, 82 and 86 when reacted with complex 11-py. However, its 
reduced Lewis acidity relative to Mg(N'')2 dictates that oxo-silylation is preferred over oxo-
metalation.72  
The uranyl(VI) Pacman complex 11-py reacts with either [Cp2TiCl(CH2)(AlMe2)] at room 
temperature or HAliBu2 at 70 °C to afford [U
VO{OAlR2(py)}(H2L
Me)] (R = Me (87), iBu (88); 
Scheme 16), the product of UVIUV reductive alumination of the uranyl ion. The U–Oexo and U–
Oendo bond lengths in complexes 87 and 88 are 1.962(3)/1.962(2) and 1.856(3)/1.855(3) Å, 
respectively, which are elongated relative to those expected for uranyl(VI) complexes, and the O–U–
O bond angles are 174.3(1) and 175.1(1)° for 87 and 88, respectively. It is likely that the reducing 
electron required in the formation of 87 and 88 is derived from either Al–C or Al–H bond homolysis. 
Subsequent reactions of complexes 87 and 88 with alkyllithium reagents and metal hydrides are 
discussed in Section 4.73  
Scheme 16. Reductive alumination of [UVIO2(py)(H2L
Me)] (11-py) using either 
[Cp2TiCl(CH2)(AlMe2)] or HAl
iBu2, yielding [U
VO{OAlR2(py)}(H2L
Me)] (R = Me (87), iBu (88)).73  
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The reductive functionalization chemistry of 11-THF and [UVIO2(S)(H2L
Et)] (S = THF (89-
THF); H2L
Et = macrocyclic Pacman-shaped Schiff-base ligand with ethyl substituents on the meso-
carbon atoms) with common actinide precursors has also been explored, resulting in the first complex 
formed from reduction of the uranyl ion by a transuranic species (Scheme 17).47  
Scheme 17. Reductive functionalization of uranyl in [UVIO2(THF)(H2L
Me)] (11-THF) and 
[UVIO2(THF)(H2L
Et)] (89-THF) by [UIIICp3] or [Np
IIICp3], providing 
[UVO(OUIVCp3)(THF)(H2L
Me)] (90), [UVO(OUIVCp3)(THF)(H2L
Et)] (91), 
[UVIO(ONpIIICp3)(THF)(H2L
Me)] (92) and [UVIO(ONpIIICp3)(THF)(H2L
Et)] (89).47  
 
Complexes 11-THF and 89-THF react with [UIIICp3] to yield oxo-functionalized 
[UVO(OUIVCp3)(THF)(H2L
Me)] (90) and [UVO(OUIVCp3)(THF)(H2L
Et)] (91; Scheme 17). Based on 
X-ray diffraction data (U–Oexo = 1.976(3)/1.986(3) Å, U–Oendo = 1.840(3)/1.844(3) Å, O–U–O = 
178.1(1)/176.9(1)⁰ for 90/91, respectively), paramagnetic shifts in the resulting 1H NMR spectra, IR 
spectra (ν[OUO asym.] = 897 and 893 cm–1, respectively) and SQUID magnetometry measurements, 
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these are best described as UIV/UV complexes formed upon UVIUV reduction of the uranyl ion. 11-
THF and 89-THF also react with [NpIIICp3], in these cases to form [U
VIO(ONpIIICp3)(THF)(H2L
Me)] 
(92) and [UVIO(ONpIIICp3)(THF)(H2L
Et)] (93; Scheme 17) in which the oxidation states are less 
clear-cut. While certain X-ray diffraction metrics for complexes 92 and 93 (U–Oexo = 
1.975(4)/1.975(7) Å, U–Oendo = 1.842(4)/1.826(7) Å, O–U–O = 178.1(2)/176.9(3)⁰ for 92/93, 
respectively), paramagnetic shifts in the 1H NMR spectra, and IR spectra (ν[OUO asym.] = 891 and 
892 cm–1, respectively) suggest UVIUV reduction of the uranyl ion has occurred, the Np–Oexo bond 
lengths and SQUID magnetometry measurements suggest that complexes 92 and 93 are best 
described as donor-acceptor oxo-bridged NpIII/UVI compounds with only partial electron transfer 
occurring; this assignment is further corroborated by DFT calculations which also suggest an 
explanation for the unexpectedly strong paramagnetically shifted resonances in the solution NMR 
spectra of 93, as they find a anomalously high s-orbital contribution to key Np orbitals. The reactions 
of 11-THF and 89-THF with [PuIIICp3] were also investigated and, in agreement with the expected 
reducing capability of PuIII, no oxo-coordination was observed; the reactions were carried out in THF, 
so there may have been an additional competition for the Pu center by the donor solvent.47  
Uranyl(V) complexes are directly accessible from uranyl(VI) precursors. The Pacman ligand 
H4L
Me reacts with 2.5 equiv. of [Li(py)2][U
VIO2{N(SiMe3)2}3] (94) in boiling pyridine over 12 hours 
to afford the doubly lithiated UV/UV complex, [{(py)3LiOU
VO}2(L
Me)] (95; Scheme 18a). Complex 
95 possesses Li-coordinated exo-oxo groups and a central diamond-shaped [UV2O2] core in which the 
two endo-oxo atoms bridge the uranium centers in axial and equatorial positions, similarly to the 
doubly silylated bis(uranyl(V)) complexes 70 and 71 (vide supra). 95 reacts with two equivalents of 
a chlorostannane, R3SnCl, to afford doubly stannylated [{R3SnOU
VO}2(L
Me)] complexes (R = nBu 
(96), Ph (97); Scheme 18b). Complexes 96 and 97 could also be prepared from the dipotassium 
analogue of 95, [{(py)2KOU
VO}2(L
Me)] (98), and the respective chlorostannane. Unexpectedly, 
reactions between 95 and [TiIVCl(OiPr)3] did not afford [{(
iPrO)3TiOU
VO}(LMe)] but instead 
provided [{(py)3LiOU
VO}(OUVOiPr)(LMe)] (99), in which one of the Li cations has been replaced by 
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an iso-propyl group (Scheme 18c). While 99 was stable as a solution in pyridine, attempts to isolate 
it on a bulk scale were unsuccessful and provided 0.5 equiv. of dilithiated 95 and the doubly 
alkoxylated complex, [(iPrOUO)2(L
Me)] (100). 100 was also obtained by treating either 95 or 99 with 
excess [TiIVCl(OiPr)3] (Scheme 18d and 18e). Attempts to prepare both 99 and 100 from 95 and 
iPrCl 
were unsuccessful, providing intractable mixtures, so it is a realistic possibility that exchange of the 
lithiated uranyl oxo group by the Ti-derived OiPr group has occurred.29 
Complex 11-py reacts with [Li(py)2][U
VIO2{N(SiMe3)2}3] (94) to provide the 
lithiated/silylated UV/UV complex, [{(py)3LiOU
VO}(Me3SiOU
VO)(LMe)] (101; Scheme 18f). 
Similarly to 95, complexes 96-101 possess a diamond-shaped [UV2O2] core.
29   
Scheme 18. (a) Synthesis of [{(py)3LiOUO}2(L
Me)] (95), (b) subsequent reactivity with stannanes to 
provide [{R3SnOU
VO}2(L
Me)] (R = nBu (96), Ph (97)), and (c)/(d)/(e) TiIV reagents to yield 
[{(py)3LiOU
VO}(OUVOiPr)(LMe)] (99) and [(iPrOUO)2(L
Me)] (100). (f) Synthesis of a mixed 
lithiated/silylated UV/UV bis(uranyl) Pacman complex, [{(py)3LiOU
VO}(Me3SiOU
VO)(LMe)] 
(101).29  
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Reduced and oxo-functionalized mixed uranyl(V)/lanthanide(III) Pacman complexes can be 
accessed for all of the rare earth cations (except Pm) using a Ln–N bond homolysis route (Scheme 
19). Treatment of 11-py with 1 equiv. of the rare-earth silylamide [LnIII{N(SiMe3)2}3] yields 
[{UVO2Ln
III(py)2(L
Me)}2] (Ln = Sc (102), Y (103), Ce (104), Sm (105), Eu (106), Gd (107), Dy (108), 
Er (109), Yb (110) and Lu (111)) in which the pyrrole groups of the bottom N4-donor pocket have 
been deprotonated and coordinated to the LnIII ion (Scheme 19a). Uranyl UVIUV reduction occurs 
upon Ln–N bond homolysis of the third silylamido ligand, which then abstracts either a proton or 
deuterium from a solvent molecule. Complexes 102-111 exist as dimers with bridging [UV2O2] 
interactions holding the two uranyl units together, and dimerization is thought to occur subsequent to 
Ln–N bond homolysis and UVIUV reduction, given the greater Lewis basicity of the UV oxo groups. 
Even so, this dimer is readily split by alkali metal halides which satisfy both the Lewis acid and base 
requirements of the uranyl(V) center. The addition of either LiCl or LiI to [{UVO2Ln
III(py)2(L
Me)}2] 
(Ln = Y, La, Sm, Dy) provided the monomeric [(py)3LiOUO(µ-X)Ln(py)(L
Me)] complexes (X = Cl, 
Ln = Y (112), La (113), Sm (114), Dy (115); X = I, Ln = Y (116), La (117), Sm (118), Dy (119)), in 
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which the exo-oxo ligand of the uranyl(V) ion is coordinated to a Li+ cation, and a halide is residing 
in a bridging position between the UV and LnIII centers (Scheme 19b).74,75 Single-electron reduction 
of the uranyl(VI) ion should also be possible if a suitable Ln–A (A = co-ligand) bond homolysis route 
is available, and indeed this has been verified through deployment of LnIII aryloxides, [Ln(OAr)3] (Ar 
= C6H2-2,6-
tBu2-4-Me). While the variable-temperature SQUID magnetometry and IR, NIR and EPR 
spectroscopies on complexes 102-119 have been studied to obtain a better understanding of the 
electronic structure of these complexes and their f-electron exchange interactions,74 these 
observations are beyond the scope of this review and will not be discussed further. 
Scheme 19. Synthesis of (a) mixed uranyl(V)/lanthanide(III) Pacman complexes 102-111 by 
reduction of [UVIO2]
2+ by Ln–N bond homolysis (Ln = Sc (102),74 Y (103),75 Ce (104),74 Sm (105),75 
Eu (106), Gd (107), Dy (108), Er (109), Yb (110), Lu (111)) and (b), cleavage of the subsequently 
formed dimer with LiCl or LiI, providing complexes 112-119 (X = Cl, Ln = Y (112), Ln = La (113), 
Sm (114), Dy (115); X = I, Ln = Y (116), La (117), Sm (118), Dy (119)).74  
 
The uranyl(VI) complex, [UVIO2(dpaea)] (120), synthesized from [U
VIO2(NO3)2(OH2)6] (121) 
and H2dpaea, reacts with 1 equiv. of [CoCp*2] to afford the uranyl(V) complex, 
[Cp*2Co][U
VO2(dpaea)] (H2dpaea = bis(pyridyl-6-methyl-2-carboxylate)-ethylamine, 122; Scheme 
20). While this is not an example of reductive functionalization of the uranyl ion, it is a rare example 
of uranyl reduction with an outer-sphere reductant to afford a thermodynamically stable uranyl(V) 
product and is therefore noteworthy for inclusion in this review. Complex 122 possesses an O–U–O 
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bond angle of 177.0(6)° and U–O bond lengths of 1.83(1) and 1.84(1) Å, which are significantly 
elongated relative to the uranyl(VI) starting complex (1.75(3) Å), although as a separated ion pair, it 
does not precisely fit the definition of oxo-functionalised. Furthermore, the asymmetric OUO 
stretching frequency was found at 787 cm–1 in the IR spectrum of 122, which is at significantly lower 
frequency relative to uranyl(VI) 120 (913 cm–1). Remarkably, once isolated uranyl(V) 122 is stable 
with respect to ligand dissociation and disproportionation in D2O.
48  
Scheme 20. [UVIO2(dpaea)] (120) reacts with [CoCp*2] to yield [Cp*2Co][U
VO2(dpaea)] 
(122). The H2dpaea ligand is depicted at the top of the Scheme.
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 Lastly, in an attempt to prepare a uranyl(VI) carbene complex by deprotonation of a 
carbene analogue bound to uranyl(VI), [UVO2Cl(BIPMH)(THF)] (BIPMH = 
HC(PPh2NSiMe3)2, 123), which was originally reported in 2003,
76 was treated with sodium 
benzyl, NaCH2C6H5. However, this provided the bimetallic uranyl(VI)/uranyl(V) complex, 
[UVIO2(BIPMH)(µ-Cl)U
VO2(BIPMH)] (124), along with NaCl and (C6H5CH2)2 as reaction 
by-products (Scheme 21). The slow elimination of chloride enables trapping of the uranyl(V) 
fragment by unreacted uranyl(VI). Complex 124 is formed irrespective of the number of 
equivalents of NaCH2C6H5 used for the reaction, and attempts to prepare 124 by treating 123 
with other alkali metal alkyls, amides and hydrides resulted in the formation of intractable 
mixtures. The 31P{1H} NMR spectrum of 124 contains one sharp (δ –5.2) and one broadened 
resonance (δ –129), the magnetic moment of 124 measured in benzene at 298 K is 2.59 µB, 
and the IR spectrum contains asymmetric OUO stretching frequencies at 906, 835 and 803 
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cm–1, all of which are indicative of one diamagnetic uranyl(VI) and one paramagnetic 
uranyl(V) ion being present in 124.77 This result contrasts to that reported from deployment 
of the [C(PPh2S)2]
2– dianion, in which deprotonation of CH2(PPh2S)2 with excess LiNEt2 in 
the presence of [UVIO2(OTf)2] (125) was found to be a viable strategy for the synthesis of a 
uranyl(VI) carbene (ylid) complex, [UVIO2(SCS)(py)2] (126; SCS = [C(PPh2S)2]
2–).49 
 Also formed in the reaction between 123 and NaCH2C6H5, albeit as a minor product 
(~2% yield), is the uranyl(VI)/uranyl(V)/uranyl(V) trimer, [UVIO2(BIPMH)(µ3-
Cl){UVO2(BIPMH)}2] (127; Scheme 21), in which oxo-bridging essentially generates the 
uranyl-functionalized oxo group. The 31P{1H} NMR spectrum of 127 contains a sharp signal 
at –5.2 ppm and a broad quartet at –149 ppm. Furthermore, the magnetic moment of 127 in 
benzene at 298 K is 4.01 µB, which is indicative of one uranyl(VI) and two uranyl(V) ions 
being present in 127.77  
Scheme 21. Synthesis of the mixed-valence complexes [UVIO2(BIPMH)(µ-
Cl)UVO2(BIPMH)] (124) and [U
VIO2(BIPMH)(µ3-Cl){U
VO2(BIPMH)}2] (127) from 
[UVIO2Cl(BIPMH)(THF)] (123) and 0.5 equiv. of sodium benzyl. The [BIPMH]
– ligand is 
depicted in the bottom left hand corner of the Scheme.77  
 
 
 Complex 124 bridges the uranyl(V) oxo group and the UVI center through both oxo and 
chlorido ligands while complex 127 is trinuclear, with two bridging uranyl(V) oxo groups and 
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one bridging UVI oxo group. Furthermore, both 124 and 127 contain a chlorido ligand that is 
bridging the U cations; the chlorido ligand in 124 is bridging two metal centers whereas that 
in 127 is bridging three metal centers. The U–O bond lengths in the uranyl(VI) ion in 124 are 
1.785(4) and 1.776(4) Å, whereas those in the uranyl(V) ion are 1.932(4) and 1.843(5) Å, in 
which the longer U–O bond length corresponds to the uranyl(V) oxo that is participating in 
the CCI. The U–O bond lengths in the uranyl(VI) ion in 127 are 1.776(4) and 1.812(4) Å, 
whereas those in the uranyl(V) ions range from 1.822(4)-1.966(4) Å. Similarly to 124, the 
longer U–O bond length corresponds to the uranyl(V) oxo that is participating in the CCI. The 
O–U–O bond angles remain nearly linear in both compounds, ranging from 171.0(2)-
177.9(2)°. The U···O bond length in the uranyl(V)/uranyl(VI) dimer in 124 is 2.316(4) Å 
whereas those in 127 are 2.544(4), 2.360(4) and 2.239(4) Å, in which the longest U···O 
distance is derived from the uranyl(VI) oxo group and a UV center. This elongated distance 
could be a consequence of the decrease in Lewis basicity of the uranyl oxo ligand moving 
from UV to UVI, as well as a contraction in the U–oxo bond length in the uranyl(VI) ion, which 
combined with the geometric constraints imparted by the fused cubane core would prohibit 
close approach to another metal center. Solutions of 124 and 127 decompose upon standing 
in toluene at room temperature, producing a mixture of unidentified products.77  
 
Table 3. Structural and spectroscopic data for reductively functionalized mixed uranyl(VI)/uranyl(V) 
and uranyl(V) complexes reported since 2010 and discussed in Section 3. With respect to the tabulated 
IR data, sym. refers to the symmetric OUO stretching frequency determined by Raman spectroscopy 
and asym. refers to the asymmetric OUO stretching frequency determined by IR spectroscopy. 
Mixed [UVIO2]2+/[UVO2]+ 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
[{{UVO(OSiMe3)}(UVO2)(LMe)}UVIO2(
µ-OH)2(THF)2]2 (76) 
[UVIO2]2+: 
1.757(9), 
1.760(8) 
[UVO2]+: 
1.909(7), 
2.052(7), 
2.170(8), 
2.034(7), 
2.045(8), 
2.099(8) 
[UVO2]+: 
1.666(8) (X 
= Si), 
2.312(7) (X 
= UVI) 
[UVIO2]2+: 
173.8(4) 
[UVO2]+: 
174.7(3), 
173.9(3) 
[UVO2]+: 
153.5(5) 
(X = Si), 
168.8(4) 
(X = UVI) 
Unassigned 45 
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[UVIO2(BIPMH)(µ-Cl)UVO2(BIPMH)] 
(124) 
[UVIO2]2+: 
1.785(4), 
1.776(4) 
[UVO2]+: 
1.932(4), 
1.843(5) 
[UVO2]+: 
2.316(4)  
[UVIO2]2+: 
177.4(2) 
[UVO2]+: 
171.0(2) 
[UVO2]+: 
126.4(2) 
[UVIO2]2+: 
906 (asym.) 
[UVO2]+: 
835, 803 
(asym.) 
77 
[UVIO2(BIPMH)(µ3-
Cl){UVO2(BIPMH)}2] (127) 
[UVIO2]2+: 
1.776(4), 
1.812(4) 
[UVO2]+: 
1.825(4), 
1.966(4), 
1.822(4), 
1.903(4) 
[UVIO2]2+: 
2.544(4) 
[UVO2]+: 
2.239(4), 
2.360(4)  
[UVIO2]2+: 
177.9(2) 
[UVO2]+: 
175.5(2), 
173.7(2) 
[UVIO2]2+: 
127.8(2) 
[UVO2]+: 
132.4(2), 
132.5(2) 
900-802 
(asym.; 
multiple 
broad 
stretches) 
77 
[Cp*2Co][{UVIO2(salen)}{UVO2(salen)(
py)}] (143) 
[UVIO2]2+: 
1.79(1), 
1.80(1)  
[UVO2]+: 
1.82(1), 
1.93(1) 
[UVO2]+: 
2.28(1) 
[UVIO2]2+: 
173.6(5) 
[UVO2]+: 
179.0(6) 
[UVO2]+: 
163.0(6) 
Unassigned 78 
[UVO2]+ 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
{K2[(UVO2)2(LMe)]}n (THF solvate) (19-
THF)a 
1.867(7), 
2.077(5) 
2.598(7), 
2.753(8)  
176.4(3) 143.8(4), 
113.1(3) 
Unassigned 38 
[K(py)3]2[K(py)]2[(UVO2)2(LMe)]2 (19-
py) a 
1.851(5), 
2.090(5), 
2.101(5), 
1.871(6) 
2.658(6), 
2.748(6), 
2.764(6)  
172.9(2), 
173.7(2)  
118.8(3), 
114.0(2), 
128.5(3) 
Unassigned 38 
[U(OB{C6F5}3)(OSiEt3)(dbm)2(THF)] 
(50) 
2.011(2) 
(U-OSi), 
1.960(2) 
(U-OB) 
1.681(2) (X 
= Si), 
1.503(4) (X 
= B) 
178.43(8) 153.5(1) 
(X = Si), 
165.8(2) 
(X = B) 
Unassigned 69 
[U(OB{C6F5}3)(OSiPh3)(dbm)2(THF)] 
(51) 
2.024(2) 
(U-OSi), 
1.952(2) 
(U-OB) 
1.665(2) (X 
= Si), 
1.525(4) (X 
= B) 
175.06(8) 164.0(1) 
(X = Si), 
172.0(2) 
(X = B) 
Unassigned 69 
[U{κ2-O,F-OB(C6F5)3}(OSiEt3)(dbm)2] 
(52) 
1.981(3) 
(U-OSi), 
1.915(2) 
(U-OB) 
1.720(3) (X 
= Si), 
1.546(5) (X 
= B) 
169.3(1) 148.7(2) 
(X = Si), 
151.6(2) 
(X = B) 
Unassigned 69 
[U(OSiPh3)2(dbm)2(OTf)] (53) 
 
 
2.005(2), 
2.018(2) 
1.669(2), 
1.668(2)  
178.81(8) 169.0(1), 
176.1(1) 
Unassigned 70 
[U(OSiPh3)2(Aracnac)2][OTf] (55) 
  
2.044(2) 1.664(2)  180.0 164.8(1) Unassigned 70 
[U(OSiMe3)2I2(Aracnac)] (56) 1.996(5), 
1.986(5) 
1.687(6), 
1.682(6) 
179.1(2) 154.9(4), 
171.4(4) 
Unassigned 46 
[{UO2(py){Li(py)3}}{(py)LiHLMe}] 
(59-py) 
1.834(4), 
1.879(5) 
1.93(1), 
1.94(2)  
174.8(2) 167.3(4), 
113.6(7) 
Unassigneda 35 
[{UO2{Li(py)3}}{{(py)Li}2LMe}] (60) 1.894(2), 
1.859(2) 
1.914(7), 
1.979(7), 
1.976(7) 
174.2(1) 169.2(3), 
123.8(2), 
123.1(2) 
704 (asym.) 35 
[{UO2{LiN(SiMe3)2(THF)}}{{(THF)Li
}3LMe}] (61) 
1.850(2), 
1.921(2) 
1.876(6), 
2.016(7), 
2.171(6), 
2.027(7) 
175.35(9) 174.0(3), 
111.7(2), 
142.8(2), 
111.8(2) 
Unassigned 35 
[UO(OSiMe3)(py)(H2LMe)] (66) 1.854(4), 
2.034(4) 
1.667(5)  176.0(2) 160.2(3) 860 (asym.) 71 
[{UO(OSiMe3)}2(LMe)] (70)a 2.034(4), 
2.099(4), 
2.085(4), 
2.040(4)  
1.666(4), 
1.665(4) 
173.4(2), 
174.9(2) 
157.7(3), 
155.1(3) 
862, 802 
(asym.) 
45 
[{UO(OSiMe2Ph)}2(LMe)] (71)a 2.030(5), 
2.081(5), 
2.087(5), 
2.039(5) 
1.665(5), 
1.664(5) 
174.4(2), 
176.7(2) 
156.1(3), 
155.5(3) 
890-850 
(asym.) 
45 
[(Me3SiOUO)(THF)(ZnCl)2(LMe)] (81-
THF) 
1.84(1), 
1.99(1) 
1.70(1) (X = 
Si); 1.96(1) 
(X = Zn) 
172.9(5) 160.2(8) 
(X = Si); 
149.6(7) 
(X = Zn) 
Unassigned 72 
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[(py)Cl2ZnOUO(py){Zn(py)}(HLMe)] 
(82) 
1.933(2), 
1.887(3) 
1.962(2), 
1.989(3)  
170.4(1) 119.5(1), 
172.9(2) 
Unassigned 72 
[(py)I2ZnOUO(THF){Zn(py)}(HLMe)] 
(83) 
1.909(3), 
1.879(3) 
1.965(3), 
1.987(3) 
173.0(1) 118.9(2), 
172.3(2) 
Unassigned 72 
[{(py)2{(Me3Si)2N}MgOUO}(py){Mg(
py)}(HLMe)] (84) 
1.85(1), 
1.87(1) 
2.04(1), 
1.97(1)  
172.6(5) 162.1(6), 
172.9(8) 
Unassigned 72 
 [UO{OAlMe2(py)}(py)(H2LMe)] (87) 1.856(3), 
1.962(3) 
1.777(3)  174.3(1) 166.2(2) 893 (asym.) 73 
 [UO{OAliBu2(py)}(THF)(H2LMe) (88) 1.855(3), 
1.962(2) 
1.785(3)  175.1(1) 167.0(2) 892 (asym.; 
py adduct) 
73 
[UO(OUCp3)(THF)(H2LMe)] (90) 1.840(3), 
1.976(3) 
2.262(3) 178.1(1) 170.7(2) 897 (asym.) 47 
[UO(OUCp3)(THF)(H2LEt)] (91) 1.844(3), 
1.986(3) 
2.245(3)  176.9(1) 171.3(1) 893 (asym.) 47 
[UO(ONpCp3)(THF)(H2LMe)] (92) 1.842(4), 
1.975(4) 
2.256(4) 178.1(2) 171.2(2) 891 (asym.) 47 
[UO(ONpCp3)(THF)(H2LEt)] (93) 1.826(7), 
1.975(7) 
2.249(7)  176.9(3) 170.5(4) 892 (asym.) 47 
[{UO{OLi(py)3}}2(LMe)] (95)a 1.877(4), 
2.111(4), 
2.100(4), 
1.883(4) 
1.87(1), 
1.93(1)  
175.1(2), 
172.7(2) 
166.8(5), 
150.2(5) 
Unassigned 29 
[{UO(OSnnBu3)}2(LMe)] (96)a 1.982(9), 
2.073(8), 
2.122(7), 
1.991(9) 
2.015(9), 
2.00(1)  
177.1(3), 
174.5(3) 
154.2(5), 
154.8(5) 
869 (asym.) 29 
[{UO(OSnPh3)}2(LMe)] (97)a 1.987(8), 
2.057(8), 
2.11(1), 
2.00(1) 
1.996(8), 
2.01(1)  
170.2(3), 
176.1(3) 
167.2(5), 
168.0(5)  
Unassigned 29 
[{UO{OLi(py)3}}{UO(OiPr)}(LMe)] 
(99)a 
2.034(2), 
2.111(2), 
2.076(2), 
1.865(2) 
1.438(4) (X 
= C); 
1.922(8) (X 
= Li) 
174.32(9), 
174.34(9) 
163.1(2) 
(X = C); 
175.2(2) 
(X = Li) 
Unassigned 29 
[{UO(OiPr)}2(LMe)] (100)a 2.013(8), 
2.105(6), 
2.081(5), 
2.011(6) 
1.48(3)*, 
1.43(1)  
174.7(3), 
174.4(2) 
155.8(2)*, 
149.5(8) 
841 (asym.) 29 
[{UO{OLi(py)3}}{UO(OSiMe3)}(LMe)] 
(101)a 
2.056(2), 
2.113(2), 
2.077(2), 
1.857(3) 
1.655(3) (X 
= Si); 
1.929(8) (X 
= Li)  
172.3(1), 
175.2(1) 
157.4(2) 
(X = Si); 
171.6(3) 
(X = Li) 
883 (asym.) 29 
[{UO2Sc(py)2(LMe)}2] (102) 1.925(2), 
1.939(2) 
2.048(2)  174.56(8) 171.5(1) Unassigned 74 
[{UO2Y(py)2(LMe)}2] (103) 1.919(4), 
1.965(3) 
2.155(4)  175.3(2) 177.3(3)  722 (asym.) 74,75 
[{UO2Ce(py)2(LMe)}2] (104) 1.895(5), 
1.924(5) 
2.253(5)  175.6(2) 173.3(3) 766 (asym.) 74 
[{UO2Sm(py)2(LMe)}2] (105) 1.890(5), 
1.941(5) 
2.238(5)  174.4(2) 174.5(3) 724 (asym.) 74,75 
[{UO2Eu(py)2(LMe)}2] (106) 1.904(2), 
1.932(2) 
2.200(2)  175.4(1) 177.0(1) 564 (asym.) 74 
[{UO2Dy(py)2(LMe)}2] (108) 1.901(4), 
1.942(4) 
2.179(4)  175.2(2) 177.5(3) 765 (asym.) 74 
[{UO2Er(py)2(LMe)}2] (109) 1.911(4), 
1.939(3) 
2.159(4)  175.6(2) 177.3(2) 770 (asym.) 74 
[{UO2Yb(py)2(LMe)}2] (110) 1.905(6), 
1.947(6) 
2.143(6)  174.3(3) 170.9(4) Unassigned 74 
[{UO2Lu(py)2(LMe)}2] (111) 1.909(3), 
1.941(3) 
2.141(3)  173.3(1) 172.7(2) Unassigned 74 
[(py)3LiOUO(µ-Cl)Sm(py)LMe] (114) 1.916(8), 
1.855(9) 
2.286(8) (X 
= Sm); 
1.90(3) (X = 
Li) 
174.9(4) 119.3(4) 
(X = Sm); 
172(1) (X 
= Li) 
Unassigned 74 
[Cp*2Co][UO2(dpaea)] (122) 1.83(1), 
1.84(1) 
– 177.0(6) – 787 (asym.) 48 
[{UO2Sm(THF)2(LMe)}2] 1.903(8), 
1.942(7) 
2.238(8) 174.2(3) 174.9(5) 771 (asym.) 74 
[{UO2Sm(py)2(LEt)}2] 1.900(2), 
1.939(2) 
2.234(2)  174.4(1) 171.4(1) Unassigned 74 
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Table Footnotes: a = U–O bond lengths are provided for the trans-uranyl oxo ligands because they possess multiple bond character, whereas the U–O 
bond lengths corresponding to the uranyl oxo groups bound in a cis-arrangment within the bridging-oxo butterfly motif are not provided because they 
do not possess any multiple bond character and as a result are not representative of the uranium oxidation state; b reassigned or reclassified as unassigned 
in the light of more recent information on this and related complexes since the original publication appeared; * averaged value due to two site disorder 
of the isopropyl carbon atoms. The compounds are numbered within Table 3 according to how they appear in the text, and any lattice solvent molecules 
are not included in the chemical formulae. 
 
The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X 
= oxo-functionalizing unit) determined by single crystal X-ray diffraction, and characteristic 
spectroscopic data (OUO vibrational stretching frequency) determined by FTIR or Raman 
spectroscopies for the reductively functionalized mixed uranyl(V)/uranyl(VI) and uranyl(VI) 
complexes reported since 2010 and discussed in Section 3 (vide supra) are provided in Table 
3, and their trends are discussed in more detail in Section 7 (vide infra). 
 
 
 4. FURTHER FUNCTIONALIZATION OF URANYL(V) COMPLEXES THAT 
RETAIN THE U(V) OXIDATION STATE 
 
This section highlights reactions that further functionalize the oxo ligands of isolated 
uranyl(V) complexes, therefore retaining the U(V) oxidation state and do not involve 
reduction of uranyl(VI). In our experience, the majority of reactions of uranyl(V) complexes 
designed to further functionalize the oxo groups, for example by replacement of an alkali 
metal cation with a p-, d- or f-block cation, result in either spontaneous re-oxidation and 
isolation of the original uranyl(VI) complex, or in rare cases, to disproportionation to UIVO2 
and [UVIO2]
2+. The success and diversity of the reactions outlined below is notable evidence 
of the maturity of this area, and it is now becoming possible to manipulate uranyl(V) 
complexes, despite their well-known kinetic instability, through the judicious choice of ligand 
design and selection of reaction conditions. 
 The readily available uranyl(V) starting complex, [{UVO2(py)5}{KI2(py)2}]n (128), 
which was first reported in 2006,79,80 reacts with the K2salan-
tBu2 ligand (H2salan-
tBu2 = N,N'-
bis(2-hydroxybenzyl-3,5-di-tert-butyl)-1,2-dimethylaminomethane) in pyridine to provide 
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polymeric {K[UVO2(salan-
tBu2)(py)]}n (129; Scheme 23) in which the uranyl(V) oxo groups 
are coordinated to K+ cations. Treatment of 128 or 129 with 18-c-6 in pyridine provides 
monomeric [UVO2(py)5]I (130) and [K(18-c-6)][U
VO2(salan-
tBu2)(py)] (131), respectively 
(Scheme 22). The stability of 130 is remarkable considering the absence of coordinating 
cations and demonstrates the ability of pyridine to stabilize uranyl(V). 131 contains one 
potassium cation bound to 1 equiv. of 18-c-6 and one of the uranyl(V) oxo ligands.81 
 
Scheme 22. Synthesis of {K[UVO2(salan-
tBu2)(py)]}n (129) from [{U
VO2(py)5}{KI2(py)2}]n 
(128) and K2salan-
tBu2. 128 and 129 react with 18-c-6 to afford [U
VO2(py)5]I (130) and [K(18-
c-6)][UVO2(salan-
tBu2)(py)] (131), respectively. The K2salan-
tBu2 ligand is depicted at the 
bottom of the Scheme.81  
   
 
 Adding KI to a solution of [Cp*2Co][U
VO2(salan-
tBu2)(py)] (132) in pyridine, which 
is prepared from [UVIO2(salan-
tBu2)(py)] (133) and excess decamethylcobaltocene, also 
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affords polymeric 129. All three uranyl(V)-salan-tBu2 complexes, 129, 131 and 132 exhibit 
the same stability with respect to disproportionation in pyridine and DMSO, up to 30 days. 
However, polymeric 129 exhibits lower stability with respect to disproportionation compared 
to monomeric 131 in THF. Only 33 % of U(V) 129 remains after 14 days in THF whereas 
there is no loss of 131 after 30 days in THF, but 33% loss after 14 days in toluene solution.81  
 When 128 was treated with the Schiff-base ligand, K2salophen (H2salophen = N,N'-
phenylene-bis(salicylideneimine)), in pyridine, a mixture of disproportionation products was 
obtained. However, when a bulkier Schiff base ligand, K2salophen-
tBu2 (H2salophen-
tBu2 = 
N,N'-phenylene-bis(3,5-di-tert-butylsalicylideneimine)), was deployed, polymeric 
{K[UVO2(salophen-
tBu2)(py)]}n (134-py) was obtained (Scheme 23), which is stable towards 
disproportionation for up to 30 days in pyridine, DMSO and toluene. This highlights the 
important effect that increasing the steric protection of the salophen ligand framework 
increases the stability of uranyl(V). If 134-py is dissolved in THF, the pyridine co-ligand 
bound to U is displaced by THF, forming {K[UVO2(salophen-
tBu2)(THF)]}n (134-THF; 
Scheme 23).81  
 
Scheme 23. Synthesis of {K[UVO2(salophen-
tBu2)(py)]}n (134-py) from 
[{UVO2(py)5}{KI2(py)2}]n (128) and K2salophen-
tBu2 in pyridine. Dissolving 134-py in THF 
provides {K[UVO2(salophen-
tBu2)(THF)]}n (134-THF). The K2salophen-
tBu2 ligand is 
depicted in the bottom left corner of the Scheme.81  
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The reactivity of 129 and 134-py with stoichiometric amounts of H2O was also 
investigated, where 129 reacts slowly with 1 equiv. of H2O to release free H2salan-
tBu2; the 
reaction proceeds much quicker in the presence of 10 equiv. of H2O, resulting in complete 
disappearance of uranyl(V) after 24 hours. Conversely, under similar conditions, ligand 
protonation and uranyl(V) oxidation is not observed in 134-py, indicating the salophen-tBu2 
ligand provides greater stability for uranyl(V) than the salan-tBu2 ligand. The electronic 
structure, electronic spectroscopy, electrochemistry and magnetic properties of complexes 
129-131, 133 and 134-py were studied in detail but are beyond the scope of this review.81  
Complexes 129-132 and 134-THF possess U–O bond lengths that range from 
1.846(9)-1.868(2) Å, which are in the expected range for uranyl(V) compounds, and maintain 
near linear O–U–O bond angles, which range from 177.14(8)-178.7(2)°.81  
[{UVO2(py)5}{KI2(py)2}]n (128) reacts with K2salen (H2salen = N,N'-ethylene-
bis(salicylideneimine), Scheme 24) in the presence of 18-c-6 to afford tetrameric [K(18-c-
6)]2[K2{U
VO2(salen)}4] (135), or with K2acacen (H2acacen = N,N'-ethylene-
bis(acetylacetoneimine), Scheme 24) in the presence of either 18-c-6 or 2.2.2-cryptand to 
afford tetrameric [K(R)]2[K2{U
VO2(acecen)}4] (R = 18-c-6 (136), 2.2.2-cryptand (137); 
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Scheme 24). While both reactions were successful with respect to retaining the UV oxidation 
state within the final product (i.e. stable with respect to disproportionation) the final products 
evaded isolation in the absence of 18-c-6 or 2.2.2-cryptand due to the formation of either 
polymeric or highly soluble species. Each UV center possesses pentagonal bipyramidal 
geometry, coordinated by the N2O2 ligand donor set in the equatorial plane with the fifth 
coordination site occupied by an oxo group of a neighboring uranyl(V) ion, forming a T-
shaped coordination geometry through oxo-bridging. The formation of the uranyl(V) 
tetramers 135-137 demonstrates the propensity for uranyl(V) to participate in oxo-bridging, 
the strength of which was highlighted by Pulsed-Field Gradient Stimulated Echo (PFGSTE) 
diffusion NMR spectroscopy in pyridine, in which calculating the Stokes radius of 135 and 
137 relative to [UVIO2(salophen)(py)] (138, used as an external reference) indicated that the 
tetrametallic motif was maintained in pyridine solution. In addition, complexes 135-137 are 
stable with respect to disproportionation.78  
Scheme 24. Synthesis of [K(18-c-6)]2[K2{U
VO2(salen)}4] (135) and 
[K(R)]2[K2{U
VO2(acecen)}4] (R = 18-c-6 (136), 2.2.2-cryptand (137)) from 
[{UVO2(py)5}{KI2(py)2}]n (128) and K2salen/2 equiv. of 18-c-6 or K2acacen/2 equiv. of 18-
c-6/2.2.2-cryptand, respectively. The K2salen and K2acecen ligands are depicted in the bottom 
left corner of the Scheme.78  
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 While 128 reacts cleanly with K2salophen (H2salophen = N,N'-phenylene-
bis(salicylideneimine), Scheme 25) that has been pre-treated with 18-c-6 to afford [K(18-c-
6)]2[K2(KI)2{U
VO2(salophen)}4] (138), it undergoes rapid disproportionation when reacted 
with K2salophen in the absence of 18-c-6 (Scheme 25). This reactivity is remarkable given 
the similarities between the K2salophen, K2salen, and K2acacen ligands. That said, once 
isolated, complex 138 is stable towards disproportionation for up to 30 days when re-dissolved 
in pyridine but undergoes complete disproportionation in 2 days in the presence of an excess 
of KI with respect to 18-crown-6 (0.1 equiv.) in pyridine. 138 was recrystallized as [K(18-c-
6)(THF)2][{U
VO2(salophen)}4(µ8-K)2(µ5-KI)2]I2 from THF and exists as a tetrameric 
structure with T-shaped coordination with respect to the uranyl(V) dimer similarly to 
complexes 135-137. However, conversely to complexes 135-137, PGFSTE diffusion NMR 
spectroscopy indicated that 138 exists as a monomer in pyridine. Complex 138 may also be 
prepared from [Cp*2Co][U
VO2(salophen)(py)] (139; synthesized from [CoCp*2] and 
[UVIO2(salophen)(py)]) and K(18-c-6)I; adding KI to a pyridine solution of 139 results in rapid 
disproportionation.78 
Scheme 25. Synthesis of [K(18-c-6)]2[K2(KI)2{U
VO2(salophen)}4] (138) from 
[{UVO2(py)5}{KI2(py)2}]n (128) and K2salophen/18-c-6. The K2salophen ligand is depicted at 
the bottom of the Scheme.78  
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 Complexes 136-138 possess uranyl(V) U–O bond lengths that range from 1.77(1)-
1.973(9) Å, with the non-bridging U–oxo bond that is pointing away from the center of the 
tetramer significantly contracted relative to the bridging U–oxo bond (1.77(1)-1.871(4) Å vs. 
1.91(1)-1.973(9) Å, respectively). In addition, the bridging U–O bond lengths within the 
[UVO2]
+···[UVO2]
+ units range from 2.344(9)-2.404(3) Å. In addition, 2 K+ ions reside in the 
center of each tetramer and are coordinated to each of the endo-oxygen atoms, and remain 
bound to the uranyl oxo groups even in the presence of excess 18-c-6 or 2.2.2-cryptand. It is 
therefore clear that potassium plays a key role in the formation of complexes 136-138 and 
their resulting structural integrity. The presence of coordinating K+ cations also has an 
electronic effect in which the uranyl(V) center is stabilized against oxidation by decreasing 
the amount of negative charge on the uranyl oxygen atoms. To gain further insight into the 
importance of K+ coordination with respect to other alkali metal cations, 
[Cp*2Co][U
VO2(salen)(py)] (140) was reacted with LiI, KI and RbI in the presence of 18-c-6 
(Scheme 27). 140 reacts with KI/18-c-6 and RbI/18-c-6 to afford tetrameric 135 and [Rb(18-
c-6)]2[Rb2{U
VO2(salen)}4] (141), respectively, which do not display any differences with 
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respect to their reactivity/stability; both complexes are stable in pyridine with respect to 
disproportionation. However, 140 reacts with LiI/18-c-6 to afford a mixture of 
disproportionation products (Scheme 26). The difference in reactivity between Li+, K+ and 
Rb+ may be attributed to the smaller size of Li+, as well as its higher ratio of charge/ionic 
radius compared to K+ and Rb+.78 
 140 also reacts with 1 equiv. of [UVIO2(salen)(py)] (142) to yield the mixed-valence 
[UVO2]
+/[UVIO2]
2+ complex, [Cp*2Co][{U
VIO2(salen)}{U
VO2(salen)(py)}] (143). The U–O 
bond lengths for the UVI center in 143 (1.79(1), 1.80(1) Å) are shorter than those for the UV 
center (1.82(1), 1.93(1) Å) indicating that the valence of each U center is localized. Each U 
center is pentagonal bipyramidal, with the axial coordination sites occupied by the U–oxo 
groups and 4 of the equatorial coordination sites occupied by the salen ligand. In terms of the 
UV center, the fifth equatorial coordination site is occupied by pyridine, whereas for the UVI 
center it is occupied by a uranyl(V) oxo group; the uranyl(VI) and uranyl(V) ions in 143 
participate in a T-shaped CCI similarly to complexes 135-138.78  
Scheme 26. Synthesis of [Cp*2Co][{U
VIO2(salen)}{U
VO2(salen)(py)}] (143), [Rb(18-c-
6)]2[Rb2{U
VO2(salen)}4] (141) and [K(18-c-6)]2[K2{U
VO2(salen)}4] (135) from 
[Cp*2Co][U
VO2(salen)(py)] (140). 140 also reacts with LiI in pyridine to give a mixture of 
disproportionation products.78  
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DFT studies on the mechanism of disproportionation of uranyl(V) in 135 in aqueous 
solution suggests that the protonation of a cation-cation intermediate is followed by electron 
transfer occurs to yield uranyl(VI), UIV aqua complexes, and water.5 This was supported 
experimentally, in which 135 was reacted with 1 equiv. of [HPy]Cl per uranium to 
immediately afford the disproportionation products [UVIO2(salen)(py)] (142), [U
IV(salen)2] 
(144) and [UIVCl2(salen)] (145) in a ratio of 6:2:3 (Scheme 27; H2O was also detected by 
1H 
NMR spectroscopy). The important role played by protons in this mechanism is highlighted 
and confirms that protonation of one uranyl oxygen atom to form a better leaving group is a 
key step, given that the UIV disproportionation products no longer contain oxo ligands.78 
Scheme 27. [K(18-c-6)]2[K2{U
VO2(salen)}4] (135) reacts with [HPy]Cl to afford a mixture of 
disproportionation products.78  
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The tetranuclear complexes 135-137 give rise to well-resolved bands at 960 nm (ε ~ 
200 L mol–1 cm–1) in their respective UV-Vis-NIR spectra in pyridine. In contrast, 129 and 
138 (vide supra) give rise to large, poorly resolved bands in the region of 800-1000 nm (ε ~ 
200 L mol–1 cm–1). These spectral differences could arise from the differences in symmetry 
between the two types of structures and could prove useful for detecting the presence of oxo-
clusters in solution.78  
The reactivity of [Cp*2Co][U
VO2(salen)(py)] (140) with [CaCl2(dme)] and Mn(NO3)2 
has also been investigated. Complex 140 reacts with [CaCl2(dme)] in a 2:1 ratio to provide 
tetrameric [Ca2{U
VO2(salen)}4] (146) and [Cp*2Co]Cl as a reaction by-product. Complex 146 
is structurally analogous to complexes 135-137 and 141, albeit with Ca2+ cations in the center 
of the tetramer and no cations on the periphery (Scheme 28). The U–O bond lengths in 146 
range from 1.79(1)-1.96(1) Å, in which the bridging UV–O bond is elongated relative to the 
terminal oxo. The O–U–O bond angles are 174.6(5) and 177.1(7)° and the U···O bond 
distances between the bridging uranyl(V) oxo groups and UV centers are 2.32(1) and 2.37(1) 
Å.82  
Compound 140 also reacts with Mn(NO3)2 in a 2:1 ratio, in this case to form the 
molecular wheel-shaped [{MnII(py)3}6{U
VO2(salen)}12] (147), along with [Cp*2Co][NO3] as 
a reaction by-product (Scheme 28). Complex 147 is held together by CCIs between the 
uranyl(V) oxo groups and the MnII ions, as opposed to the UV center of a neighboring 
uranyl(V) ion, as is the case in complexes 135-137, 141 and 146 (vide supra). Six of the 
uranyl(V) ions in 147 form Mn-oxo-bridges through both uranyl oxo atoms, whereas the other 
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six form bridges through just one oxo ligand. The U–O bond lengths range from 1.79(2)-
1.90(2) Å, the O–U–O bond angles range from 169.9(6)-176.5(9)° and the Mn···Obridging 
distances range from 2.12(2)-2.18(2) Å. The structural motif seen in 147 is likely a 
consequence of the 2:1 [UVO2]
+:[MnII]2+ ratio, the 2+ charge of the MnII ion and the preference 
of MnII to adopt an octahedral coordination geometry. As a result, the [UVO2]
+···MnII 
interactions in 147 play a structure-directing role. The magnetic properties of complexes 146 
and 147 have also been studied.82  
 
Scheme 28. Synthesis of [Ca2{U
VO2(salen)}4] (146) and [{Mn
II(py)3}6{U
VO2(salen)}12] 
(147) from [Cp*2Co][U
VO2(salen)(py)] (140) and [CaCl2(dme)] and Mn(NO3)2, 
respectively.82  
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Polymeric [UVO2(Mesaldien)K]n (Mesaldien = N,N'-(2-
aminomethyl)diethylenebis(salicylideneimine); 148) can be obtained from the K2Mesaldien 
and 128 and possesses U–O bond lengths ranging from 1.79(2)-1.86(2) Å, indicating that the 
UV oxidation state is maintained. Complex 148 (6 equiv.) reacts with [UIVI4(OEt2)2] (3 equiv.) 
in the presence of K2Mesaldien (3 equiv.) in pyridine to afford tetrameric 
{[{UVO2(Mesaldien)}{U
IV(Mesaldien)}]2(µ-O)} (149) along with uranyl(VI), 
[UVIO2(Mesaldien)] (150), from partial disproportionation (Scheme 29). Complex 149 is 
made up of two uranyl(V)-Mesaldien/UIV-Mesaldien units connected by a bridging oxo 
ligand. The U–O bond lengths in the uranyl(V) fragment are 1.82(1) and 2.00(1) Å, and the 
O–U–O unit retains its linearity (176.5(6)°).50  
Scheme 29. Synthesis of {[{UVO2(Mesaldien)}{U
IV(Mesaldien)}]2(µ-O)} (149) and 
[UVIO2(Mesaldien)] (150) from [U
VO2(Mesaldien)K]n (148), K2Mesaldien and 
[UIVI4(OEt2)2]. The K2Mesaldien ligand is depicted in the bottom left corner of the Scheme.
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 Complex 128 also reacts with the KLnacnac ligand (KLnacnac = 2-(4-tolyl)-1,3-
bis(quinolyl)malondiiminate) in pyridine to afford the uranyl(V) trimer, [UVO2(L
nacnac)]3 (151; 
Scheme 30). Each UV center possesses pentagonal bipyramidal geometry, coordinated by one 
equivalent of the tetradentate β-diketiminate ligand in the equatorial plane with the fifth 
coordination site occupied by an oxo group of a neighboring uranyl(V) ion. PFGSTE diffusion 
NMR spectroscopy in pyridine indicated that the trimetallic motif is maintained in solution. 
However, dissolution of 151 into DMSO does result in partial dissociation of the trimer.51  
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 The U–O bond lengths in 151 range from 1.84(1)-1.940(8) Å, and the O–U–O bond 
angles range from 176.4(3)-176.7(4)°. Complex 151 reacts with oxidizing agents, forming 
uranyl(VI) [UVIO2Cl(L
nacnac)] (152) when dissolved in CH2Cl2 through chloride abstraction 
from the solvent, or [{UVIO2(L
nacnac)}2(µ-O)] (153) when treated with dry O2 in acetonitrile 
(Scheme 30). The U–O bond lengths range from 1.757(9)-1.82(1) Å in 152 and 153, the 
shorter of these in agreement with UVUVI oxidation, although those around 1.8 Å are 
remarkably long for a formal UVI oxidation state and the oxo-group reactions of these 
complexes may warrant further study.51  
Scheme 30. Synthesis of [UVO2(L
nacnac)]3 (151) from KL
nacnac and [{UVO2(py)5}{KI2(py)2}]n 
(128). 151 reacts further with CH2Cl2 or dry O2 to afford [U
VIO2Cl(L
nacnac)] (152) and 
[{UVIO2(L
nacnac)}2(µ-O)] (153), respectively.
51  
  
A series of trimetallic 3d-5f and 4d-5f complexes featuring the uranyl(V) ion, [UVO2]
+ have 
also been prepared to target single molecule magnetism in uranyl(V)-containing complexes, given its 
highly anisotropic nature and potential for magnetic exchange through metal–O–UV linkages.83-85  
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Scheme 31. Synthesis of MII-OUVO-MII and CoII-OUVO complexes, 
[{UVO2(Mesaldien)}{M
IIX(TPA)}2]X (M = Fe, X = Cl (154); M = Mn, X = I (155); M = Cd, X = I 
(156)) and [{UVO2(Mesaldien)}{Co
II(TPA)}]I (157), featuring uranyl(V).83-85   
 
 [UVO2(Mesaldien)K]n (148) reacts with 2 equiv. of a 3d- or 4d-metal complex of the 
tetradentate tris(pyridyl)amine ligand, TPA (TPA = tris(2-pyridylmethyl)amine), to afford the 
trimetallic MII-OUVO-MII complexes, [{UVO2(Mesaldien)}{M
IIX(TPA)}2]X (M = Fe, X = Cl (154); 
M = Mn, X = I (155); M = Cd, X = I (156); Scheme 32). Treatment of 148 with 1 equiv. of 
[CoIII2(TPA)] affords bimetallic [{U
VO2(Mesaldien)}{Co
II(TPA)}]I (157, Scheme 31).83-85   
Scheme 32. Synthesis of MII-OUVO-MII complexes, 
[{MII(BPPA)(L)}{UVO2(Mesaldien)}{M
II(BPPA)(py)}]I (M = Ni, L = py (158); M = Fe, L = py 
(159); M = Co, L = vacant coordination site (160)), featuring uranyl(V).83,85   
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Trimetallic MII-OUVO-MII complexes may also be obtained from polymeric 
[UVO2(Mesaldien)K]n and 2 equiv. of [M
III(BPPA)] (BPPA = bis(2-picolyl)(2-oxybenzyl)amine), 
affording [{MII(BPPA)(L)}{UVO2(Mesaldien)}{M
II(BPPA)(py)}]X (M = Ni, L = py (158); M = Fe, 
L = py (159); M = Co, L = vacant coordination site (160); Scheme 32).83,85   
Scheme 33. Synthesis of polymeric MII-OUVO complexes, [{UVO2(salen)(py)}{M
II(py)4}(NO3)]n (M 
= Cd (161); M = Mn (162)), of uranyl(V).86  
 
Alternatively, the uranyl(V) complex [Cp*2Co][U
VO2(salen)(py)] (140) reacts with the simple 
3d or 4d metal precursors [MII(NO3)2] to yield polymeric [{U
VO2(salen)(py)}{M
II(py)4}(NO3)]n (M 
= Cd (161); M = Mn (162); Scheme 33),86 while [Cp*2Co][U
VO2(Mesaldien)] (163) reacts with 
[MnII(NO3)2(py)2] to afford polymeric {[U
VO2(Mesaldien)][Mn
II(NO3)(py)2]}n (164).
87 Complexes 
154-161 and 164 all contain the uranyl(V) ion with U–O bond lengths and O–U–O bond angles 
ranging from 1.837(3)-1.934(3) Å and 171.6(2)-178.7(5)⁰, respectively, and possess bridging MII–
O–UV–O–MII interactions between cationic MII and anionic UV fragments.83-87 
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It has also been shown that the dipotassium salt of a ferrocene-based tetradentate Schiff-base 
ligand, K2salfen-
tBu2, reacts with [{U
VO2(py)5}{KI2(py)2}]n (128) to afford [{K(18-c-
6)}UVO2(salfen-
tBu2)] (165, Scheme 34), which possesses U–O and U–OK bond lengths of 
1.831(4)/1.838(4) and 1.853(4)/1.860(4) Å, respectively, and O–U–O bond angle of 
176.8(2)/177.5(2)⁰ for two crystallographically independent molecules within the unit cell. K2salfen-
tBu2 also reacts with [U
VIO2I2(py)3)] (166-py) to yield [U
VIO2(salfen-
tBu2)] (167). If the less bulky 
K2salfen (in which the tert-butyl groups are replaced with hydrogen atoms) is used a mixture of U(IV) 
and [UVIO2]
2+ species are formed over 12 hours through disproportionation of a transiently formed 
uranyl(V) species.52  
Scheme 34. Synthesis of [{K(18-c-6)}UVO2(salfen-
tBu2)] (165) from [{U
VO2(py)5}{KI2(py)2}]n 
(128) and K2salfen-
tBu2.
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 [{UVO2(py)5}{KI2(py)2}]n (128) also reacts with K2dpaea in the presence of 2.2.2-cryptand 
in pyridine to yield the uranyl(V) complex, [K(2.2.2-crypt)][UVO2(dpaea)] (168; Scheme 35). 
Uranyl(V) 168 possesses a O–U–O bond angle 176.06(8)°, U–O bond lengths of 1.837(2) and 
1.847(2) Å and an asymmetric stretching frequency of 794 cm–1. Complex 168 is stable in aprotic 
solvents for up to 4 months, or until the addition of 1 equiv. of [HPy]OTf (in DMSO), which results 
in disproportionation; X-ray quality crystals of the UIV species, [UIV(dpaea)2] (169), were isolated 
from this reaction. Analogously to [Cp*2Co][U
VO2(dpaea)] (122), introduced in Section 3, once 
isolated 168 is stable against disproportionation when dissolved in D2O. Complex 168 (7-15 mM, pH 
= 9.2-10) is in fact stable in D2O for up to 2 weeks, but slowly begins to precipitate from solution 
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after this point. Small amounts of the disproportionation products begin to appear after 5 days in D2O 
(16 mM of 168, pH = 7), and more than 80 % of 168 has undergone disproportionation after 2 days 
in 20 mM D2O solutions at pH = 6. These results indicate that 168 is stable in aqueous solutions with 
a pH between 7 and 10, and that acid-induced disproportionation of 168 occurs rapidly in organic 
solutions in the presence of stoichiometric amounts of a proton source. CV studies on 168 indicate 
that the UVI/UV redox couple (E1/2 = –1.25 V vs. Fc/Fc+) is reversible in pyridine but irreversible in 
aqueous solution (0.02 M HEPES buffered water solution, pH = 7; UV/UVI oxidation occurs at E = –
0.16 to 0.00 V vs. Ag/AgCl, UVI/UV reduction occurs at E = –1.56 to –1.65 V vs. Ag/AgCl); the 
UV/UIV redox couple is not observed in aqueous solution. The different electrochemical behavior of 
168 in pyridine versus aqueous solution has been attributed to U–OH2 binding and/or the potential 
for proton exchange reactions to occur.48      
Scheme 35. Synthesis of [K(2.2.2-crypt)][UVO2(dpaea)] (168) from [{U
VO2(py)5}{KI2(py)2}]n (128), 
K2dpaea and 2.2.2-cryptand (see Scheme 20 in Section 3 for a depiction of H2dpaea).
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 [{UVO2(py)5}{KI2(py)2}]n (128) also reacts with K3trensal (H3trensal = 2,2',2''-
tris(salicylideneimino)triethylamine), to afford K[UVO2(trensal)K] (170, Scheme 36a). Treating 170 
with 2.2.2-cryptand allows for isolation of [K(2.2.2-crypt)]2[U
VO2(trensal)] (171), in which one of 
the U–oxo groups is coordinated to a K+ cation (Scheme 36b; U–O = 1.82(2) Å, U–OK = 1.87(2) Å). 
Alternatively, 170 reacts with 1 or 1.5 equiv. of FeI2 in pyridine to substitute the K
+ cation for a 
coordinated FeII fragment to afford [UVO2(trensal)Fe
II(py)3] (172; U–O = 1.837(3) Å, U–OFe = 
1.930(2) Å) and 0.5 equiv. of [{UVO2(trensal)Fe
II(py)3}2Fe
II(py)3]I2 (173; U–O = 1.920(4)-1.935(4) 
Å), respectively (Scheme 36c and 36d). Both complexes 172 and 173 possess contracted U–O bond 
lengths at the unfunctionalized oxo group compared with the functionalized oxo group. Complex 170 
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also reacts with [UIV(trensal)]I to afford [UVO2(trensal)Fe
II(py)3U
IV(trensal)]I (174; Scheme 36e), 
which possesses a contracted FeII-functionalized U–O bond length (1.922(6) Å) relative to the UIV-
functionalized U–O group (1.960(6) Å). Complexes 171-174 possess O–U–O bond angles that range 
from 173.7(6)-177.2(2)⁰. Remarkably, complexes 172-174, which exhibit FeII functionalization of a 
uranyl-oxo group, demonstrate increased stability with respect to proton-induced disproportionation. 
Complex 172 reacts with 2 equiv. of pyridinium chloride ([HPy]Cl) to afford 174, a product of partial 
disproportionation which possesses a FeII-[OUVO]+-UIV core, whereas complexes 170 and 171 react 
with 2 equiv. of [HPy]Cl to yield UIV and [UVIO2]
2+ complexes via complete disproportionation. 
Furthermore, redox reactivity and CV experiments display an increased range of stability for the 
uranyl(V) species functionalized by FeII with respect to both oxidation and reduction reactions. As 
FeII-containing minerals are known to participate in [UVIO2]
2+ reduction and stabilization of uranyl(V) 
species with its exact role remaining ambiguous, these results shed light on the function of iron in the 
environmental mineral-mediated reduction of UVI.66 
Scheme 36. Synthesis of (a) K[UVO2(trensal)K] (170) from [{U
VO2(py)5}{KI2(py)2}]n (128) and 
K3trensal, followed by conversion into (b) [K(2.2.2-crypt)]2[U
VO2(trensal)] (171), (c) 
[UVO2(trensal)Fe
II(py)3] (172), (d) [{U
VO2(trensal)Fe
II(py)3}2Fe
II(py)3]I2 (173) and (e) 
[UVO2(trensal)Fe
II(py)3U
IV(trensal)]I (174) by treatment with 2.2.2-cryptand, 1 and 1.5 equiv. of FeI2 
and 1 equiv. of [UIV(trensal)], respectively.66  
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While [{UVO2(py)5}{KI2(py)2}]n (128) has been used as an effective starting uranyl(V) 
complex for further oxo-functionalization while maintaining the uranyl(V) oxidation state, it has been 
demonstrated to undergo immediate disproportionation in the presence of benzoic acid in pyridine, 
forming the hexanuclear UIV-benzoate cluster, [UIV6O4(OH)4(PhCOO)12(py)3] (175), and the 
uranyl(VI) complex, [UVIO2(PhCOO)2(py)2] (176). Water, pyridinium iodide and KI are formed as 
by-products during this reaction.53  
The synthesis of [UVO{OAlR2(py)}(H2L
Me)] (R = Me (87), iBu (88); Scheme 16 in Section 
3) from the uranyl(VI) Pacman complex 11-py and [Cp2TiCl(CH2)(AlMe2)] and HAl
iBu2, 
respectively, was discussed previously in Section 3. The oxo-coordinated -AlR2 group in 87 or 88 is 
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readily replaced by Group 1 metal cations by treatment with alkyl lithium reagents (MeLi, 
(Me3Si)2CHLi, Me3SiCH2Li) in C6D6 to provide [{(OU
VO)Li(py)(H2L
Me)}2] (177; Scheme 37a). 
Alternatively, 87 and 88 react with LiH in pyridine to afford a trilithiated complex, 
[UVO{OLi(py)3}(py){{Li(py)}2L
Me}] (60-py; Scheme 37b and Scheme 9 in Section 3), or with NaH 
or KH in pyridine to provide [UVO{OM(py)3}(py)(H2L
Me)] (M = Na (178), K (179); Scheme 37c). 
Furthermore, 177 may be converted into [UVO{OLi(py)3}(py)(H2L
Me)] (180) through the addition of 
pyridine (Scheme 37d).73 This reactivity contrasts that of the uranyl(VI) complex 11-py, in which 
deprotonation of the acidic pyrrole NH groups35 occurs instead of transmetalation of the oxo-
coordinated functional group, suggesting that hydrogen-bonding between the uranyl endo-oxo group 
and the pyrrole protons is significant enough to negate deprotonation.73   
Scheme 37. Transmetalation of the oxo-coordinated -AlR2 group with Group 1 metal cations 
using either alkyl lithium reagents affording (a) [{(OUVO)Li(py)(H2L
Me)}2] (177), or Group 1 metal 
hydrides providing (b) [UVO{OLi(py)3}(py){{Li(py)}2L
Me}] (60-py) and (c) 
[UVO{OM(py)3}(py)(H2L
Me)] (M = Na (178), K (179)). The addition of pyridine to 177 provides (d) 
[UVO{OLi(py)3}(py)(H2L
Me)] (180).73 
 
Interestingly, this clean substitution of the AlR2 group has enabled the development of a one-pot, 
DIBAL-catalyzed reduction of the U(VI) uranyl complexes to all three mono-alkali metal 
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uranyl(V) complexes 178-180 (Scheme 38). This DIBAL-catalyzed route could also have 
applications in d-block metal oxo chemistry.73  
Scheme 38. Complexes 178-180 may be prepared catalytically from HAl(iBu)2 (10 mol %) and 
excess MH (M = Li, Na, K) in toluene (70 ⁰C, 3-4 days).73  
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Table 4. Structural and spectroscopic data for functionalized uranyl(V) complexes reported since 
2010 and discussed in Section 4. With respect to the tabulated IR data, sym. refers to the symmetric 
OUO stretching frequency determined by Raman spectroscopy and asym. refers to the asymmetric 
OUO stretching frequency determined by IR spectroscopy. 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
[K(18-c-6)][UO2(salan-tBu2)(py)] (131) 1.853(2), 
1.868(2) 
2.651(3)  177.4(1) 138.0(1) Unassigneda 81 
[Cp*2Co][UO2(salan-tBu2)(py)] (132) 1.846(9), 
1.866(9) 
– 178.7(4) – Unassigned 81 
{[K(THF)2][UO2(salophen-tBu2)(THF)]}n 
(134-THF) 
1.853(2), 
1.850(2) 
2.630(2), 
2.685(2)  
177.14(8) 144.55(9)
, 
115.75(9) 
Unassigned 81 
[K(18-c-6)]2[K2{UO2(acacen)}4] (136) 1.85(1), 
1.94(1), 
1.86(1), 
1.973(9) 
X = K: 
2.65(1), 
2.89(1), 
3.06(1), 
2.88(1), 
2.93(1) 
X = UV: 
2.40(1), 
2.344(9)  
177.4(5), 
179.3(5) 
X = K: 
137.7(5), 
96.4(5), 
88.2(3), 
94.1(4), 
84.1(4), 
97.1(4), 
96.2(3), 
89.4(3) 
X = UV: 
175.0(7), 
172.2(6) 
Unassigned 78 
[K(2.2.2-crypt)]2[K2{UO2(acacen)}4] 
(137) 
1.77(1), 
1.91(1), 
1.799(9), 
1.91(1) 
X = K: 
2.907(8), 
3.05(1), 
2.885(9), 
3.118(9) 
X = UV: 
2.40(1), 
2.40(1)  
179.3(4), 
179.2(4) 
X = K: 
97.4(3), 
89.2(3), 
95.5(3), 
84.1(3), 
98.6(3), 
87.7(3), 
93.2(3), 
84.7(3) 
X = UV: 
173.4(5), 
173.4(4) 
Unassigned 78 
[K(18-c-
6)(THF)2][{UVO2(salophen)}4(µ8-K)2(µ5-
KI)2]I2 (138) 
1.871(4), 
1.942(3), 
1.818(3), 
1.954(3) 
X = K: 
2.372(3), 
2.816(3), 
2.856(3), 
3.121(3), 
2.815(3) 
X = UV: 
2.404(3), 
2.374(3)  
175.4(1), 
174.7(2) 
X = K: 
90.3(1), 
99.5(1), 
94.1(1), 
136.2(2), 
90.4(1), 
83.30(9) 
X = UV: 
154.4(2), 
155.3(2) 
Unassigned 78 
[Rb(18-c-6)]2[Rb2{UO2(salen)}4] (141) 1.84(1), 
1.928(9), 
1.882(8), 
1.909(9) 
X = Rb: 
3.065(8), 
3.154(9), 
3.04(1), 
3.41(1), 
2.742(9) 
X = UV: 
2.414(9), 
2.419(9)  
175.3(3), 
177.1(5) 
X = Rb: 
100.3(3), 
86.9(3), 
95.0(3), 
88.7(3), 
97.6(4), 
88.6(3), 
91.0(4), 
82.3(3), 
148.1(6) 
X = UV: 
171.2(4), 
171.2(6) 
Unassigned 78 
[Ca2{UO2(salen)}4] (146) 1.80(1), 
1.96(1), 
1.79(1), 
1.93(1) 
X = Ca: 
2.553(1), 
2.81(1), 
2.56(1), 
2.83(2) 
174.6(5), 
177.1(7) 
X = Ca: 
102.0(5), 
92.0(4), 
102.2(5), 
91.9(5), 
756 (asym.) 82 
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X = UV: 
2.32(1), 
2.37(1) 
94.9(5), 
86.5(4), 
94.2(6), 
86.2(4) 
X = UV: 
159.4(7), 
178.5(8) 
[{Mn(py)3}6{UO2(salen)}12] (147) 1.85(1), 
1.88(1), 
1.87(1), 
1.88(2), 
1.89(1), 
1.89(1), 
1.84(2), 
1.89(2), 
1.90(1), 
1.90(2), 
1.79(2), 
1.90(2)    
2.15(1), 
2.18(2), 
2.17(2), 
2.18(2), 
2.18(2), 
2.12(2), 
2.17(1), 
2.12(2), 
2.18(2), 
2.12(2)  
176.1(6), 
169.9(6), 
171.4(7), 
176.5(9), 
172.4(6), 
175.2(8) 
155.6(8), 
145.9(7), 
167.8(9), 
169.1(9), 
148.0(8), 
154.2(8), 
169.8(8), 
147.4(8), 
155.6(8) 
752 (asym.) 82 
[UO2(Mesaldien)K]n (148) 1.79(2), 
1.86(2), 
1.79(2), 
1.83(2) 
2.63(2), 
2.80(2), 
2.72(2), 
2.82(2)  
174.1(9), 
177.4(9) 
151(1), 
108.9(7), 
154(1), 
103.3(7) 
Unassigned 50 
{[{UVO2(Mesaldien)}{UIV(Mesaldien)}]2
(µ-O)} (149) 
1.82(1), 
2.00(1) 
2.20(1)  176.5(6) 162.8(7) Unassigned 50 
[UO2(Lnacnac)]3 (151) 1.84(1), 
1.91(1), 
1.844(9), 
1.940(8), 
1.820(8), 
1.906(8) 
2.374(8), 
2.371(9), 
2.356(9)  
176.7(4), 
176.4(3), 
176.7(4) 
157.1(5), 
156.4(4), 
154.9(5) 
Unassigned 51 
[{UO2(Mesaldien)}{FeCl(TPA)}2]I (154) 1.917(4), 
1.877(4) 
1.998(4), 
2.132(4) 
174.8(2) 163.8(2), 
175.4(2) 
Unassigned 83 
[{UO2(Mesaldien)}{MnI(TPA)}2]I (155) 1.91(1), 
1.90(1)  
2.05(1), 
2.06(1)  
175.7(4) 168.1(8), 
171.4(7) 
Unassigned 83 
[{UO2(Mesaldien)}{CdI(TPA)}2]I (156) 1.89(2) 2.20(2)  172.7(8) 168.7(8) Unassigned 84 
[{UO2(Mesaldien)}{Co(TPA)}]I (157) 1.837(3), 
1.934(3) 
1.924(3)  175.0(2) 151.5(2) Unassigned 85 
[{UO2(Mesaldien)}{Ni(BPPA)(py)}2]I 
(158) 
1.896(5), 
1.891(5) 
2.068(5), 
2.026(5) 
175.0(2) 174.4(3), 
168.5(3) 
Unassigned 83 
[{UO2(Mesaldien)}{Fe(BPPA)(py)}2]I 
(159) 
 
 
1.917(4), 
1.895(4) 
2.006(4), 
2.049(4)  
174.1(2) 167.9(3), 
168.9(3) 
Unassigned 83 
[{UO2(Mesaldien)}{Co(BPPA)}2]I (160) 1.913(6), 
1.897(6) 
1.983(6), 
2.037(7)  
173.8(3) 175.2(4), 
170.9(4) 
Unassigned 85 
[{UO2(salen)(py)}{Cd(NO3)(py)4}]n 
(161) 
 
1.87(1), 
1.88(1), 
1.88(1), 
1.88(1), 
1.87(1), 
1.89(1) 
2.30(1), 
2.28(1), 
2.30(1), 
2.34(1), 
2.34(1), 
2.32(1), 
2.30(1)  
178.7(5), 
177.5(5), 
178.7(5) 
173.5(6), 
161.8(7), 
166.0(7), 
170.0(6), 
175.1(7), 
162.8(7) 
Unassigned 86 
[CoCp*2][UO2(Mesaldien)] (163) 
 
1.845(8), 
1.846(8) 
– 171.5(4) – Unassigned 87 
{[UO2(Mesaldien)][Mn(NO3)(py)2]}n 
(164) 
1.900(3), 
1.910(3) 
2.066(3), 
2.090(4)  
171.6(2) 164.4(2), 
177.2(2) 
Unassigned 87 
[{K(18-c-6)}UO2(salfen-tBu2)] (165) 
 
 
1.831(4), 
1.853(4), 
1.838(4), 
1.860(4) 
2.568(4), 
2.791(4)  
176.8(2), 
177.5(2) 
150.7(2), 
110.2(2) 
Unassigned 52 
[K(2.2.2-crypt)][UO2(dpaea)] (168) 1.837(2), 
1.847(2) 
– 176.06(8) – 794 (asym.) 48 
[K(2.2.2-crypt)]2[UO2(trensal)] (171) 1.87(2), 
1.82(2) 
2.83(2)  173.7(6) 160.0(7) Unassigned 66 
[UO2(trensal)Fe(py)3] (172) 1.837(3), 
1.930(2) 
2.018(3) 177.1(1) 173.5(2) Unassigned 66 
[{UO2(trensal)Fe(py)3}2Fe(py)3]I2 (173) 1.920(4), 
1.935(4), 
1.927(4), 
1.927(5) 
2.067(4), 
1.984(4), 
1.992(5), 
2.055(5)  
175.5(2), 
175.3(2) 
173.2(2), 
166.6(3), 
153.1(3), 
171.1(3) 
Unassigned 66 
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Table Footnotes: a reassigned or reclassified as unassigned in the light of more recent information on this and related complexes since the original 
publication appeared; * two values are provided due to two site disorder of the Na cation. The compounds are numbered within Table 4 according to 
how they appear in the text, and any lattice solvent molecules are not included in the chemical formulae. 
 
The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X 
= oxo-functionalizing unit) determined by single crystal X-ray diffraction, and characteristic 
spectroscopic data (OUO vibrational stretching frequency) determined by FTIR or Raman 
spectroscopies for the functionalized uranyl(V) complexes reported since 2010 and discussed 
in Section 4 (vide supra) are provided in Table 4, and their trends are discussed in more detail 
in Section 7 (vide infra). 
  
[UO2(trensal)Fe(py)3U(trensal)]I (174) 1.960(6), 
1.922(6) 
2.317(6) (X = 
U), 2.144(6) 
(X = Fe) 
177.2(2) 171.2(3) 
(X = U), 
170.3(3) 
(X = Fe) 
Unassigned 66 
[{(UO2)Li(py)(H2LMe)}2] (177) 1.908(2), 
1.891(2) 
1.901(7)  177.7(1) 147.2(2) 894 (asym.) 73 
[UO{ONa(py)3}(py)(H2LMe)] (178) 1.844(5), 
1.856(7) 
2.15(2), 
2.28(2)* 
174.2(3) 167.7(6), 
170.3(8)* 
891 (asym.) 73 
[UO{OK(py)3}(py)(H2LMe)] (179) 1.871(2), 
1.837(2) 
2.707(3) 176.1(1) 116.0(1) 894 (asym.) 73 
[UO{OLi(py)3}(py)(H2LMe)] (180) 1.853(6), 
1.884(7) 
1.94(2)  173.8(3) 166.7(8) 891 (asym.) 73 
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5. UVIUIV REDUCTIVE FUNCTIONALIZATION 
The treatment of the trianionic pyridine(diamine) uranium(IV) complexes 
[Cp*UIV(MesPDIMe)(L)] (MesPDIMe = 2,6-((Mes)N=CMe)2C5H3N; L = THF or (Me2N)3PO) and 
[Cp*UIV(tBu-MesPDIMe)(THF)] (tBu-MesPDIMe = 2,6-((Mes)N=CMe)2-p-C(CH3)3C5H3N) with N-
methylmorpholine-N-oxide affords the uranyl(VI) complexes, [Cp*UVIO2(
MesPDIMe)] (181) and 
[Cp*UVIO2(
tBu-MesPDIMe)] (182), which are best described as containing uranyl(VI) supported by a 
singly reduced pyridine(diamine) ligand. Treatment of 181 or 182 with 2 equiv. of Me3SiI results in 
UVIUIV reduction and silylation of both oxo ligands, forming [UIVI2(OSiMe3)2(MesPDIMe)] (183) 
and [UIVI2(OSiMe3)2(
tBu-MesPDIMe)] (184), respectively (Scheme 39).54 
Scheme 39. UVIUIV reductive silylation of [Cp*UVIO2(MesPDIMe)] (181) with Me3SiI, affording 
[UIVI2(OSiMe3)2(
MesPDIMe)] (183) via intermediate [UVOI(OSiMe3)(
MesPDIMe)] (185).54  
 
Only complex 183 was crystallographically characterized and in the solid-state the UIV center 
possesses pentagonal bipyramidal geometry with the trans-trimethylsiloxy ligands occupying the 
axial coordination sites. The formation of 183 was thought to progress from 181 via a UV 
intermediate, which was identified as [UVOI(OSiMe3)(
MesPDIMe)] (185) by 1H NMR and IR 
spectroscopy. Intermediate 185 is the product of homolytic cleavage of the U–Cp* bond with 
concomitant Me3Si–I addition across one of the U=O bonds; its presence during the formation of 179 
was verified by electronic absorption spectroscopy of the reaction solution. The formation of 184 is 
thought to proceed via an analogous intermediate.54  
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Scheme 40. UVIUIV reductive silylation of [Cp*UVIO2(MesPDIMe)] (181), providing 
[(R3SiO)2U
IVX2(OPPh3)2] (R = Ph, X = Cl (186); R = Me, X = SPh (187); R = Me, X = Cl (188); R 
= Me, X = I (189); R = Me, X = OTf (190)).88  
 
The scope of the reductive silylation of 181 using Me3SiI was expanded to other silanes via a 
reductive functionalization strategy that entailed the addition of a Lewis base to generate the silylium 
ion, [base-SiR3][X]. It was envisaged that the more electrophilic silylium ion would facilitate uranyl 
functionalization, and while previously the addition of Ph3Si-Cl or Me3Si-SPh to 181 did not result 
in a reaction, and the addition of Me3Si-Cl or Me3Si-OTf yielded intractable mixtures, the 
introduction of two equiv. of Ph3P=O into the reaction mixtures resulted in complete conversion into 
[(R3SiO)2U
IVX2(OPPh3)2] (R = Ph, X = Cl (186); R = Me, X = SPh (187); R = Me, X = Cl (188); R 
= Me, X = I (189); R = Me, X = OTf (190); Scheme 40). The more sterically encumbered iPr3Si-Cl 
remained unreactive with 181, which was attributed to the inability of O=PPh3 to undertake 
nucleophilic attack at Si.88,89 The reducing electrons for the two electron reduction of the UVI center 
in 181 originate from the redox-active pyridine(diamine) ligand and from homolytic cleavage of the 
U–Cp* bond, forming [MesPDIMe]0 and Cp*2 as by-products.54  
Scheme 41. UVIUIV reductive silylation of [UVIO2X2(OPPh3)2] (191, 197, 198) and 
[UVIO2(OTf)2(2,2'-bipy)2] (199): by (1) alkylation followed by (2) bis(alkyl) reductive elimination 
and U–O silylation, forming [{R3SiO)UIVX2(OPPh3)] (186-189, 192-196, 200) and 
[{Me3SiO)U
IV(OTf)2(2,2'-bipy)2)] (201).
89 
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The reductive functionalization of the simple uranyl(VI) compound [UVIO2Cl2(OPPh3)2] 
(191) has also been explored. Salt metathesis using M-R alkylating reagents (M-R = KCH2Ph, 
nBuLi, 
MCH2SiMe3; M = Li, Na, K), forms the corresponding U
VI (dialkyl) complexes which undergo 
reductive elimination of the alkyl co-ligands upon addition of R3Si–X halosilanes across the U=O 
bond. The reductive elimination of alkane provides the two reducing electrons requisite for UVIUIV 
reduction. Alkylation of 191 with two equiv. of NaCH2SiMe3, followed by the addition of R3Si-Cl 
provided [(R3SiO)2U
IVCl2(OPPh3)2] (R = Ph (186), Me (188), Et (192) or H (193); Scheme 41) in 
high yields. The use of this protocol with Me2PhSi-Cl, MePh2Si-Cl, Ph2HSi-Cl and Me3Si-SPh also 
provided the desired UIV bis(siloxide) products, [(Me3SiO)2U
IV(SPh)2(OPPh3)2] (187) and 
[(R3SiO)2U
IVCl2(OPPh3)2] (R3Si = Me2PhSi (194), MePh2Si (195) and Ph2HSi (196); Scheme 41). 
The same method was also applied to different uranyl and silyl starting materials, in particular, 
[UVIO2X2(OPPh3)2] (X = Br (197), I (198)) and [U
VIO2(OTf)2(2,2'-bipy)2] (199), and Me3Si-X (X = 
Br, I, OTf) which successfully generated the corresponding UIV bis(siloxide) products, 
[(Me3SiO)U
IVBr2(OPPh3)] (200), [(Me3SiO)U
IVI2(OPPh3)] (189) and [(Me3SiO)U
IV(OTf)2(2,2'-
bipy)2] (201), respectively (Scheme 41); the halide co-ligands incorporated with the uranyl starting 
materials were matched with the R3Si-X halide to avoid halide scrambling.
89  
Scheme 42. UVIUIV reductive silylation of cationic [UVIO2(OTf)(dppmo)][OTf] (202) resulting in 
oxo-group silylation and abstraction, yielding [UIV(OSiPh3)(OTf)2(dppmo)2][OTf] (204).
90 
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Cationic uranyl(VI) complexes have been studied in reductive silylation chemistry as they 
should be susceptible to reduction at more positive reduction potentials. However, treatment of the 
cationic uranyl(VI) complex [UVIO2(dppmo)2(OTf)][OTf] (202; dppmo = Ph2P(O)CH2P(O)PPh2) 
with 2 equiv. of Ph3SiOTf did not result in a reaction, which is likely due to the decrease in 
nucleophilicity of the uranyl oxo-ligands. In contrast, the addition of 2 equiv. of [CoCp2] and 4 equiv. 
of Ph3SiOTf to 202 afforded [U
IV(OTf)4(dppmo)] (203), likely through initial U
VIUV reduction to 
render the uranyl oxo-groups more nucleophilic and susceptible to silylation. The formation of 203 
proceeds through a UIV bis(siloxide) intermediate, detected by 1H NMR spectroscopy, and 
[UIV(OSiPh3)(OTf)2(dppmo)2][OTf] (204), which was characterized crystallographically. 204 is the 
product of UVIUIV reduction and oxo-group silylation followed by oxo-group abstraction; 2 equiv 
of [Cp2Co][OTf] and Ph3SiOSiPh3 were detected as by-products during the formation of 204 (Scheme 
42).90  
Scheme 43. Synthesis of a dipyrrin-coordinated uranyl(VI) complex, [UVIO2Cl(L')] (205).
55  
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It was recently demonstrated that the mono-anionic, tetradentate dipyrrin ligand, L' (Scheme 
43) acts as a ligand for uranyl(VI), and that treatment with either inner- or outer-sphere reductants 
leads to different, and reagent-dependent, degrees of reduction of the complex. Treatment of 
[UVIO2{N(SiMe3)2}2(THF)2] (2-THF) with HL' followed by [HPy]Cl provided [U
VIO2Cl(L')] (205; 
Scheme 43). Alternatively, 205 may be obtained by treating HL' with 0.5 equiv. of 2-THF and 0.5 
equiv. of [UVIO2Cl2(THF)2] (4-THF; Scheme 43). Complex 205 reacts with the inner-sphere 
reductant, [Cp2TiCl]2, to yield the uranium(IV) complex [U
IV(OTiClCp2)2(Cl)(L')] (206) which is the 
product of UVIUIV reduction and titanation of each of the uranyl oxo groups (Scheme 44a). 
Attempts to react 205 with 0.5 equiv. of [Cp2TiCl]2 to cleanly isolate the U
V analogue of 206, 
[UVO(OTiClCp2)(Cl)(L')] (207), were unsuccessful, as 207 slowly disproportionates into 205 and 
206 over time. 205 reacts with a sub-stoichiometric amount (0.95 equiv.) of the outer-sphere 
reductant, [CoCp2], to provide [CoCp2][U
VIO2Cl(L')] (208) which, based on EPR and NMR 
spectroscopy and X-ray crystallography, is best described as a ligand-centered radical of the 
uranyl(VI) ion (Scheme 44b). Despite CV data suggesting that [CoCp2] is reducing enough to access 
the reduced uranyl complex, [CoCp2]2[U
VO2(Cl)(L')], only the ligand-centered radical was 
observed.55  
Scheme 44. (a) UVIUIV reduction observed upon treating [UVIO2Cl(L')] (205) with the inner-sphere 
reductant, [Cp2TiCl]2, to provide [U
IV(OTiClCp2)2(Cl)(L')] (206), and (b) ligand-based reduction 
observed when treating 205 with the outer-sphere reductant, [CoCp2], to provide 
[CoCp2][U
VIO2Cl(L')] (208).
55  
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It is interesting to note that while [Cp2TiCl]2 and [CoCp2] possess similar reduction potentials, 
UVIUIV reduction is seen when 205 reacts with the former (inner-sphere) reductant whereas ligand-
based reduction is observed when 205 reacts with the latter (outer-sphere) reductant. It was 
determined by DFT calculations that in the case of the inner-sphere reductant, while the first reduction 
is ligand-based, coordination of the Lewis acidic TiIV ion to one of the uranyl oxo groups promotes 
electron transfer from the ligand to the UVI center, resulting in UVIUV reduction. The subsequent 
electron transfer and oxo group titanation step then occurs at the U center, resulting in UVUIV 
reduction.55  
When two uranyl(VI) ions are installed into the same ligand, facile reductive functionalization 
to uranium(IV) complexes is achieved using mild reducing agents such as boranes or silanes. 
[{UVIO2(py)}2(L
A)] (209), which is prepared from H4L
A and 2.5 equiv. of 2-THF (H4L
A = a Pacman-
shaped macrocyclic Schiff-base ligand with ethyl substituents on the meso-carbon atoms and an 
anthracenyl hinge linking the N4-donor pockets, Scheme 45), reacts with 2 equiv. of B2pin2 or B2cat2 
at 80 °C in pyridine to afford [(py)(pinBO)UIVOUIV(OBpin)(py)(LA)] (210) and 
[(py){cat(py)BO}UIVOUIV(OBcat)(py)(LA)] (211), respectively (Scheme 45a). While complex 210 
is isolated in 47 % yield, 211 is only generated in situ or in small quantities (ca. 10 mg) and of reduced 
purity (ca. 90 %) because it reacts with a third equiv. of B2cat2 to ultimately yield [(py)U
IVOUIV(µ-
O2C6H4)(L
A)] (212). Complex 209 also reacts with 10 equiv. of HBpin or HBcat at 125 °C in pyridine 
to afford 210 and 211/212, respectively. Alternatively, 209 reacts with excess Ph2SiH2 (15 equiv.) in 
the presence of 0.25 equiv. of MX salts (M = K, X = N(SiMe3)2 or O
tBu; M = Li, X = N(SiMe3)2) at 
125 °C in pyridine to afford the reductively silylated uranium(IV) complex 
[(py)(HPh2SiO)U
IVOUIV(OSiPh2H)(py)(L
A)] (213; Scheme 45b). Complexes 210, 211 and 213 are 
the products of UVIUIV reductive borylation or silylation, oxo-atom abstraction and fusion of the 
former uranyl(VI) ions. Initial functionalization is thought to proceed through a UV/UV intermediate 
upon B–B or Si–H bond homolysis and borylation/silylation of the exo-oxo ligands. The ultimate 
UVUIV reduction is anticipated to proceed through a second B–B or Si–H bond homolysis and 
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attack at one of the endo-oxo-groups, resulting in loss of one of the endo-oxo-ligands and formation 
of (R2B)2O/(HPh2Si)2O.
91  
Scheme 45. (a) UVIUIV reductive borylation of a bis(uranyl(VI)) complex [{UVIO2(py)}2(LA)] 
(209) through reaction with B2pin2 and B2cat2, yielding and [(py)(pinBO)U
IVOUIV(OBpin)(py)(LA)] 
(210) and [(py){cat(py)BO}UIVOUIV(OBcat)(py)(LA)] (211), and (b) UVIUIV reductive silylation 
of 209 through reaction with Ph2SiH2, providing [(py)(HPh2SiO)U
IVOUIV(OSiPh2H)(py)(L
A)] (213). 
The anthracenyl-Pacman ligand, H4L
A, is depicted at the top of the Scheme.91  
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Table 5. Structural and spectroscopic data for reductively functionalized uranium(IV) dioxo 
complexes reported since 2010 and discussed in Section 5. With respect to the tabulated IR data, sym. 
refers to the symmetric OUO stretching frequency determined by Raman spectroscopy and asym. 
refers to the asymmetric OUO stretching frequency determined by IR spectroscopy. 
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Table Footnotes: * Structure contains positional disorder. The compounds are numbered within Table 5 according to how they appear in the text, and 
any lattice solvent molecules are not included in the chemical formulae. 
 
The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X 
= oxo-functionalizing unit) determined by single crystal X-ray diffraction, and characteristic 
spectroscopic data (OUO vibrational stretching frequency) determined by FTIR or Raman 
spectroscopies for the reductively functionalized uranium(IV) dioxo complexes reported since 
2010 and discussed in Section 5 (vide supra) are provided in Table 5, and their trends are 
discussed in more detail in Section 7 (vide infra). 
 
6. UVIUIV REDUCTIVE FUNCTIONALIZATION VIA CHARACTERIZED U(V) 
INTERMEDIATES 
As discussed in Section 3, treating a uranyl(VI)-Aracnac complex (Aracnac = 
ArNC(Ph)CHC(Ph)O; Ar = 3,5-tBu2C6H3) with either 2 equiv. of Ph3SiOTf or excess Me3SiI 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
[UI2(OSiMe3)2(MesPDIMe)] (183) 2.09(1), 
2.10(1) 
1.63(1), 
1.64(1)  
172.3(4) 173.6(7), 
156.5(7) 
Unassigned 54 
[U(OSiPh3)2Cl2(OPPh3)2] (186) 2.112(5) 1.638(5) 178.9(2) 171.0(3) Unassigned 88 
[U(OSiMe3)2(SPh)2(OPPh3)2] (187) 2.113(5) 1.640(6) 174.2(3) 162.8(4) Unassigned 88 
[U(OSiMe3)2Cl2(OPPh3)2] (188) 2.127(2), 
2.104(2) 
1.620(2), 
1.639(8)  
173.56(7) 169.6(1), 
158.9(4) 
Unassigned 89 
[U(OSiMe3)2I2(OPPh3)2] (189) 2.082(6) 1.607(7) 180.0 167.4(5) Unassigned 88 
[U(OSiMe3)2(OTf)2(OPPh3)2] (190) 2.053(6), 
2.066(6) 
1.667(6), 
1.675(6) 
176.9(2) 178.1(3), 
173.9(3) 
Unassigned 88 
[U(OSiEt3)2Cl2(OPPh3)2] (192) 2.107(2), 
2.108(2) 
1.70(1), 
1.650(7), 
1.601(8), 
1.632(2) * 
174.56(9) 163.9(3), 
173.3(3), 
166.7(2), 
145.4(5) 
Unassigned 89 
[U(OSiHPh2)2Cl2(OPPh3)2] (196) 2.120(5), 
2.138(5) 
1.608(5), 
1.600(5)  
177.4(2) 174.0(3), 
174.2(3) 
Unassigned 89 
[U(OSiMe3)2(OTf)2(2,2'-bipy)2] (201) 2.12(1), 
2.16(1) 
1.62(1), 
1.61(1)  
155.5(5) 162.8(9), 
154.4(8) 
Unassigned 89 
[U(OTiClCp2)2(Cl)(L')] (206) 2.066(7), 
2.061(6) 
1.843(7), 
1.841(7) 
177.0(2) 170.9(4), 
169.1(3) 
630 (asym.) 55 
[(py)(pinBO)UOU(OBpin)(py)(LA)] (210) 
 
2.161(2), 
2.139(2), 
2.112(2), 
2.172(2) 
1.334(4), 
1.341(4)  
169.05(8), 
96.51(7) 
145.7(2), 
166.9(2) 
566 (asym.) 91 
[(py){cat(py)BO}UOU(OBcat)(py)(LA)] 
(211) 
 
2.092(2), 
2.219(2), 
2.176(2), 
2.068(2) 
1.400(5), 
1.315(5)  
170.7(1), 
99.2(1) 
158.8(3), 
171.1(3) 
580, 531 
(asym., 
tentative) 
91 
[(py)(HPh2SiO)UOU(OSiPh2H)(py)(LA)] 
(213) 
2.142(2), 
2.1486(3)  
1.623(3)  172.09(9) 146.9(2) Unassigned 91 
[(THF)(HPh2SiO)UOU(OSiPh2H)(THF)(
LA)] 
2.135(2), 
2.1425(3) 
2.160(2) 169.23(9) 154.0(2) Unassigned 91 
[U(OSiMe3)2BrI(OPPh3)2]*  2.078(3) 1.631(8), 
1.63(1)  
180.0 166.1(5), 
170.2(8) 
Unassigned 89 
[U(OSiMePh2)2Cl0.25I1.75(OPPh3)2]*  2.116(2), 
2.104(4), 
2.100(2), 
2.119(4) 
1.632(2)  176.73(8), 
172.5(1) 
168.7(1), 
163.4(1), 
157.4(1), 
153.2(1) 
Unassigned 89 
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results in UVIUV reduction and silylation of the oxo groups. Attempts have been made to 
react the same uranyl(VI) starting complex, [UVIO2(
Aracnac)2] (54), with Ph3SiH, but no 
reaction occurs until B(C6F5)3 is added to the reaction mixture, in which case 
[UV{OB(C6F5)3}(OSiPh3)(
Aracnac)2] (214; Scheme 46a) was formed. The addition of borane 
is thought to result in Ph3SiHB(C6F5)3 adduct formation, thus activating the silane and 
rendering it susceptible to nucleophilic attack by a uranyl oxo group. This hypothesis was 
verified by repeating the same reaction but with iPr3SiH, in which the sterically bulky iso-
propyl substituents are known to disfavor B(C6F5)3 coordination and activation, resulting in 
no reaction. Upon Ph3Si
+ and B(C6F5)3 coordination to the uranyl oxo ligands, U
VIUV 
reduction is facilitated by H–, resulting in the formation of H2. The CV indicated that an 
irreversible reduction feature was located at E1/2 = –0.72 (vs. Fc/Fc+), which is shifted 0.49 V 
to a more positive reduction potential relative to [Cp*2Co][U
V{OB(C6F5)3}2(
Aracnac)2] (E1/2 
= –1.21 V vs. Fc/Fc+),92 and is attributed to coordination of the more Lewis acidic Ph3Si+ 
cation to one of the uranyl(V) oxo groups. Treating 214 with CoCp2 resulted in the formation 
of [Cp2Co][U
IV{OB(C6F5)3}(OSiPh3)(
Aracnac)2] (215; Scheme 46a). The U–O bond lengths 
in 215 (U–OB = 2.056(8) Å, U–OSi = 2.173(8) Å) are elongated relative to those in 214 (U–
OB = 1.941(8) Å, U–OSi = 2.034(9) Å), as expected for [UIVO2] versus [UVO2]+, and the O–
U–O bond angles remain linear in both (175.3(3)⁰ and 174.6(3)⁰ in 215 and 214, respectively). 
Attempts were made to oxidize 215 back to 54 using either I2 or AgOTf, but were 
unsuccessful.93  
Scheme 46. (a) Monosilylation of an oxo group in [UVIO2(
Aracnac)2] (54) by treatment with 
Ph3SiH/B(C6F5)3, providing [U
V{OB(C6F5)3}(OSiPh3)(
Aracnac)2] (214), and subsequent reduction to 
afford [CoCp2][U
IV{OB(C6F5)3}(OSiPh3)(
Aracnac)2] (215). (b) Disilylation of 54 using 2 equiv. of 
Et3SiH and 1 equiv. of B(C6F5)3, providing [U
V(OSiEt3)2(
Aracnac)2][HB(C6F5)3] (216) and 
[UV{OB(C6F5)3}(OSiEt3)(
Aracnac)2] (217; minor component); 216 may be converted into 217 by 
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heating in toluene at 85 ⁰C for 24 hours. 217 reacts with CoCp2 to provide [UIV(OSiEt3)2(Aracnac)2] 
(219).93,94 
 
 Alternatively, treating 54 with 2 equiv. of Et3SiH and 1 equiv. of B(C6F5)3 results in double 
silylation of the uranyl oxo groups, providing [UV(OSiEt3)2(
Aracnac)2][HB(C6F5)3] (216) following 
UVIUV reduction. During this reaction, [UV{OB(C6F5)3}(OSiEt3)(Aracnac)2] (217) is formed as a 
minor product (216:217 = 4:1), but can be isolated on a preparative scale either by heating 54 with 
equimolar quantities of Et3SiH and B(C6F5)3, or by heating 216 to 85 ⁰C for 24 hours in toluene 
(Scheme 46b). However, several unidentified decomposition products are observed when using the 
latter method. Complex 54 also reacts with 1 equiv. of Et3SiH/B(C6F5)3 at room temperature to 
provide 216 and unreacted 54. The formation of complexes 216 and 217 indicates that a [UVO2]
+-
silylated intermediate, [UVO(OSiR3)(
Aracnac)2] (R = Et, Ph), must be formed during the reaction. 
Furthermore, the silyl cation in Et3SiHB(C6F5)3 must be more prone to nucleophilic attack by the 
silylated-uranyl(V) oxo group, and therefore reacts faster than uranylborane adduct formation 
compared to Ph3SiHB(C6F5)3, given that a doubly silylated product is isolated in the reaction 
75 
 
involving the former reactive species while only a singly silylated product is isolated in the latter 
case.94 A quasi-reversible redox couple was observed at –0.37 V (vs. Fc/Fc+) in the CV of 216, which 
is shifted 0.35 V and 0.84 V to a more positive reduction potential relative to 214 and 
[Cp*2Co][U
V{OB(C6F5)3}2(
Aracnac)2] (218), respectively, consistent with the positive charge on 216 
versus the neutral and anionic charges on 214 and 218, respectively. Complex 216 reacts with CoCp2 
to provide [UIV(OSiEt3)(
Aracnac)2] (219), which possesses U–O bond lengths (2.129(2) Å) that are 
elongated relative to 216 (2.011(4), 2.013(4) Å) and 217 (2.017(6), 1.957(6) Å), and representative 
of a [UIV(OSiR3)2]
2+ complex (Scheme 46b).92,94 
Scheme 47. Treatment of [UVIO2(
tBuacnac)2] (220) with excess Me3SiI/PPh3 provides 
[Ph3PI][U
V(OSiMe3)2I4] (221). The addition of 2 equiv. of either 4,4'-bipyridine (bipy) or 1,10-
phenanthroline (phen) to a toluene solution of 221 affords [UIV(OSiMe3)2I2(bipy)2] (222) or 
[UIV(OSiMe3)2I2(phen)2] (223), respectively, and the addition of excess THF yields 
[UIV(OSiMe3)2I(THF)4][I3] (224).
57  
 
The reductive silylation chemistry of uranyl(VI) of a β-ketoiminate ligand (i.e. acnac ligand) 
that possesses an N-bound tert-butyl substituent instead of an aryl substituent, [UVIO2(
tBuacnac)2] 
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(220; tBuacnac = tBuNC(Ph)CHC(Ph)O), has also been explored. In this case, treating 220 with excess 
Me3SiI (10 equiv.) in the presence of PPh3 affords [Ph3PI][U
V(OSiMe3)2I4] (221), in which both oxo 
groups of uranyl have been silylated, the UVI center has undergone a one-electron reduction, and both 
tBuacnac ligands have been substituted for iodo ligands and converted into their silylated analogue, 
tBuacnacSiMe3 (Scheme 47). The loss of both equivalents of 
tBuacnac ligand when treating 220 with 
excess Me3SiI compared to only one equivalent when 
Aracnac is used (see Section 3, vide supra) has 
been attributed to the extra steric bulk imparted by the tert-butyl substituents, making ligand 
abstraction more facile. The formation of 221 is thought to proceed through the UV intermediate, 
[UV(OSiMe3)2I3], which is formed via U
VIUV reduction by I– following Me3Si+ coordination to the 
uranyl oxo groups. The resulting I2 reaction by-product (0.5 equiv.) then reacts with Ph3P to provide 
[Ph3PI]I, which is trapped by the proposed U
V intermediate. Due to fact that only 0.5 equiv. of I2 is 
produced during this reaction, the maximum yield of 221 is 50 %. When 2 equiv. of either 4,4'-
bipyridine (bipy) or 1,10-phenanthroline (phen) are added to a toluene solution of 221, 
[UIV(OSiMe3)2I2(bipy)2] (222) or [U
IV(OSiMe3)2I2(phen)2] (223) are obtained, respectively (Scheme 
47). Alternatively, the addition of excess THF to a toluene solution of 221 provides 
[UIV(OSiMe3)2I(THF)4][I3] (224; Scheme 47). Compounds 222-224 are the product of U
VUIV 
reduction, which is thought to occur by I– dissociation and oxidation to I2. Complex 221 possesses 
U–O bond lengths of 1.990(6) and 1.976(8) Å and complexes 222 and 224 possess U–O bond lengths 
that range from 2.065(6)-2.084(4) Å, which are representative of UV and UIV dioxo complexes, 
respectively. Complexes 221-224 are thermally unstable in solution, decomposing slowly to provide 
(Me3Si)2O as a decomposition product.
57  
 As was highlighted in Section 3, the macrocyclic Pacman ligand, H4L
Me, or the mono(uranyl) 
Pacman complex 11-py react with 2.5 equiv. or 1.5 equiv. of [UVIO2{N(SiMe3)2}2(py)2] (2-py), 
respectively, to afford the doubly oxo-silylated bis(uranyl(V)) complex, [{UVO(OSiMe3)}2(L
Me)] 
(70). Complex 70 may be further reduced with 2 equiv. of K metal to afford 
K2[{U
IVO(OSiMe3)}2(L
Me)] (225; Scheme 48), which was characterized by 1H NMR, IR and UV/VIS 
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spectroscopies, and elemental analysis. Complex 70 may be regenerated from 225 and I2, producing 
KI as a reaction by-product. Alternatively, 225 undergoes a double desilylation reaction with 
pyridine-N-oxide to afford [K(py)3]2[K(py)]2[(U
VO2)2(L
Me)]2 (19-py) in pyridine or 
{K2[(U
VO2)2(L
Me)]}n (19-THF) in THF. Treating 19 with 2 equiv. of Cl-SiMe3 results in regeneration 
of 70 (Scheme 48). Complexes 19-py and 19-THF possess significantly more contracted U–Oexo 
bond lengths (1.851(5)-1.871(6) Å) relative to the U–Oendo bond lengths (2.077(5)-2.101(5) Å), 
indicating that they retain greater multiple bond character and display appreciable air-sensitivity 
compared with the silyl-protected 70.38   
Scheme 48. Doubly oxo-silylated [{UVO(OSiMe3)}2(L
Me)] (70), which may be obtained by treating 
H4L
Me with 2.5 equiv. of [UVIO2{N(SiMe3)2}2(py)2] (2-py), reacts with 2 equiv. of potassium to 
provide K2[{U
IVO(OSiMe3)2}2(L
Me)] (225). 225 reacts with either C5H5NO or 0.5 equiv. of O2 to 
yield [K(py)3]2[K(py)]2[(U
VO2)2(L
Me)]2 (19-py; see Section 2), and 70 may be regenerated by treating 
225 or 19 with I2 or 2 equiv. of Cl-SiMe3, respectively.
38  
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In addition to UVIUIV reduction upon treating [UVIO2Cl(L')] (205) with the inner-sphere 
reductant, [Cp2TiCl]2, as was highlighted in Section 5 (vide supra) complex 205 has been exploited 
to demonstrate the effects of axial and equatorial ligand manipulation on the reductive 
functionalization chemistry of the uranyl(VI) ion. Complex 205 reacts with 1 equiv. of KNHAr (Ar 
= 2,6-iPr2C6H3) to yield the U
V/UV dimer [UVO2(L')]2 (226; Scheme 49). The formation of 226 
presumably proceeds through the unisolated anilido complex, [UVIO2(NHAr)(L')], which then 
undergoes U–N bond homolysis. Complex 226 reacts with either 1 or 2 equiv. of B(C6F5)3 to afford 
singly or doubly oxo-functionalized [UVO{OB(C6F5)3}(L')] (227) and [U
V{OB(C6F5)3}2(L')] (228), 
respectively (Scheme 49). Complex 228 is also formed from the reaction of 205 with 2 equiv. of 
B(C6F5)3, resulting in loss of Cl
•, but this reaction does not reach completion (even with heating in 
the presence of 8 equiv. of B(C6F5)3) unless elemental mercury is added, which enables the removal 
of the Cl• by-product in the form of solid Hg2Cl2 via reduction to Cl
– (Scheme 49). Complex 205 also 
reacts with Na[B{C6H3-3,5-(CF3)2}4] to yield the cationic uranyl(VI) complex, [U
VIO2(L')][B{C6H3-
3,5-(CF3)2}4] (229), and with AgOTf to form [U
VIO2(OTf)(L')] (230).
58  
Scheme 49. UVIUV reduction of [UVIO2Cl(L')] (205) using either KNHAr (Ar = 2,6-iPr2C6H3) or 
2B(C6F5)3/Hg to provide [U
VO2(L')]2 (226) and [U
V{OB(C6F5)3}2(L')] (228), respectively. 226 also 
reacts with 1 equiv. of B(C6F5)3 to afford [U
VO{OB(C6F5)3}(L')] (227).
58  
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In this system, the sequential addition of borane to coordinate to the uranyl(V) ion shifts the 
UVUIV reduction potential step-wise from –1.14 V vs. Fc/Fc+ for 226 to –0.78 V for 227, then –
0.49 V for 228, enabling the use of very mild reducing agents to achieve UVUIV reduction. As such, 
228 is reduced by [FeCp*2] (Ered = –0.56 V vs. Fc/Fc+) to yield the anionic uranium(IV) complex 
[FeCp*2][U
IV{OB(C6F5)3}2(L')] (231), and also by H2 (Ered = –0.54 V vs. Fc/Fc+) to provide 
[UIV{OB(C6F5)3}{OB(C6F5)2}(L')] (232). In this latter case, one of the B–C bonds of one of the oxo-
coordinated B(C6F5)3 groups is cleaved, producing C6F5H as a by-product and converting the oxo-
coordinated B-ligand from a neutral borane to an anionic boroxy ligand (Scheme 50); at a bond angle 
of 162.8(1)⁰, the O–U–O group is now significantly more bent than other bis(silyloxide) complexes 
derived from uranyl reduction, indicating the loss of 'yl' character.58  
Scheme 50. UVUIV enabled by uranyl(V) oxo groupborane coordination. [UV{OB(C6F5)3}2(L')] 
(228) reacts with [FeCp*2] and H2 to afford [FeCp*2][U
IV{OB(C6F5)3}2(L')] (231) and  
[UIV{OB(C6F5)3}{OB(C6F5)2}(L')] (232), respectively.
58  
 
The reductive functionalization of uranyl(VI) may also be achieved through deployment of a 
suitable donor solvent in the absence of intricately designed and strictly equatorially coordinating 
ligands. As such, a new class of highly symmetrical, linear oxo-bridged mixed actinide/lanthanide 
complexes (Scheme 51) are accessible from uranyl reduction by low oxidation-state lanthanide and 
actinide halides.95  
Scheme 51. Reductive functionalization of [UVIO2{N(SiMe3)2}2(THF)2] (2-THF) or 
[UVIO2Cl2(THF)2] (4-THF) with Ln
II (Ln = Sm, Dy) or UIII salts in donor solvents (pyridine or 
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acetonitrile). (a) 1.25[LnIII2(THF)2] (Ln = Sm, Dy), (b) 2[Sm
III2(THF)2], (c) 2[U
IIII3(dioxane)1.5, (d) 
3DyIII2.
95 
 
The reactions between [UVIO2Cl2(THF)2] (4-THF) and 1.25 equiv. of either [Sm
III2(THF)2] 
or DyIII2 provide the mixed Ln/An complexes [{U
VO2(py)5}2(Ln
IIII4)]I (Ln = Sm (233), Dy (234)), 
which display linear, oxo-bridged units made up of a [LnIIII4]
– anion sandwiched between two 
[UVO2]
+ cations (Scheme 51a). Alternatively, 4-THF reacts with 2 equiv. of [SmIII2(THF)2] in 
acetonitrile to provide the one-dimensional coordination polymer [(UVO2I4){Sm
III(NCMe)6}]n (235; 
Scheme 51b), and with 2 equiv. of [UIIII3(diox)1.5] to yield the trimetallic U
IV/UIV/UIV complex 
[(UIVO2I4){U
IVICl(py)4}2] (236; Scheme 51c). Complex 235 is composed of alternating anionic 
[UVO2]
– and cationic SmIII units and 236 comprises a central [UIVO2]
2– dianion bridged by two [UIV]+ 
cations. While treating 4-THF with excess DyIII2 only yielded 234, treatment of 
[UVIO2{N(SiMe3)2}2(THF)2] (2-THF) with 3 equiv. of Dy
III2 provided access to 
[(UIVO2I4){Dy
IIII(py)5}2] (237), which similarly to 236, possesses an anionic [U
IVO2I4]
2– unit 
sandwiched between two DyIII cations and is the product of [UVIO2]
2+[UIVO2] reduction (Scheme 
51d).95 
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Table 6. Structural and spectroscopic data for reductively functionalized uranyl(V) and uranium(IV) 
dioxo complexes reported since 2010 and discussed in Section 6. With respect to the tabulated IR 
data, sym. refers to the symmetric OUO stretching frequency determined by Raman spectroscopy and 
asym. refers to the asymmetric OUO stretching frequency determined by IR spectroscopy. 
Table Footnotes: The compounds are numbered within Table 6 according to how they appear in the text, and any lattice solvent molecules are not 
included in the chemical formulae. 
 
The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X 
= oxo-functionalizing unit) determined by single crystal X-ray diffraction, and characteristic 
spectroscopic data (OUO vibrational stretching frequency) determined by FTIR or Raman 
spectroscopies for the reductively functionalized uranyl(V) and uranium(IV) dioxo complexes 
[UVO2]+ 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
[U{OB(C6F5)3}(OSiPh3)(Aracnac)2] (214) 1.941(8) (U–
OB), 2.034(9) 
(U–OSi) 
1.666(9) (X = 
Si), 1.52(2) 
(X = B) 
174.6(3) 173.2(5) 
(X = Si), 
170.2(7) 
(X = B) 
Unassigned 93 
[U(OSiEt3)2(Aracnac)2][HB(C6F5)3] (216)  2.011(4), 
2.013(4) 
1.678(4), 
1.684(4) 
180.0 161.5(3), 
159.4(3) 
Unassigned 94 
[U{OB(C6F5)3}(OSiEt3)(Aracnac)2] (217) 2.017(6) (U–
OSi), 
1.957(6) (U–
OB) 
1.664(7) (X = 
Si), 1.53(1) 
(X = B) 
175.0(3) 168.0(4) 
(X = Si), 
166.6(6) 
(X = B) 
Unassigned 94 
[Ph3PI][U(OSiMe3)2I4] (221) 1.976(8), 
1.990(6) 
1.688(8), 
1.674(7) 
180.0 176.9(5), 
177.8(4) 
Unassigned 57 
[UO2(L')]2 (226) 1.928(2), 
1.829(3) 
3.5351(2) 174.5(1) 109.97(9) 783 (asym.) 58 
[UO{OB(C6F5)3}(L')] (227) 1.914(7), 
1.785(7) 
1.53(1)  178.7(3) 167.4(6) 837 (asym.) 58 
[U{OB(C6F5)3}2(L')] (228) 1.922(3), 
1.917(3) 
1.578(5), 
1.554(5)  
176.4(1) 174.6(2), 
172.9(2) 
Unassigned 58 
[{UO2(py)5}2(SmI4)]I (233) 1.802(6), 
1.915(6) 
2.331(6)  177.8(3) 176.1(3) 818 (asym.) 95 
[{UO2(py)5}2(DyI4)]I (234) 1.808(5), 
1.919(5) 
2.270(5)  177.6(2) 176.9(3) 825 (asym.) 95 
[(UO2I4){Sm(NCMe)6}]n (235) 1.868(5), 
1.883(4) 
2.351(5), 
2.318(4) 
179.3(2) 179.2(3), 
169.5(3) 
722 (asym.) 95 
[UIVO2] 
Compound U–O [Å] O–X [Å] O–U–O [°] U–O–X 
[°] 
ν(OUO) 
[cm–1] 
Reference 
[CoCp2][U{OB(C6F5)3}(OSiPh3)(Aracnac)
2] (215) 
2.173(8) (U–
OSi), 
2.056(8) (U–
OB) 
1.610(9) (X = 
Si), 1.44(2) 
(X = B) 
175.3(3) 170.3(6) 
(X = Si), 
176.9(8) 
(X = B) 
Unassigned 93 
[U(OSiEt3)2(Aracnac)2] (219) 2.129(2) 1.628(2) 180.0 159.0(2) Unassigned 94 
[U(OSiMe3)2I2(bipy)2] (222) 2.084(4) 1.639(4) 115.5(2) 165.4(3) Unassigned 57 
[U(OSiMe3)2I(THF)4][I3] (224) 2.065(6), 
2.080(6) 
1.670(6), 
1.659(6) 
173.8(3) 170.0(4), 
172.8(4) 
Unassigned 57 
[Cp*2Fe][U{OB(C6F5)3}2(L')] (231) 2.030(5), 
2.022(5) 
1.51(1), 
1.475(9)  
170.6(2) 163.1(5), 
170.0(5) 
631 (asym.) 58 
[U{OB(C6F5)3}{OB(C6F5)2}(L')] (232) 2.196(4), 
1.990(3) 
1.323(6), 
1.490(6) 
162.8(1) 152.0(3), 
166.8(3) 
Unassigned 58 
[(UO2I4){UICl(py)4}2] (236) 2.166(5) 2.042(5)  180.0 173.8(3) Unassigned 95 
[(UO2I4){DyI(py)5}2] (237) 2.058(3), 
2.068(3) 
2.126(3), 
2.119(3)  
177.7(1) 170.5(2), 
173.6(2) 
Unassigned 95 
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reported since 2010 and discussed in Section 6 (vide supra) are provided in Table 6, and their 
trends are discussed in more detail in Section 7 (vide infra). 
 
 
7. STRUCTURAL AND SPECTROSCOPIC CHARACTERISTICS OF [UVIO2]2+, [UVO2]+ 
AND [UIVO2] COMPLEXES 
The structural data (U–O and O–X bond lengths, O–U–O and U–O–X bond angles; X = oxo-
functionalizing unit) determined by single crystal X-ray diffraction, and characteristic spectroscopic 
data (OUO vibrational stretching frequency) determined by FTIR or Raman spectroscopies for 
uranyl(VI) and reductively functionalized uranyl(V) and U(IV) dioxo complexes reported since 2010 
are provided in Tables 1-6. The U-O bond lengths in Tables 1-6 are also represented pictorially in 
Chart 1.  
a)  
b)  
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Chart 1 U–O bond length versus uranium oxidation state for unfunctionalized and functionalized uranyl(VI), 
uranyl(V) and uranium(IV) dioxo complexes reported in Tables 1-6. (a) mean values; (b)-(e) ranges for the 
different formal oxidation states from U(VI) to U(IV). 
 
While for the most part there is a distinct difference in U–O bond lengths depending on the oxidation 
state of the uranium center, there is some overlap amongst the bond lengths, particularly with respect to 
uranyl(V) compounds. We have found that uranyl(V) compounds that possess particularly elongated U–OR 
bonds (R = functionalizing unit of the former oxo ligand) also possess particularly short U=O bonds to the 
other oxo ligand, resulting in overlap in the ranges of U–O bond lengths of U(IV) dioxo and uranyl(VI) 
compounds, respectively. The mean U–O bond length for each uranium oxidation state is plotted below in 
Chart 2. The mean U–O bond lengths for unfunctionalized and functionalized uranyl(VI) complexes, uranyl(V) 
and U(IV) dioxo complexes are 1.777, 1.800, 1.922 and 2.108 Å, respectively. However, we recognize that 
the mean values for the different U oxidation states is only a crude measure given that the compounds bear 
significantly different equatorially coordinating ligands and oxo ligand functionalizing units. 
The U–Oyl bond lengths and asymmetric OUO stretching frequency (when observable) are 
important aids in assignment of the formal oxidation state of the uranium center. The U–Oyl bond 
lengths of uranyl(VI) complexes reported since 2010 range from 1.746(6)-1.82(1) Å for 
unfunctionalized uranyl(VI) complexes and 1.759(5)-1.885(4) Å for functionalized uranyl(VI) 
complexes. The U–Oyl bond lengths of uranyl(V) and U(IV) dioxo complexes range from 1.77(1)-
2.122(7) Å and 1.990(3)-2.219(2) Å, respectively. When one of the oxo ligands is functionalized, 
uranyl(V) complexes will tend to contain one short and one long U–Oyl bond, resulting in some 
overlap of the bond length range with the range observed for U–Oyl bond lengths in uranyl(VI) 
compounds. Furthermore, the asymmetric OUO stretching frequencies for uranyl(VI) complexes 
range from 860-964 cm–1 in the solid-state with stretching frequencies being reported as high as 973 
cm–1 in solution, whereas those for uranyl(V) and U(IV) dioxo complexes range from 704-907 cm–1 
(with one exception being [{UVO2Eu(py)2(L
Me)}2] (106), located at 564 cm
–1; see section 3) and 531-
631 cm–1, respectively. The latter range derives from only four examples in the literature, and 
tentative assignments are provided for one of those complexes. The O–U–O bond angle remains 
nearly linear for uranyl(VI) and reductively functionalized uranyl(V) and U(IV) dioxo complexes, 
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ranging from 180-161.7(5)⁰, 180-169.3(1)⁰ and 180-155.5(5)⁰ for the +6, +5 and +4 oxidation states, 
respectively; three outliers exist for the U(IV) dioxo complexes, which are 
[(py)(pinBO)UIVOUIV(OBpin)(py)(LA)] (210), [(py){cat(py)BO}UIVOUIV(OBcat)(py)(LA)] (211) 
and [UIV(OSiMe3)2I2(bipy)2] (222), which possess O–U–O angles of 96.51(7), 99.2(1) and 115.5(2)⁰, 
respectively (see Sections 5 and 6 for discussion). In addition, the O–X bond lengths and U–O–X 
bond angles are dependent on the oxo-functionalizing unit, rendering these two structural parameters 
less useful for uranium oxidation state determination. 
While Raman spectroscopy is an excellent technique to measure the symmetric OUO 
stretching frequency, many of the more complicated ligands now being used in molecular uranyl(V) 
and U(IV) dioxo complexes fluoresce or burn in the laser beam, so few data are available for isolated 
uranyl(V) complexes. Furthermore, data collection with air and moisture sensitive compounds while 
avoiding sample decomposition is difficult to achieve with these compounds. However, an outline 
for successful Raman data collection with respect to excitation wavelength and 
fluorescence/decomposition while maximizing signal intensity for the identification and relative 
abundance evaluation of uranyl(VI) species in solution was recently published.96 This method takes 
into account approximate vibrational band locations and band widths using second derivative spectral 
analysis and could perhaps be extended to uranyl(V) and U(IV) dioxo complexes. 
Authors tend to report the observed stretching frequencies obtained by IR and Raman 
spectroscopy for uranyl compounds rather than the associated calculated force constants within the 
OUO unit. We encourage the reporting of calculated force contants since this can provide additional 
information regarding the bonding within the uranyl ion.42,97,98 
8. [UVIO2]2+ PHOTOCHEMICAL REACTIVITY 
Similarly to thermal pathways, photochemical reactivity studies of the uranyl(VI) ion invoke 
uranyl(V) intermediates, and when applied to photochemical transformations, including C–H bond 
activation, the resulting [O=UV-OH]2+ motif is H-functionalized. We therefore also discuss recent 
advances in the photochemistry of the uranyl(VI) ion. 
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In a transformation key to medicinal and agrochemical industries, the first photochemical, 
uranyl-mediated fluorination of sp3 C–H bonds was recently reported.99 Combining uranyl nitrate, 
[UVIO2(NO3)2(OH2)2]·4H2O (238) and a source of electrophilic fluorine (i.e. “F+”) with a visible light 
source (λmax > 400 nm) in an optically transparent solvent (CH3CN) under an argon atmosphere, it 
was demonstrated that the uranyl ion can catalyze the fluorination of saturated, unactivated C–H 
bonds in good yields (Scheme 52). It is notable that (i) visible light is sufficient to drive the 
photocatalytic reaction, thus avoiding specialized UV sources, and (ii) catalyst turnover does not 
require dioxygen to regenerate U(VI), suggesting a greater scope of photoreactions with uranyl may 
be possible.99  
Scheme 52. C–H bond fluorination using “F+” source. R = cyclooctyl, C8H15 (yield > 95 %); R = 
cyclohexyl, C6H11 (yield = 42 %); R = cyclopentyl, C5H9 (yield = 32 %); R = tolyl, C6H5CH2 (yield 
= trace).99  
 
The reaction proceeds through H-Atom Abstraction, HAA, and while no mechanism was 
directly discussed, it is clear that conversion is influenced through choice of uranyl co-ligand; using 
a blue LED strip, the nitrate (complex 238) gives 52% conversion for the monofluorination of 
cyclooctane (i.e. fluorocyclooctane) whereas the acetate, [UO2(OAc)2]·2H2O (235), has ca. 8% 
conversion. Conversion increased to 95% with 238 using a high-intensity lamp.99 Recent studies on 
conversion rates for a series of NiIII–X HAT (hydrogen atom transfer) complexes with X = AcO– or 
NO3
– uncovered a 15× rate enhancement with X = NO3
– over AcO–, attributed to different electron 
deficiency on the O-ligand(s).100  
Following this report, the chiral uranyl salen complex, [UVIO2(HOEt)(L
salen)] (240; Lsalen = 
2,2'-((1E,1'E)-((1R,2R)-cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenol), as 
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used to probe the α-cyanation of anilines with NaCN, CH3COOH and an oxidant, and determined that 
relative to conversion with uranyl acetate (< 1%), conversion is greatly enhanced (> 80 %, in-situ; 
Scheme 53).59 Though a mechanism is proposed (HAA followed by nucleophilic cyanide attack), the 
authors did not hypothesize why conversion is higher for the salen complex. It is likely that blocking 
four of the five normal equatorial uranyl binding sites reduces the deactivation (quenching) of the 
photoexcited state *[UVIO2]
2+ through non-radiative vibrational mechanisms that would be facilitated 
by water binding and dynamic exchange.59 
Scheme 53. α-Cyanation of anilines with [UVIO2(HOEt)(Lsalen)] (240); R = H, CH3, OCH3, Cl, Br; R' 
= H, CH3.
59  
 
Exposure of an anoxic pyridine solution of 238 to sunlight generated 
[UVIO2(py)2(NO3)2]2O2·py (241) in 48% yield (based on [U]), which incorporates a bridging peroxide 
ligand, and suggests that uranyl peroxides are formed from water and not dioxygen.101 Larger uranyl-
oxo clusters were obtained on exposure of 238 to light with in the presence of C6H5COOK and 
pyridine, so forming the mixed U(V)/U(VI) cluster [UV(UVIO2)5(µ-O)5(C6H5COO)5(py)]7 (242; 
Scheme 54).60 By treating 0.5 equiv. of the preformed UVO2
+ polymer {[UVO2(py)5][KI2(py2)]}n 
(128) with C6H5COOK, the larger mixed U(IV)/U(V) U
IV
12U
V
4O24 cluster 
{[K(py)2]2[K(py)]2[U16O24(C6H5COO)24(py)2]} (243) was crystallized, along with 
{[UVIO2(C6H5COO)3][K(py)2)]}n (244; Scheme 54) and other unidentified products.
60 Functionalized 
uranyl peroxides have been suggested as precursors for nuclear fuel fabrication,102 while larger 
mixed-valence actinide oxo-clusters are postulated as relevant intermediates in environmental 
actinide speciation.60  
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Scheme 54. Reactivity of potassium benzoate to probe likely intermediates with UV (top) (244) and 
with light and UVIO2
2+ to isolate a mixed U(VI)/U(V) cluster (bottom) (242).60  
 
A practical example of how uranyl may behave in the environment is exemplified in the 
degradation of the dye Rhodamine B, RhB, which is often used as a “model” organic pollutant.103 
Recent work has shown that when supported by salen or derivatised catecholate ligands, uranyl ions 
may assist in the photodegradation of herbicidal viologen-type pollutants (Scheme 53). The 
complexes tested as photocatalysts for RhB destruction were a mixture of species, suggested to be 
geometric isomers by the authors, formed from the reaction between two asymmetric catecholamides 
and uranyl nitrate ([UO2(L
x)(solv)] (solv = THF (245) or C2H5OH (246)) and “[UO2(Lx-y)]·2H2O” 
(247)).104,105 The extent of photocatalytic decomposition of RhB in aqueous solution by 245 and 246 
over three hours is found to be 90 % and 70 % vs. 65-75% for 247, respectively, with a first-order 
rate constant for the latter measured as approximately –0.4 s–1. Both reports invoke de-ethylation of 
RhB by a *UO2
2+ electron transfer mechanism, with further oxidative degradation by superoxyl 
anions, O2
•–, peroxide radicals, or anion radicals, formed from water or dissolved O2.
106 An analogous 
mechanism is postulated in the degradation of the antibiotic tetracycline hydrochloride using [H2-
bpp][UVIO2(p-nba)3]2 (248) and [H2-bipy][(U
VIO2)4(µ3-O)2(p-nba)6] (249) (bpp = 1,3-di(4-pyridyl)-
propane, p-Hnba = p-nitrobenzoic acid, bipy = 4,4'-bipyridine) as photocatalysts with H-atom 
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abstraction from the phenol group followed by oxidative degradation by reactive oxygen species 
(ROS) occurring.107 Optimized UV-Vis spectroscopic measurements on the aqueous suspensions 
show degradation of 70 % (for 248) and 75 % (for 249) over 5 h, with rate constants of –0.2412 s–1 
and –0.291 s–1, respectively, illustrating that photoactive uranyl compounds may be viable routes to 
the sunlight-induced photodegradation of environmental organic pollutants, particularly in uranyl-
contaminated water. Indeed, uranyl carbonates, which occur naturally in many uranium-bearing ores, 
i.e. rutherfordine, [UVIO2(CO3)] (250),
108 have very recently been shown to be photoactive; the anion 
[UVIO2(CO3)3]
4– (251) photooxidizes borohydrides to boric acid.109 
A second developing application for uranyl photoreactivity is the in vitro study of 
biomolecules, for titrimetric metal detection from environmental samples, and to elucidate structure-
property relationships in bio-oligomers. Oligomeric, metal-sensing ‘DNAzymes’ (deoxyribozymes) 
are nucleotide sequences capable of metal-sensing, often possessing selectivity at the ppb level for 
metal ions. The extraction of uranium from seawater (ca. 3 ppb)110 has been proposed using 
DNAzymes, and in a proof-of-concept study secondary protein structure vital to [UVIO2]
2+ selectivity 
in a uranyl-selective DNAzyme was identified through combining controlled, [UVIO2]
2+-mediated 
photocleavage and DNA footprinting.111 Detection limits of 0.08 µg uranium per liter of seawater 
have recently been reported using a similar system.112 The synthetic utility of [UVIO2]
2+-mediated 
photocleavage for protein purification and C-terminus peptide amidation (i.e. –CONH2) has been 
demonstrated,113,114 and a HAA mechanism invoked. In accordance with pharmaceutically-relevant 
amide formation being identified as a key challenge by the American Chemical Society,115 the 
controlled cleavage of a peptide backbone with photo-activated uranyl represents a noteworthy 
alternative to traditional enzymatic or synthetic approaches. 
During the course of writing this review several new reports on uranyl photocatalysis have 
emerged.  We reported the new uranyl-phenanthroline complex [UVIO2(NO3)2(Ph2phen)] (Ph2phen = 
4,7-diphenyl-1,10-phenanthroline, 251) as a selective catalyst for the oxidation of benzylic C–H 
bonds and also C–C bond cleavage in a model of a lignin component; a large substrate scope study 
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was reported, alongside comparisons of activity with the parent nitrate complex 238 
([UVIO2(NO3)2(OH2)2]·4H2O).
116 Analogous H-atom abstraction from cyclohexane and the 
subsequent radical addition to electrophilic alkenes was also demonstrated for 238,117 while the 
oxidation of cyclohexene with [UVIO2(OPCyPh2)4][ClO4]2·2EtOH (252) to a range of products has 
been studied.118 These reactions are illustrated in Scheme 55.  
Scheme 55. Reactions of recently reported uranyl(VI) photocatalysts under visible light irradiation 
with selected hydrocarbon substrates: A) the oxidation of substrates with benzylic C-H bonds with 
238 or 251; B) formation of new C-C bonds using cyclohexane and 238; C) oxidation of cyclohexene 
using complex 252, characterized by GC-MS (R is hydrocarbyl).116-118 
 
While demonstrating further the potential scope of uranyl photocatalysts in selective C–H 
bond activation, these reports also highlight that visible light is sufficient in a variety of cases to 
access the *[UVIO2]
2+ ion. 
 
9. CONCLUSIONS AND OUTLOOK 
The decade since the first formal reductive silylation of [UVIO2]
2+ was reported40 has seen a 
rapid growth in uranyl oxo-group functionalization chemistry that now includes alumination, 
borylation, silylation, stannylation, alkylation, and metalation of the oxo groups by elements from all 
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areas of periodic table, from a proton to pertinently, the transuranic neptunium. Such functionalization 
enables not only a controlled study of uranyl-oxo interactions with environmentally-relevant cations, 
but also a fundamental exploration of the chronically underexplored actinide-oxo motif. 
Indeed, one of the academic, curiosity-driven research targets in uranyl chemistry is 
the synthesis of a cis-uranyl(VI) ion.31,62,119 We envision that a potentially more effective route 
to cis-uranyl complexes may be through reductive functionalization to U(V) or U(IV) dioxo 
complexes followed by re-oxidation; a decrease in U–O bond order upon reduction would 
enable the manipulation of the O–U–O bond angle.119 It is expected that such compounds 
could provide information on the mechanisms of yl-oxo exchange processes that occur at high 
pH,120 and could also be more susceptible to new transformative reactivity pathways.  
Ligand design has a profound effect on the reductive functionalization chemistry of the 
uranyl ion. For example, using a Pacman-shaped ligand that possesses a phenylene hinge 
between the top and bottom N4-donor pockets enables access to one electron U
VIUV 
reductive functionalization, whereas two electron UVIUIV is not observed. Alternatively, 
when a redox-active dipyrrin ligand or a Pacman ligand that possesses an anthracenyl-hinge 
and can incorporate two uranyl(VI) ions are used in uranyl chemistry, UVIUIV reductive 
functionalization is observed, as opposed to a one electron UVIUV process. While a wide 
variety of ligand designs that differ in both electron donor ability and steric properties have 
been used in uranyl chemistry to-date, a continued effort towards new ligand designs and their 
effects on the reactivity of the uranyl ion should be pursued. For example, redox-active ligands 
have only recently been used to support uranyl oxo chemistry, and so far with great effect. For 
the most part, N- and O-donor ligands have been targeted for coordination to the U center; a 
progression towards both neutral and anionic P- and S-donor ligands to stabilize lower 
oxidation state complexes, or a combination of N/O- and P/S-donor groups within the same 
ligand to stabilize both high and low oxidation states may give rise to marked changes in the 
overall reactivity of the uranyl ion. Alternatively, the use of ambiphilic ligands that possess 
both Lewis acid and base functionality appears to be unexplored territory in uranyl chemistry, 
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and may provide an avenue for expanding on the functionalization chemistry accessed through 
coordination of the uranyl ion to unsupported Lewis acids such as 
tris(pentafluorophenyl)borane.58,69,92,93,121 Finally, the DIBAL-catalyzed route to selective 
mono-Group 1-metalated uranyl ions73 could provide opportunities for other catalyzed uranyl 
functionalization reactions with d- and f-group metal cations. It could also offer a general low-
cost, one-pot route to the selective Group-1 cation metalation of d-block metal oxo complexes.  
CV experiments have provided the reduction potentials for a number of the complexes 
described, confirming that while the uranyl(VI) ion is not particularly difficult to reduce, the 
resulting products can often be difficult to isolate as kinetically inert complexes. Increased 
reporting of the reduction potentials for both UVIUV and UVUIV couples would be very useful 
for the community and would accelerate both the understanding and exploitation of these 
reduced states. 
Raman spectroscopic monitoring of the change in the symmetric OUO stretching 
frequency upon reduction of uranyl complexes should be clearer than IR spectroscopic 
methods since Raman spectra are less cluttered by ligand-derived absorptions. Modern 
spectrometers give excellent data and solution analyses are generally recommended to avoid 
excessive sample heating, so suitable containment methods will undoubtedly need further 
development.  
The utility of photochemical routes to new compounds and applications for uranyl-
containing materials is also becoming more recognized, with reports of targeted C–H bond 
photo-activation catalyzed by uranyl in organic solvents, and the use of ligand design to impart 
unique reactivity not seen in the prototypical uranyl compounds such as 
[UO2(NO3)2(OH2)2]·4H2O and [UO2(OAc)2]·2H2O in wholly- or semi-aqueous systems. 
Multidentate salen- or salen-type ligands that block equatorial uranyl coordination sites are 
excellent candidates for controlling or enhancing the photochemical reactivity of uranyl, and 
recent work demonstrates that calix[4]pyrroles may have potential for small molecule 
activation, via molecular photo-switching and activation of dioxygen.122 Through the use of 
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photochemically-robust groups, it is conceptually possible to improve both the quantum yield 
and conversion efficiency of photocatalytic reactions involving the uranyl(VI) ion. As visible 
light induced C–H bond cleavage and functionalization reactions are rapidly becoming 
commonplace in organic chemistry, further examples of uranyl-mediated, visible-light 
induced C–H bond cleavage reactions will undoubtedly be forthcoming over the next several 
years. Practically, we note also that photochemical reduction of [UVIO2(NO3)2(OH2)2]·4H2O 
to hydrated [UIVO2] has previously been examined, and while not historically considered 
viable for industrial implementation in nuclear waste remediation,123 recent applications, 
particularly environmental (uranium detection), biochemical (peptide photocleavage) and 
geologic ([UO2(CO3)3]
4– photoreactivity), continue to be explored and, we hope, applied.  
As a final point, we also note that previously almost all uranyl chemistry has been studied 
with the aim of understanding the fundamental electronic structure and reactivity of the cation, and 
its behavior in the environment. Now, as a wide variety of new oxo chemistry is developed, there 
should be opportunities for these reactions, both stoichiometric and catalytic, to inform metal oxo 
chemistry being carried out in other areas of the periodic table. 
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ABBREVIATIONS 
py = pyridine 
 
Opy = pyridine-N-oxide 
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dme = 1,2-dimethoxyethane 
 
THF = tetrahydrofuran 
 
DMSO = dimethylsulfoxide 
 
OEt2 = diethyl ether 
 
OTf = OS(O)2CF3 
 
TMEDA = Me2N(CH2)2NMe2 
 
2,2'-bipy = 2,2'-bipyridine 
 
4,4'-bipy = 4,4'-bipyridine  
 
Cp = cyclopentadienyl 
 
Cp* = 1,2,3,4,5-pentamethylcyclopentadienyl 
 
Mes/mesityl = 2,4,6-trimethylphenyl 
 
Me = methyl 
 
Et = ethyl 
 
iPr = iso-propyl 
 
tBu = tert-butyl 
 
iBu = iso-butyl 
 
Ph = phenyl 
 
DMAP = 4-(dimethylamino)pyridine 
 
[CoCp*2] = decamethylcobaltocene 
 
pin = pinacolato 
 
cat = catecholato 
 
tolyl = p-C6H4Me 
 
ferrocenyl = [Fe(η5-C5H5)(η5-C5H4)] 
 
Fc = ferrocene, [Fe(η5-C5H4)2] 
 
Fc+ = ferrocenium, [Fe(η5-C5H4)2]+ 
 
NO3
– = nitrate  
 
AcO– = acetate 
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CO3
2– = carbonate 
 
2.2.2-crypt = 2.2.2-cryptand 
 
-c- = crown, a crown ether 
 
µ- = a bridging ligand between two or more metals 
 
ε = molar absorptivity 
 
mol = moles 
 
L = litres 
 
cm = centimetres 
 
µg = micrograms 
 
mM = millimolar  
 
M = molar 
 
Å = angstroms 
 
° = degrees 
 
ppb = parts per billion 
 
N'' = N(SiMe3)2 
 
[HPy]+ = pyridinium 
 
uranyl(VI) = [UVIO2]
2+ 
 
uranyl(V) = [UVO2]
+ 
 
Oexo = Exogenous oxo atom bound to the uranyl ion  
 
Oendo = Endogenous oxo atom bound to the uranyl ion 
 
CCI = cation-cation interaction 
 
ROS = reactive oxygen species 
 
LMe = a macrocyclic “Pacman” ligand; dimethylphenylene hinge between N4-donor pockets, methyl 
substituents on meso-carbon atom of each N4-donor pocket 
 
LEt = a macrocyclic “Pacman” ligand; dimethylphenylene hinge between N4-donor pockets, ethyl 
substituents on meso-carbon atom of each N4-donor pocket 
 
LA = a macrocyclic “Pacman” ligand; anthracenylene hinge between N4-donor pockets, ethyl 
substituents on meso-carbon atom of each N4-donor pocket 
 
Lm = meso-Bis(pentafluorophenyl)dipyriamethyrin 
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L' = a mono-anionic, tetradentate dipyrrin ligand 
 
L'' = a radical anion of L' 
 
Aracnac = ArNC(Ph)CHC(Ph)O (Ar = 3,5-tBu2C6H3) 
 
tBuacnac = tBuNC(Ph)CHC(Ph)O 
 
Ar2nacnac = ArNC(Me)CHC(Me)NAr (Ar = 2,6-
iPr2C6H3) 
 
AracnacSiMe3 = ArNC(Ph)CHC(Ph)OSiMe3 (Ar = 3,5-
tBu2C6H3) 
 
NPhF = -N(C6F5)2 
 
NPhFPh = -N(C6F5)(C6H5) 
 
NPhFpy = -N(C6F5)(C5H4N) 
 
NArFPh = -N(3,5-{CF3}2-C6H3)(C6H5) 
 
DOPOq = 2,4,6,8-tetra-tert-butyl-1-oxo-1H-phenoxazin-9-olate (q = monoanionic quinone form) 
 
dippIQ = 4,6-di-tert-butyl-2-{(2,6-diisopropylphenyl)imino}quinone 
 
dippISQ = 4,6-di-tert-butyl-2-{(2,6-diisopropylphenyl)imino}semiquinone 
 
dippAP = 4,6-di-tert-butyl-2-{(2,6-diisopropylphenyl)amido}phenolate 
 
MesPDIMe = 2,6-((Mes)N=CMe)2C5H3N 
 
tBu-MesPDIMe = 2,6-((Mes)N=CMe)2-p-C(CH3)3-C5H2N 
 
HN4 = 2,11-diaza[3,3](2,6)pyridinophane 
 
MeN4 = N,N'-dimethyl-2,11-diaza[3,3](2,6)pyridinophane 
 
tmtaa = dibenzotetramethyl-tetraaz[14]annulene 
 
LtBu = 2,6-bis[1-[(2-hydroxy-3,5-di-tert-butylphenyl)imino]ethyl]pyridine 
 
Lnap = 2,6-bis[1-[(2-hydroxynaphthyl)imino]ethyl]pyridine 
 
BPPA = bis(2-picolyl)(2-oxybenzyl)amine 
 
Mesaldien = N,N'-(2-aminomethyl)diethylenebis(salicylidene-imine) 
 
H2salan-
tBu2 = N,N'-bis(2-hydroxybenzyl-3,5-di-tert-butyl)-1,2-dimethylaminomethane 
 
salen = (2--O-C6H4-CH=NCH2)2 
 
salfen = (2--O-3,5-(tBu)2-CH=N)2-(FeCp2) 
 
TPA = tris(2-pyridylmethyl)amine 
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H2dpaea = bis(pyridyl-6-methyl-2-carboxylate)-ethylamine 
 
H2salophen = N,N'-phenylene-bis(salicylideneimine) 
 
H2salophen-
tBu2 = N,N'-phenylene-bis(3,5-di-tert-butylsalicylideneimine) 
 
H2acacen = N,N'-ethylene-bis(acetylacetoneimine) 
 
BIPMH = HC(PPh2NSiMe3)2 
 
Lsalen = 2,2'-((1E,1'E)-((1R,2R)-cyclohexane-1,2-
diylbis(azanylylidene))bis(methanylylidene))diphenol 
 
KLnacnac = 2-(4-tolyl)-1,3-bis(quinolyl)malondiiminate 
 
H3trensal = 2,2',2''-tris(salicylideneimino)triethylamine 
 
SCHS = [HC(PPh2S)2]
– 
 
SCS = [C(PPh2S)2]
2– 
 
DPPFO2 = [Fe{η5-C5H4(Ph2PO)}2] 
 
dipyR = RC(C4H2NH)2 (R = tolyl, mesityl, ferrocenyl, p-C6H4OMe) 
 
MeIm = 1-methylimidazole 
 
dbm = OC(Ph)CHC(Ph)O 
 
dppmo = Ph2P(O)CH2P(O)PPh2 
 
TEMPO = (2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl 
 
bpp = 1,3-di(4-pyridyl)-propane 
 
p-Hnba = p-nitrobenzoic acid 
 
phen = 1,10-phenanthroline  
 
DIBAL = diisobutylaluminum hydride 
 
HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
 
NMR = nuclear magnetic resonance 
 
IR = infrared 
 
PFGSTE = Pulsed-Field Gradient Stimulated Echo 
 
DFT = density functional theory 
 
UV-Vis-NIR = ultra violet-visible-near infrared 
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CV = cyclic voltammetry 
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